<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T03:28:34Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6548389" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6548389</identifier>
        <datestamp>2019-06-17</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-id journal-id-type="pmc">plosone</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6548389</article-id>
              <article-id pub-id-type="pmcid">PMC6548389</article-id>
              <article-id pub-id-type="pmc-uid">6548389</article-id>
              <article-id pub-id-type="pmid">31163045</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0217273</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-19-00555</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Women's Health</subject>
                    <subj-group>
                      <subject>Maternal Health</subject>
                      <subj-group>
                        <subject>Pregnancy</subject>
                        <subj-group>
                          <subject>Pregnancy Complications</subject>
                          <subj-group>
                            <subject>Preeclampsia</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Women's Health</subject>
                    <subj-group>
                      <subject>Obstetrics and Gynecology</subject>
                      <subj-group>
                        <subject>Pregnancy</subject>
                        <subj-group>
                          <subject>Pregnancy Complications</subject>
                          <subj-group>
                            <subject>Preeclampsia</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Women's Health</subject>
                    <subj-group>
                      <subject>Maternal Health</subject>
                      <subj-group>
                        <subject>Pregnancy</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Women's Health</subject>
                    <subj-group>
                      <subject>Obstetrics and Gynecology</subject>
                      <subj-group>
                        <subject>Pregnancy</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and Analysis Methods</subject>
                  <subj-group>
                    <subject>Mathematical and Statistical Techniques</subject>
                    <subj-group>
                      <subject>Statistical Methods</subject>
                      <subj-group>
                        <subject>Forecasting</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Physical Sciences</subject>
                  <subj-group>
                    <subject>Mathematics</subject>
                    <subj-group>
                      <subject>Statistics</subject>
                      <subj-group>
                        <subject>Statistical Methods</subject>
                        <subj-group>
                          <subject>Forecasting</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Developmental Biology</subject>
                    <subj-group>
                      <subject>Embryology</subject>
                      <subj-group>
                        <subject>Placenta</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Anatomy</subject>
                    <subj-group>
                      <subject>Reproductive System</subject>
                      <subj-group>
                        <subject>Placenta</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Anatomy</subject>
                    <subj-group>
                      <subject>Reproductive System</subject>
                      <subj-group>
                        <subject>Placenta</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Endocrinology</subject>
                    <subj-group>
                      <subject>Endocrine Physiology</subject>
                      <subj-group>
                        <subject>Growth Factors</subject>
                        <subj-group>
                          <subject>Placental Growth Factor</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Endocrine Physiology</subject>
                      <subj-group>
                        <subject>Growth Factors</subject>
                        <subj-group>
                          <subject>Placental Growth Factor</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Endocrine Physiology</subject>
                      <subj-group>
                        <subject>Growth Factors</subject>
                        <subj-group>
                          <subject>Placental Growth Factor</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Proteomics</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Genetics</subject>
                    <subj-group>
                      <subject>Gene Expression</subject>
                      <subj-group>
                        <subject>Gene Regulation</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Proteomics</subject>
                      <subj-group>
                        <subject>Protein Abundance</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>The prediction of early preeclampsia: Results from a longitudinal proteomics study</article-title>
                <alt-title alt-title-type="running-head">The prediction of early preeclampsia: Results from a longitudinal proteomics study</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1712-7588</contrib-id>
                  <name>
                    <surname>Tarca</surname>
                    <given-names>Adi L.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Project administration</role>
                  <role content-type="http://credit.casrai.org/">Software</role>
                  <role content-type="http://credit.casrai.org/">Supervision</role>
                  <role content-type="http://credit.casrai.org/">Validation</role>
                  <role content-type="http://credit.casrai.org/">Visualization</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff003">
                    <sup>3</sup>
                  </xref>
                  <xref ref-type="corresp" rid="cor001">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4448-5121</contrib-id>
                  <name>
                    <surname>Romero</surname>
                    <given-names>Roberto</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Funding acquisition</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Supervision</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff004">
                    <sup>4</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff005">
                    <sup>5</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff006">
                    <sup>6</sup>
                  </xref>
                  <xref ref-type="corresp" rid="cor001">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Benshalom-Tirosh</surname>
                    <given-names>Neta</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Than</surname>
                    <given-names>Nandor Gabor</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff007">
                    <sup>7</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff008">
                    <sup>8</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff009">
                    <sup>9</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gudicha</surname>
                    <given-names>Dereje W.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Done</surname>
                    <given-names>Bogdan</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pacora</surname>
                    <given-names>Percy</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chaiworapongsa</surname>
                    <given-names>Tinnakorn</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Panaitescu</surname>
                    <given-names>Bogdan</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Tirosh</surname>
                    <given-names>Dan</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gomez-Lopez</surname>
                    <given-names>Nardhy</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff010">
                    <sup>10</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff011">
                    <sup>11</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Draghici</surname>
                    <given-names>Sorin</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Software</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hassan</surname>
                    <given-names>Sonia S.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Funding acquisition</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Project administration</role>
                  <role content-type="http://credit.casrai.org/">Supervision</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff012">
                    <sup>12</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Erez</surname>
                    <given-names>Offer</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Supervision</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff013">
                    <sup>13</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, <italic>Eunice Kennedy Shriver</italic> National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS), Bethesda, Maryland, and Detroit, Michigan, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, Michigan, United States of America</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Department of Computer Science, Wayne State University College of Engineering, Detroit, Michigan, United States of America</addr-line>
              </aff>
              <aff id="aff004">
                <label>4</label>
                <addr-line>Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan, United States of America</addr-line>
              </aff>
              <aff id="aff005">
                <label>5</label>
                <addr-line>Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, Michigan, United States of America</addr-line>
              </aff>
              <aff id="aff006">
                <label>6</label>
                <addr-line>Center for Molecular Medicine and Genetics, Wayne State University, Detroit, Michigan, United States of America</addr-line>
              </aff>
              <aff id="aff007">
                <label>7</label>
                <addr-line>Systems Biology of Reproduction Research Group, Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary</addr-line>
              </aff>
              <aff id="aff008">
                <label>8</label>
                <addr-line>First Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary</addr-line>
              </aff>
              <aff id="aff009">
                <label>9</label>
                <addr-line>Maternity Clinic, Kutvolgyi Clinical Block, Semmelweis University, Budapest, Hungary</addr-line>
              </aff>
              <aff id="aff010">
                <label>10</label>
                <addr-line>C.S. Mott Center for Human Growth and Development, Wayne State University, Detroit, Michigan, United States of America</addr-line>
              </aff>
              <aff id="aff011">
                <label>11</label>
                <addr-line>Department of Biochemistry, Microbiology, and Immunology, Wayne State University School of Medicine, Detroit, Michigan, United States of America</addr-line>
              </aff>
              <aff id="aff012">
                <label>12</label>
                <addr-line>Department of Physiology, Wayne State University School of Medicine, Detroit, Michigan, United States of America</addr-line>
              </aff>
              <aff id="aff013">
                <label>13</label>
                <addr-line>Maternity Department "D," Division of Obstetrics and Gynecology, Soroka University Medical Center, School of Medicine, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Crispi</surname>
                    <given-names>Fatima</given-names>
                  </name>
                  <role>Editor</role>
                  <xref ref-type="aff" rid="edit1"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>Universitat de Barcelona, SPAIN</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist. ALT, TC, SSH, and RR are co-authors of an invention disclosure based on results from this study. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>prbchiefstaff@med.wayne.edu</email> (RR); <email>atarca@med.wayne.edu</email> (ALT)</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>4</day>
                <month>6</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2019</year>
              </pub-date>
              <volume>14</volume>
              <issue>6</issue>
              <elocation-id>e0217273</elocation-id>
              <history>
                <date date-type="received">
                  <day>7</day>
                  <month>1</month>
                  <year>2019</year>
                </date>
                <date date-type="accepted">
                  <day>8</day>
                  <month>5</month>
                  <year>2019</year>
                </date>
              </history>
              <permissions>
                <license xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">
                  <license-p>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0217273.pdf"/>
              <abstract>
                <sec id="sec001">
                  <title>Objectives</title>
                  <p>To identify maternal plasma protein markers for early preeclampsia (delivery &lt;34 weeks of gestation) and to determine whether the prediction performance is affected by disease severity and presence of placental lesions consistent with maternal vascular malperfusion (MVM) among cases.</p>
                </sec>
                <sec id="sec002">
                  <title>Study design</title>
                  <p>This longitudinal case-control study included 90 patients with a normal pregnancy and 33 patients with early preeclampsia. Two to six maternal plasma samples were collected throughout gestation from each woman. The abundance of 1,125 proteins was measured using high-affinity aptamer-based proteomic assays, and data were modeled using linear mixed-effects models. After data transformation into multiples of the mean values for gestational age, parsimonious linear discriminant analysis risk models were fit for each gestational-age interval (8–16, 16.1–22, 22.1–28, 28.1–32 weeks). Proteomic profiles of early preeclampsia cases were also compared to those of a combined set of controls and late preeclampsia cases (n = 76) reported previously. Prediction performance was estimated via bootstrap.</p>
                </sec>
                <sec id="sec003">
                  <title>Results</title>
                  <p>We found that 1) multi-protein models at 16.1–22 weeks of gestation predicted early preeclampsia with a sensitivity of 71% at a false-positive rate (FPR) of 10%. High abundance of matrix metalloproteinase-7 and glycoprotein IIbIIIa complex were the most reliable predictors at this gestational age; 2) at 22.1–28 weeks of gestation, lower abundance of placental growth factor (PlGF) and vascular endothelial growth factor A, isoform 121 (VEGF-121), as well as elevated sialic acid binding immunoglobulin-like lectin 6 (siglec-6) and activin-A, were the best predictors of the subsequent development of early preeclampsia (81% sensitivity, FPR = 10%); 3) at 28.1–32 weeks of gestation, the sensitivity of multi-protein models was 85% (FPR = 10%) with the best predictors being activated leukocyte cell adhesion molecule, siglec-6, and VEGF-121; 4) the increase in siglec-6, activin-A, and VEGF-121 at 22.1–28 weeks of gestation differentiated women who subsequently developed early preeclampsia from those who had a normal pregnancy or developed late preeclampsia (sensitivity 77%, FPR = 10%); 5) the sensitivity of risk models was higher for early preeclampsia with placental MVM lesions than for the entire early preeclampsia group (90% versus 71% at 16.1–22 weeks; 87% versus 81% at 22.1–28 weeks; and 90% versus 85% at 28.1–32 weeks, all FPR = 10%); and 6) the sensitivity of prediction models was higher for severe early preeclampsia than for the entire early preeclampsia group (84% versus 71% at 16.1–22 weeks).</p>
                </sec>
                <sec id="sec004">
                  <title>Conclusion</title>
                  <p>We have presented herein a catalogue of proteome changes in maternal plasma proteome that precede the diagnosis of preeclampsia and can distinguish among early and late phenotypes. The sensitivity of maternal plasma protein models for early preeclampsia is higher in women with underlying vascular placental disease and in those with a severe phenotype.</p>
                </sec>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000071</institution-id>
                      <institution>National Institute of Child Health and Human Development</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>HHSN275201300006C</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4448-5121</contrib-id>
                    <name>
                      <surname>Romero</surname>
                      <given-names>Roberto</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>This research was supported, in part, by the Perinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS); and, in part, with federal funds from NICHD/NIH/DHHS under contract no. HHSN275201300006C. ALT was also supported by the Perinatal Initiative of the Wayne State University School of Medicine.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="7"/>
                <table-count count="4"/>
                <page-count count="34"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>All relevant data are included within the paper and its Supporting Information files.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>All relevant data are included within the paper and its Supporting Information files.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec005">
              <title>Introduction</title>
              <p>Preeclampsia is a major obstetrical syndrome [<xref rid="pone.0217273.ref001" ref-type="bibr">1</xref>–<xref rid="pone.0217273.ref003" ref-type="bibr">3</xref>], classified according to the time of its clinical manifestation as “early preeclampsia” if it occurs prior to 34 weeks of gestation and, otherwise, as “late preeclampsia” [<xref rid="pone.0217273.ref004" ref-type="bibr">4</xref>–<xref rid="pone.0217273.ref010" ref-type="bibr">10</xref>]. The 34-week cut-off is most commonly used [<xref rid="pone.0217273.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0217273.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0217273.ref012" ref-type="bibr">12</xref>] given the substantial decline in maternal [<xref rid="pone.0217273.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0217273.ref013" ref-type="bibr">13</xref>–<xref rid="pone.0217273.ref017" ref-type="bibr">17</xref>] and neonatal [<xref rid="pone.0217273.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0217273.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0217273.ref018" ref-type="bibr">18</xref>–<xref rid="pone.0217273.ref024" ref-type="bibr">24</xref>] morbidity compared to later gestational ages.</p>
              <p>Early preeclampsia accounts for approximately 10% of the cases [<xref rid="pone.0217273.ref008" ref-type="bibr">8</xref>], and its pathophysiology involves both maternal predisposing factors and disorders of deep placentation [<xref rid="pone.0217273.ref025" ref-type="bibr">25</xref>,<xref rid="pone.0217273.ref026" ref-type="bibr">26</xref>]. Indeed, in early preeclampsia, the frequency of placental vascular lesions consistent with maternal vascular malperfusion (MVM) is higher than in late preeclampsia [<xref rid="pone.0217273.ref027" ref-type="bibr">27</xref>–<xref rid="pone.0217273.ref030" ref-type="bibr">30</xref>], suggesting that the underlying pathological processes leading to this phenotype begin in the early stages of gestation and involve an angiogenic imbalance [<xref rid="pone.0217273.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0217273.ref031" ref-type="bibr">31</xref>–<xref rid="pone.0217273.ref037" ref-type="bibr">37</xref>]. This finding has clinical implications given that patients identified to be at risk by the end of the first trimester can benefit from treatment [<xref rid="pone.0217273.ref038" ref-type="bibr">38</xref>–<xref rid="pone.0217273.ref041" ref-type="bibr">41</xref>].</p>
              <p>Current prediction models for preeclampsia combine maternal risk factors, Doppler velocimetry of the uterine arteries, and maternal blood proteins [<xref rid="pone.0217273.ref032" ref-type="bibr">32</xref>,<xref rid="pone.0217273.ref037" ref-type="bibr">37</xref>,<xref rid="pone.0217273.ref042" ref-type="bibr">42</xref>–<xref rid="pone.0217273.ref046" ref-type="bibr">46</xref>]. Although the detection rate of these models [<xref rid="pone.0217273.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0217273.ref047" ref-type="bibr">47</xref>–<xref rid="pone.0217273.ref050" ref-type="bibr">50</xref>] for the identification of patients at risk for early/preterm preeclampsia is sufficient to enable preventive strategies [<xref rid="pone.0217273.ref040" ref-type="bibr">40</xref>], the contribution of biochemical markers in these models is limited. Moreover, Doppler velocimetry required in the current screening models [<xref rid="pone.0217273.ref047" ref-type="bibr">47</xref>,<xref rid="pone.0217273.ref051" ref-type="bibr">51</xref>–<xref rid="pone.0217273.ref057" ref-type="bibr">57</xref>] to compensate for the sub-optimal prediction by biochemical markers may not be available in all clinical settings.</p>
              <p>Therefore, we used a novel high-affinity aptamer-based proteomic platform to identify longitudinal changes in maternal plasma proteins that have the potential to improve prediction of early preeclampsia and to distinguish between the early and late phenotypes. We also investigated whether the predictive performance of protein markers is impacted by disease severity and the presence of placental lesions consistent with MVM among cases.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec006">
              <title>Materials and methods</title>
              <sec id="sec007">
                <title>Study design</title>
                <p>A nested case-control study was conducted, including patients diagnosed with early preeclampsia (cases, n = 33) and those with a normal pregnancy (controls, n = 90). Women were enrolled as participants of a longitudinal cohort study conducted at the Center for Advanced Obstetrical Care and Research of the Perinatology Research Branch, NICHD/NIH/DHHS, the Detroit Medical Center, and Wayne State University. Women with a multiple gestation, severe chronic maternal morbidity (i.e., renal insufficiency, congestive heart disease, and/or chronic respiratory insufficiency), acute maternal morbidity (i.e., asthma exacerbation requiring systemic steroids and/or active hepatitis), or fetal chromosomal abnormalities and congenital anomalies were excluded from the study.</p>
                <p>Plasma samples were collected at the time of each prenatal visit scheduled at four-week intervals from the first or early second trimester until delivery. All patients provided written informed consent prior to sample collection. The plasma proteome of each patient was profiled in two to six samples collected from each patient and included, for some of the cases, the sample collected after the diagnosis of early preeclampsia. Although data collected after diagnosis are displayed in longitudinal plots, all analyses reported herein were based only on samples collected prior to the diagnosis [median (interquartile range or IQR) of 3 (2–4) for cases and 2 (2–5) for controls].</p>
                <p>The analysis presented in this manuscript is based on data and specimens collected under the protocol entitled “Biological Markers of Disease in the Prediction of Preterm Delivery, Preeclampsia and Intra-Uterine Growth Restriction: A Longitudinal Study.” The study was approved by the Institutional Review Boards of Wayne State University (WSU IRB#110605MP2F) and NICHD/NIH/DHHS (OH97-CH-N067).</p>
              </sec>
              <sec id="sec008">
                <title>Clinical definitions</title>
                <p>Preeclampsia was defined as new-onset hypertension that developed after 20 weeks of gestation (systolic or diastolic blood pressure ≥140 mm Hg and/or ≥90 mm Hg, respectively, measured on at least two occasions, 4 hours to 1 week apart) and proteinuria (≥300 mg in a 24-hour urine collection, or two random urine specimens obtained 4 hours to 1 week apart containing ≥1+ by dipstick or one dipstick demonstrating ≥2+ protein) [<xref rid="pone.0217273.ref058" ref-type="bibr">58</xref>].</p>
                <p>Early preeclampsia was defined as preeclampsia diagnosed and delivered before 34 weeks of gestation, and late preeclampsia was defined as preeclampsia delivered at or after 34 weeks of gestation [<xref rid="pone.0217273.ref004" ref-type="bibr">4</xref>]. Severe preeclampsia was diagnosed as preeclampsia with systolic blood pressure ≥ 160 mmHg, or diastolic blood pressure ≥ 110 mmHg, platelet count &lt; 100,000 per mm<sup>3</sup>, elevated liver enzymes, renal insufficiency, pulmonary edema or cyanosis, new-onset cerebral/visual disturbances, and/or right upper quadrant or epigastric pain [<xref rid="pone.0217273.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0217273.ref059" ref-type="bibr">59</xref>].</p>
              </sec>
              <sec id="sec009">
                <title>Histologic placental examination</title>
                <p>Placentas were examined according to standardized protocols by perinatal pathologists blinded to clinical diagnoses and obstetrical outcomes, as previously described [<xref rid="pone.0217273.ref060" ref-type="bibr">60</xref>]. Placental lesions were diagnosed using criteria established by the Perinatal Section of the Society for Pediatric Pathology [<xref rid="pone.0217273.ref061" ref-type="bibr">61</xref>] and the terminology was updated to be consistent with that recommended by the Amsterdam Placental Workshop Group consensus statement [<xref rid="pone.0217273.ref062" ref-type="bibr">62</xref>]. The definitions of lesions consistent with MVM were previously described [<xref rid="pone.0217273.ref063" ref-type="bibr">63</xref>].</p>
              </sec>
              <sec id="sec010">
                <title>Proteomics analysis</title>
                <p>Maternal plasma protein abundance was determined by using the SOMAmer (Slow Off-rate Modified Aptamer) platform and reagents to profile 1,125 proteins [<xref rid="pone.0217273.ref064" ref-type="bibr">64</xref>,<xref rid="pone.0217273.ref065" ref-type="bibr">65</xref>]. Proteomics profiling services were provided by Somalogic, Inc. (Boulder, CO, USA). The plasma samples were diluted and then incubated with the respective SOMAmer mixes, and after following a suite of steps described elsewhere [<xref rid="pone.0217273.ref064" ref-type="bibr">64</xref>,<xref rid="pone.0217273.ref065" ref-type="bibr">65</xref>], the signal from the SOMAmer reagents was measured using microarrays.</p>
              </sec>
              <sec id="sec011">
                <title>Statistical analysis</title>
                <sec id="sec012">
                  <title>Demographics data analysis</title>
                  <p>Clinical characteristics of the patient population were summarized as median and IQRs for continuous variables or as percentages for categorical variables. The comparison of demographic variables between the groups was performed using the Fisher’s exact test for binary variables and the Wilcoxon rank-sum test for continuous variables.</p>
                </sec>
                <sec id="sec013">
                  <title>Proteomic data transformation</title>
                  <p>The raw protein abundance data consisted of relative fluorescence units obtained from scanning the microarrays with a laser scanner. A sample-by-sample adjustment in the overall signal within a single plate (85 samples processed per plate/run) was performed in three steps: <italic>Hybridization Control Normalization</italic>, <italic>Median Signal Normalization</italic>, and <italic>Calibration</italic>, using the manufacturer’s protocol. Outlier values (larger than 2×the 98<sup>th</sup> percentile of all samples) were set to 2×the 98<sup>th</sup> percentile of all samples (<italic>data thresholding</italic>). Protein abundance was then log<sub>2</sub> transformed to improve normality. Linear mixed-effects models with cubic splines (number of knots = 3) were used to model protein abundance in the control group as a function of gestational age using the <italic>lme4</italic> package [<xref rid="pone.0217273.ref066" ref-type="bibr">66</xref>] under the R statistical language and environment (<ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">www.r-project.org</ext-link>). Data for all samples were then expressed as multiple of the mean (MoM) values for the corresponding gestational age in the normal pregnancy group. Longitudinal protein abundance averages and confidence intervals in sub-groups (MVM vs non-MVM, and severe vs mild preeclampsia) were estimated using generalized additive mixed models implemented in the <italic>mgcv</italic> package and illustrated using <italic>ggplot2</italic> package in R.</p>
                </sec>
                <sec id="sec014">
                  <title>Development of multi-marker prediction models</title>
                  <p>To develop proteomics prediction models based on protein abundance collected in each gestational-age interval (8–16, 16.1–22, 22.1–28, 28.1–32, 32.1–36 weeks) and, at the same time, to obtain unbiased prediction performance estimates on the available dataset, we implemented advances in predictive modeling with omics data [<xref rid="pone.0217273.ref067" ref-type="bibr">67</xref>–<xref rid="pone.0217273.ref069" ref-type="bibr">69</xref>]. Log<sub>2</sub> MoM values for one protein at a time were used to fit a linear discriminant analysis (LDA) model and to compute by leave-one-out cross-validation, a classification performance measure for each protein. With leave-one-out cross-validation, data from one patient at a time is left out when fitting the LDA model, and then the fitted model is applied to the data of the subject left out. The resulting predictions were combined over all patients to calculate prediction performance. The performance measure considered was the partial area under the curve (pAUC) of the receiver operating characteristic (ROC) curve (false-positive rate [FPR] &lt;50%). Proteins that failed to reach at least a 10% change in the average MoM value between the study groups were filtered out from the analysis. Next, LDA models were fit by using increasing sets of up to five of the top proteins ranked by the pAUC. To enforce model parsimony, the inclusion of each additional protein was conditioned on the increase of 0.01 units in the pAUC statistic.</p>
                  <p>To obtain an unbiased estimate of the prediction performance of multi-marker models, we used bootstrap (200 iterations). Each iteration involved the following steps: 1) draw a random sample with the replacement of 33 cases and 90 controls to create a <italic>training set</italic> and consider all patients not selected in the bootstrap sample as a <italic>test set</italic>; 2) apply all analytical steps involved in the prediction model development described above (including the selection of predictor proteins) for each gestational-age interval using the training set; 3) apply the resulting prediction model and determine its prediction performance on data from patients in the test set. The average performance over 200 test sets was reported as a robust estimate of the prediction performance. Alternatively, instead of creating training and test partitions via bootstrap, repeated (n = 67 times) 3-fold cross-validation was used to generate 201 training and test set pairs, while keeping all other parameters of the analysis the same as described above for bootstrap.</p>
                </sec>
                <sec id="sec015">
                  <title>Differential abundance analysis</title>
                  <p>The classifier development pipeline described above identifies a parsimonious set of proteins that predict early preeclampsia, yet it will not necessarily retain all proteins showing evidence of differential abundance between groups. Therefore, a complementary analysis was performed to identify all proteins with significant differences in mean log<sub>2</sub> MoM values between the cases and controls at each gestational-age interval. Linear models with coefficient significance evaluated via moderated t-tests were applied using the <italic>limma</italic> package [<xref rid="pone.0217273.ref070" ref-type="bibr">70</xref>] of Bioconductor [<xref rid="pone.0217273.ref071" ref-type="bibr">71</xref>]. Significance was inferred based on the FDR-adjusted p-value (q-value) &lt;0.1 after adjusting for body mass index, smoking status, maternal age, and parity.</p>
                  <p>Both prediction model development and differential abundance analyses described above were also applied, including only controls and early preeclampsia cases i) with placental MVM lesions and ii) those with a severe phenotype.</p>
                </sec>
                <sec id="sec016">
                  <title>Comparison between the proteomic profiles of early and late preeclampsia</title>
                  <p>To identify protein changes specific to early onset, but not late onset, of the disease, data from the early preeclampsia (n = 33) group were compared to a combined group that included both late preeclampsia cases (N = 76) [<xref rid="pone.0217273.ref072" ref-type="bibr">72</xref>] and normal pregnancies (n = 90).</p>
                </sec>
                <sec id="sec017">
                  <title>Gene ontology and pathway analysis</title>
                  <p>Proteins were mapped to Entrez gene identifiers [<xref rid="pone.0217273.ref073" ref-type="bibr">73</xref>] based on Somalogic, Inc. annotation and, subsequently, to gene ontology [<xref rid="pone.0217273.ref074" ref-type="bibr">74</xref>]. Biological processes over-represented among the proteins that changed with early preeclampsia were identified using a Fisher’s exact test. Gene ontology terms with three or more hits and a q-value &lt; 0.1 were considered significantly enriched. Identification of signaling pathways from the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database [<xref rid="pone.0217273.ref075" ref-type="bibr">75</xref>] that were enriched in proteins with differential abundance was performed using a pathway impact analysis method previously described [<xref rid="pone.0217273.ref076" ref-type="bibr">76</xref>,<xref rid="pone.0217273.ref077" ref-type="bibr">77</xref>]. The analysis was conducted using the web-based implementation available in <italic>iPathwayGuide</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.advaitabio.com/">http://www.advaitabio.com</ext-link>). All enrichment analyses used, as reference, the set of all 1,125 proteins that were profiled on the Somalogic platform.</p>
                </sec>
              </sec>
            </sec>
            <sec sec-type="results" id="sec018">
              <title>Results</title>
              <p>In the early preeclampsia group, 33% (11/33) of the women delivered a small-for-gestational-age neonate, 73% (24/33) had placental lesions consistent with MVM and 70% (23/33) were severe cases. Cases were diagnosed from 24.6 to 33.4 weeks of gestation. Other characteristics of the study population classified by outcome and presence of placental MVM lesions are shown in <bold><xref rid="pone.0217273.t001" ref-type="table">Table 1</xref></bold>.</p>
              <table-wrap id="pone.0217273.t001" orientation="portrait" position="float">
                <object-id pub-id-type="doi">10.1371/journal.pone.0217273.t001</object-id>
                <label>Table 1</label>
                <caption>
                  <title>Demographic characteristics of the study population.</title>
                </caption>
                <alternatives>
                  <graphic id="pone.0217273.t001g" xlink:href="pone.0217273.t001"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="center" rowspan="2" colspan="1">Characteristic</th>
                        <th align="center" rowspan="2" colspan="1">Normal pregnancy (n = 90)</th>
                        <th align="center" colspan="2" rowspan="1">Early PE (n = 33)<break/>With MVM (n = 24) Without MVM (n = 9)</th>
                      </tr>
                      <tr>
                        <th align="center" rowspan="1" colspan="1">With MVM (n = 24)</th>
                        <th align="center" rowspan="1" colspan="1">With MVM (n = 24) Without MVM (n = 9)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Gestational age at enrolment (weeks)</td>
                        <td align="center" rowspan="1" colspan="1">9.1 (8.0–10.1)</td>
                        <td align="center" rowspan="1" colspan="1">10.4 (8.3–15.2) [p = 0.024]</td>
                        <td align="center" rowspan="1" colspan="1">13.1 (8.4–14.6)<break/>[p = 0.042]</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Gestational age at delivery (weeks)</td>
                        <td align="center" rowspan="1" colspan="1">39.4 (39.0–40.4)</td>
                        <td align="center" rowspan="1" colspan="1">31.2 (28.3–33.0) [p&lt;0.001]</td>
                        <td align="center" rowspan="1" colspan="1">33.4 (32.1–33.6) [p&lt;0.001]</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td>
                        <td align="center" rowspan="1" colspan="1">26.5 (22.8–33.2)</td>
                        <td align="center" rowspan="1" colspan="1">26.3 (20.5–30.6) [p = 0.27]</td>
                        <td align="center" rowspan="1" colspan="1">28.2 (22.3–32.9) [p = 0.62]</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Maternal age (years)</td>
                        <td align="center" rowspan="1" colspan="1">24 (21.0–27.8)</td>
                        <td align="center" rowspan="1" colspan="1">22 (19.0–25.5) [p = 0.05]</td>
                        <td align="center" rowspan="1" colspan="1">24 (22.0–30.0) [p = 0.88]</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Smoking status</td>
                        <td align="center" rowspan="1" colspan="1">18 (20%)</td>
                        <td align="center" rowspan="1" colspan="1">5 (20.83%) [p = 1]</td>
                        <td align="center" rowspan="1" colspan="1">5 (55.56%) [p = 0.03]</td>
                      </tr>
                      <tr>
                        <td align="center" rowspan="1" colspan="1">Nulliparity</td>
                        <td align="center" rowspan="1" colspan="1">26 (28.9%)</td>
                        <td align="center" rowspan="1" colspan="1">15 (62.5%) [p = 0.004]</td>
                        <td align="center" rowspan="1" colspan="1">1 (11.11%) [p = 0.44]</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="t001fn001">
                    <p>Data are presented as median (interquartile range) or number (percentage); P-values are given for the comparison to the normal pregnancy group. Early PE: early preeclampsia; MVM: maternal vascular malperfusion.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <sec id="sec019">
                <title>Proteomic prediction models for early preeclampsia by gestational age at blood draw</title>
                <p>The prediction performance indices of the multi-marker models involving up to five proteins were estimated by bootstrap and are illustrated in <bold><xref ref-type="fig" rid="pone.0217273.g001">Fig 1</xref></bold>and <bold><xref rid="pone.0217273.t002" ref-type="table">Table 2</xref></bold>. <bold><xref ref-type="fig" rid="pone.0217273.g001">Fig 1</xref></bold>presents the sensitivity (10% FPR) of multi-marker models for early preeclampsia at each gestational-age interval.</p>
                <fig id="pone.0217273.g001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0217273.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <title>Sensitivity for early preeclampsia using multi-protein markers.</title>
                    <p>Sensitivity (y-axis) at a 10% FPR are shown by gestational-age interval (x-axis) for early preeclampsia (PE), early PE with placental lesions consistent with MVM, and severe early PE. The vertical bars represent the average (with 95% confidence intervals) of sensitivity obtained from 200 bootstrap iterations. Early PE: early preeclampsia; FPR: false-positive rate; MVM: maternal vascular malperfusion.</p>
                  </caption>
                  <graphic xlink:href="pone.0217273.g001"/>
                </fig>
                <table-wrap id="pone.0217273.t002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0217273.t002</object-id>
                  <label>Table 2</label>
                  <caption>
                    <title>Summary of bootstrap results for prediction of early preeclampsia vs normal pregnancy.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0217273.t002g" xlink:href="pone.0217273.t002"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Outcome</th>
                          <th align="left" rowspan="1" colspan="1">Sample GA</th>
                          <th align="center" rowspan="1" colspan="1">AUC</th>
                          <th align="center" rowspan="1" colspan="1">Sensitivity</th>
                          <th align="center" rowspan="1" colspan="1">Specificity</th>
                          <th align="left" rowspan="1" colspan="1">Predictor Symbols (% inclusion in best combination)</th>
                        </tr>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"> </th>
                          <th align="left" rowspan="1" colspan="1">(weeks)</th>
                          <th align="left" rowspan="1" colspan="1"> </th>
                          <th align="left" rowspan="1" colspan="1"> </th>
                          <th align="left" rowspan="1" colspan="1"> </th>
                          <th align="left" rowspan="1" colspan="1"> </th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">8–16</td>
                          <td align="center" rowspan="1" colspan="1">0.64</td>
                          <td align="center" rowspan="1" colspan="1">0.31</td>
                          <td align="center" rowspan="1" colspan="1">0.90</td>
                          <td align="left" rowspan="1" colspan="1">MMP-7(42%), gpIIbIIIa(23%), HMG-1(10%), vWF(10%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">All</td>
                          <td align="left" rowspan="1" colspan="1">16.1–22</td>
                          <td align="center" rowspan="1" colspan="1">0.88</td>
                          <td align="center" rowspan="1" colspan="1">0.71</td>
                          <td align="center" rowspan="1" colspan="1">0.90</td>
                          <td align="left" rowspan="1" colspan="1">MMP-7(90%), gpIIbIIIa(18%), Soggy-1(10%),</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Early PE</td>
                          <td align="left" rowspan="1" colspan="1">22.1–28</td>
                          <td align="center" rowspan="1" colspan="1">0.90</td>
                          <td align="center" rowspan="1" colspan="1">0.81</td>
                          <td align="center" rowspan="1" colspan="1">0.90</td>
                          <td align="left" rowspan="1" colspan="1">Siglec-6(58%), PlGF(52%), Activin A(25%), VEGF121(18%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">28.1–32</td>
                          <td align="center" rowspan="1" colspan="1">0.94</td>
                          <td align="center" rowspan="1" colspan="1">0.85</td>
                          <td align="center" rowspan="1" colspan="1">0.90</td>
                          <td align="left" rowspan="1" colspan="1">ALCAM(38%), VEGF121(32%), Siglec-6(32%)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"> </td>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">8–16</td>
                          <td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">0.63</td>
                          <td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">0.32</td>
                          <td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">0.90</td>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">MMP-7(33%), gpIIbIIIa(26%), ACE2(18%)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Early PE</td>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">16.1–22</td>
                          <td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">0.96</td>
                          <td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">0.90</td>
                          <td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">0.90</td>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">MMP-7(99%),</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">MVM</td>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">22.1–28</td>
                          <td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">0.95</td>
                          <td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">0.87</td>
                          <td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">0.92</td>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Siglec-6(76%), PlGF(21%), Activin A(14%)</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"> </td>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">28.1–32</td>
                          <td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">0.95</td>
                          <td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">0.90</td>
                          <td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">0.90</td>
                          <td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Siglec-6(63%), VEGF121(33%), ALCAM(10%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">8–16</td>
                          <td align="center" rowspan="1" colspan="1">0.67</td>
                          <td align="center" rowspan="1" colspan="1">0.35</td>
                          <td align="center" rowspan="1" colspan="1">0.90</td>
                          <td align="left" rowspan="1" colspan="1">MMP-7(44%); gpIIbIIIa(17%); Glutathione S-transferase Pi(12%); SMAC(10%); C4b(10%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Early PE</td>
                          <td align="left" rowspan="1" colspan="1">16.1–22</td>
                          <td align="center" rowspan="1" colspan="1">0.94</td>
                          <td align="center" rowspan="1" colspan="1">0.84</td>
                          <td align="center" rowspan="1" colspan="1">0.90</td>
                          <td align="left" rowspan="1" colspan="1">MMP-7(97%); gpIIbIIIa(14%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Severe</td>
                          <td align="left" rowspan="1" colspan="1">22.1–28</td>
                          <td align="center" rowspan="1" colspan="1">0.89</td>
                          <td align="center" rowspan="1" colspan="1">0.81</td>
                          <td align="center" rowspan="1" colspan="1">0.91</td>
                          <td align="left" rowspan="1" colspan="1">Siglec-6(68%); PlGF(34%); VEGF121(24%); Activin A(14%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">28.1–32</td>
                          <td align="center" rowspan="1" colspan="1">0.95</td>
                          <td align="center" rowspan="1" colspan="1">0.88</td>
                          <td align="center" rowspan="1" colspan="1">0.90</td>
                          <td align="left" rowspan="1" colspan="1">Siglec-6(52%); VEGF121(26%); ALCAM(22%)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t002fn001">
                      <p>The number in parentheses following the name of each protein (column Predictor Symbols) represents the percentage of bootstrap iterations in which the protein was selected in the best model. Only proteins selected in 10% or more of the 200 bootstrap iterations are listed. ACE2: angiotensin converting enzyme 2; ALCAM: activated leukocyte cell adhesion molecule; AUC: area under the receiver operating characteristic curve; GA: gestational age; gpIIbIIIa: glycoprotein IIb/IIIa; HMG-1: high-mobility group protein 1; MMP: matrix metalloproteinase; early PE: early preeclampsia; MVM: maternal vascular malperfusion; PE: preeclampsia; PlGF: placental growth factor; Siglec-6: sialic acid binding immunoglobulin-like lectin; VEGF121: vascular endothelial growth factor A, isoform 121; vWF: von Willebrand factor; SMAC: Diablo homolog, mitochondrial; C4b: Complement C4b.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>At 8–16 weeks of gestation, multi-marker proteomics models predicted early preeclampsia with 31% sensitivity (FPR = 10%), which was higher than that of PlGF alone (17%). The importance of individual proteins in the prediction models was evaluated by the percentage of the 200 bootstrap iterations in which they were included in the best LDA prediction model. Matrix metalloproteinase 7 (MMP-7) and glycoprotein IIbIIIa (gpIIbIIIa) were chosen in the best model in 42% and 23% of the iterations, respectively, while high-mobility group protein 1 (HMG-1) and von Willebrand factor were selected in 10% of the iterations (<bold><xref rid="pone.0217273.t002" ref-type="table">Table 2</xref></bold>). Individual patient longitudinal profiles of MMP-7 and gpIIbIIIa protein abundance are presented in <bold><xref ref-type="fig" rid="pone.0217273.g002">Fig 2A and 2B</xref></bold>, respectively.</p>
                <fig id="pone.0217273.g002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0217273.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>Longitudinal maternal plasma abundance of MMP-7 and gpIIbIIIA in normal pregnancy and early preeclampsia.</title>
                    <p>Each line corresponds to a single patient (grey = normal pregnancy, red = early preeclampsia). Individual dots represent samples at 8–16 weeks (<bold>A, B</bold>) and 16.1–22 weeks (<bold>C, D</bold>) of gestation. Samples taken at the time of diagnosis with early preeclampsia are marked with an “x” and were not included in the analysis but only displayed. The thick black line represents the mean value in normal pregnancy. AUC: area under the receiver operating characteristic curve of the protein using data in the current interval; early PE: early preeclampsia; FC: fold change; gpIIbIIIa: glycoprotein IIb/IIIa; MMP-7: matrix metalloproteinase 7; MoM: multiples of the mean; p: the nominal significance p-value comparing mean MoM values between groups with a moderated t-test. Log<sub>2</sub>FC is the log (base 2) of the fold change between the cases and control groups, with negative values denoting lower MoM values in cases than in controls.</p>
                  </caption>
                  <graphic xlink:href="pone.0217273.g002"/>
                </fig>
                <p>At 16.1–22 weeks of gestation, multi-marker prediction models identified women at risk to develop early preeclampsia with a sensitivity of 71% (FPR = 10%) which was again higher than the estimate for PlGF alone (18%). MMP-7, gpIIbIIIa, and Soggy-1 were selected in the best model 90%, 18%, and 10% of the time, respectively. The longitudinal profiles of MMP-7 and gpIIbIIIa, emphasizing the differences in the samples taken between 16.1 to 22 weeks of gestation, are presented in <bold><xref ref-type="fig" rid="pone.0217273.g002">Fig 2C and 2D</xref></bold>.</p>
                <p>At 22.1–28 weeks of gestation, the proteins most often selected in the best risk model for early preeclampsia out of 200 bootstrap iterations were sialic acid binding immunoglobulin-like lectin 6 (siglec-6) (58%), PlGF (52%), activin-A (25%), and VEGF121 (18%). Longitudinal profiles of these four proteins emphasizing the differences in the samples taken between 22.1 and 28 weeks of gestation are shown in <bold><xref ref-type="fig" rid="pone.0217273.g003">Fig 3</xref></bold>.</p>
                <fig id="pone.0217273.g003" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0217273.g003</object-id>
                  <label>Fig 3</label>
                  <caption>
                    <p><bold>Longitudinal maternal plasma abundance of siglec−6 (A), PlGF (B), VEGF121 (C), and activin-A (D) in normal pregnancy and early preeclampsia cases, highlighting differences at 22.1–28 weeks.</bold> AUC: area under the receiver operating characteristic curve; early PE: early preeclampsia; FC: fold change; PlGF: placental growth factor; Siglec-6: sialic acid binding immunoglobulin-like lectin; VEGF121: vascular endothelial growth factor A, isoform 121.</p>
                  </caption>
                  <graphic xlink:href="pone.0217273.g003"/>
                </fig>
                <p>At 28.1–32 weeks of gestation, the bootstrap-estimated sensitivity of multi-marker risk models was 85% (FPR = 10%), with activated leukocyte cell-adhesion molecule (ALCAM), siglec-6, and VEGF121 being the most frequently selected markers (38%, 32%, and 32% of the bootstrap iterations, respectively). The longitudinal profiles of ALCAM are depicted in <bold><xref ref-type="fig" rid="pone.0217273.g004">Fig 4</xref></bold>.</p>
                <fig id="pone.0217273.g004" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0217273.g004</object-id>
                  <label>Fig 4</label>
                  <caption>
                    <title>Longitudinal maternal plasma ALCAM abundance in normal pregnancy and early preeclampsia cases, highlighting differences at 28.1–32 weeks.</title>
                    <p>ALCAM: activated leukocyte cell adhesion molecule; AUC: area under the receiver operating characteristic curve; early PE: early preeclampsia; FC: fold change; MVM: maternal vascular malperfusion.</p>
                  </caption>
                  <graphic xlink:href="pone.0217273.g004"/>
                </fig>
                <p>Of note, prediction performance estimates for early preeclampsia were slightly higher when estimated by repeated cross-validation (<bold><xref ref-type="supplementary-material" rid="pone.0217273.s001">S1 Table</xref></bold>) than by bootstrap (<bold><xref rid="pone.0217273.t002" ref-type="table">Table 2</xref></bold>), yet the variance of the estimates with the former method was somewhat higher (data not shown). The most predictive proteins retained in the prediction models were similar between the two approaches (see <bold>Tables <xref rid="pone.0217273.t002" ref-type="table">2</xref></bold>and <bold><xref ref-type="supplementary-material" rid="pone.0217273.s001">S1</xref></bold>).</p>
              </sec>
              <sec id="sec020">
                <title>Prediction of early preeclampsia according to the presence of placental lesions consistent with maternal vascular malperfusion</title>
                <p>To determine whether the sub-classification of early preeclampsia cases by placental lesions can lead to different protein markers and/or better prediction performance, a secondary analysis was performed that included the control group and only cases with placental lesions consistent with MVM. Bootstrap-based sensitivity estimates (at a fixed FPR of 10%) were higher for cases with MVM compared to those for the overall early preeclampsia group (16.1–22 weeks: 90% versus 71%; 22.1–28 weeks: 87% versus 81%; and 28.1–32 weeks: 90% versus 85%) (see bars in <bold><xref ref-type="fig" rid="pone.0217273.g001">Fig 1</xref></bold>and <bold><xref rid="pone.0217273.t002" ref-type="table">Table 2</xref></bold>).</p>
                <p>In addition to a higher sensitivity for cases with placental MVM lesions compared to the overall early preeclampsia group, differences in the sets of best predictors also emerged at particular intervals of gestation (<bold><xref rid="pone.0217273.t002" ref-type="table">Table 2</xref></bold>). For example, angiotensin-converting enzyme 2 (ACE2) at 8–16 weeks (see raw data in <bold><xref ref-type="fig" rid="pone.0217273.g005">Fig 5</xref></bold>) and siglec-6 at 22.1–32 weeks of gestation were more frequently selected as the best markers for early preeclampsia with MVM lesions than for overall early preeclampsia (see <bold><xref rid="pone.0217273.t002" ref-type="table">Table 2</xref></bold>).</p>
                <fig id="pone.0217273.g005" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0217273.g005</object-id>
                  <label>Fig 5</label>
                  <caption>
                    <title>Longitudinal maternal plasma ACE2 abundance in normal pregnancy and early preeclampsia cases, highlighting differences at 8–16 weeks of gestation.</title>
                    <p>See <xref ref-type="fig" rid="pone.0217273.g002">Fig 2</xref> legend for more details. ACE2: angiotensin-converting enzyme 2; AUC: area under the receiver operating characteristic curve; early PE: early preeclampsia; FC: fold change; MVM: maternal vascular malperfusion.</p>
                  </caption>
                  <graphic xlink:href="pone.0217273.g005"/>
                </fig>
              </sec>
              <sec id="sec021">
                <title>Prediction of early preeclampsia according to disease severity</title>
                <p>When only severe early preeclampsia cases were included in the analysis and compared to normal pregnancy cases, the sensitivity of analysis (10% FPR) was significantly higher than for overall early preeclampsia (90% vs 71%) in the 16.1–22 week interval. At this gestational-age interval, but unlike early preeclampsia with MVM that was predicted mostly by an increase in MMP-7, the prediction for severe early preeclampsia also involved the increase in gpIIbIIIa for 14% of the models trained on bootstrap samples of the original dataset. Other differences in the set of best predictors for severe early preeclampsia compared to overall early preeclampsia were noted in the 8–16 weeks gestational-age interval (see <bold><xref rid="pone.0217273.t002" ref-type="table">Table 2</xref></bold>).</p>
              </sec>
              <sec id="sec022">
                <title>Proteomic markers that differentiate between early and late preeclampsia</title>
                <p>Discrimination between early preeclampsia and both normal pregnancy and late preeclampsia was rather low in the 8-16-week and 16.1-22-week intervals (21% and 31% sensitivity, respectively, FPR = 10%) and involved different sets of proteins than those found when the comparison was only against the normal pregnancy group (<bold><xref rid="pone.0217273.t003" ref-type="table">Table 3</xref></bold>). However, later in gestation, the sensitivity of multi-marker models to discriminate between early preeclampsia and both the controls and late preeclampsia increased to 77% and 82% at 16.1-22-week and 22.1-28-week intervals, respectively (FPR = 10%).</p>
                <p>Of note, discriminating early preeclampsia from both normal pregnancy and late preeclampsia cases involved more stringent cut-offs for the same proteins (see <bold><xref ref-type="fig" rid="pone.0217273.g006">Fig 6</xref></bold>) and also new proteins such as ficolin 2 (FCN2) (see <bold><xref rid="pone.0217273.t003" ref-type="table">Table 3</xref></bold>).</p>
                <fig id="pone.0217273.g006" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0217273.g006</object-id>
                  <label>Fig 6</label>
                  <caption>
                    <p><bold>Longitudinal maternal plasma abundance of siglec-6 (A) and activin-A (B) in normal pregnancy and early preeclampsia, highlighting differences at 22.1–28 weeks.</bold> Blue dots correspond to samples taken from late preeclampsia cases. AUC: area under the receiver operating characteristic curve; early PE: early preeclampsia; FC: fold change; late PE: late preeclampsia; Siglec-6: sialic acid binding immunoglobulin-like lectin.</p>
                  </caption>
                  <graphic xlink:href="pone.0217273.g006"/>
                </fig>
                <table-wrap id="pone.0217273.t003" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0217273.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>Summary of bootstrap results for prediction of early preeclampsia versus normal pregnancy and late preeclampsia.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0217273.t003g" xlink:href="pone.0217273.t003"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" rowspan="1" colspan="1">Outcome</th>
                          <th align="center" rowspan="1" colspan="1">Sample GA (weeks)</th>
                          <th align="center" rowspan="1" colspan="1">AUC</th>
                          <th align="center" rowspan="1" colspan="1">Sensitivity</th>
                          <th align="center" rowspan="1" colspan="1">Specificity</th>
                          <th align="center" rowspan="1" colspan="1">Predictor Symbols (% inclusion in best combination)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">Early PE</td>
                          <td align="center" rowspan="1" colspan="1">8–16</td>
                          <td align="center" rowspan="1" colspan="1">0.55</td>
                          <td align="center" rowspan="1" colspan="1">0.21</td>
                          <td align="center" rowspan="1" colspan="1">0.90</td>
                          <td align="center" rowspan="1" colspan="1">gpIIbIIIa(34%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">Early PE</td>
                          <td align="center" rowspan="1" colspan="1">16.1–22</td>
                          <td align="center" rowspan="1" colspan="1">0.65</td>
                          <td align="center" rowspan="1" colspan="1">0.31</td>
                          <td align="center" rowspan="1" colspan="1">0.90</td>
                          <td align="center" rowspan="1" colspan="1">Soggy-1(26%); IMDH2(20%); Siglec-6(14%); PKC-D(12%); MMP-12(10%); RBP(10%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">Early PE</td>
                          <td align="center" rowspan="1" colspan="1">22.1–28</td>
                          <td align="center" rowspan="1" colspan="1">0.89</td>
                          <td align="center" rowspan="1" colspan="1">0.77</td>
                          <td align="center" rowspan="1" colspan="1">0.90</td>
                          <td align="center" rowspan="1" colspan="1">Siglec-6(72%); Activin A(63%); VEGF121(34%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">Early PE</td>
                          <td align="center" rowspan="1" colspan="1">28.1–32</td>
                          <td align="center" rowspan="1" colspan="1">0.93</td>
                          <td align="center" rowspan="1" colspan="1">0.82</td>
                          <td align="center" rowspan="1" colspan="1">0.90</td>
                          <td align="center" rowspan="1" colspan="1">Siglec-6(72%); ALCAM(15%); FCN2(14%); VEGF121(12%)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t003fn001">
                      <p>ALCAM: activated leukocyte cell adhesion molecule; AUC: area under the receiver operating characteristic curve; early PE: early preeclampsia; <italic>FCN2</italic>: ficolin 2; GA: gestational age; gpIIbIIIa: glycoprotein IIb/IIIa; IMDH2: inosine-5'-monophosphate dehydrogenase (IMDH2); MMP: matrix metalloproteinase; PKC-D: protein kinase C delta type; RBP: retinol binding protein; Siglec-6: sialic acid binding immunoglobulin-like lectin; VEGF121: vascular endothelial growth factor A, isoform 121. Only proteins selected in 10% or more of the 200 bootstrap iterations are listed.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="sec023">
                <title>Differential protein abundance summary</title>
                <p>In addition to the proteins included in the parsimonious models predictive of early preeclampsia at different gestational-age intervals (<bold><xref rid="pone.0217273.t002" ref-type="table">Table 2</xref></bold>), other proteins (total, n = 175) had a significant differential abundance (after adjustment for body mass index, smoking status, maternal age, and parity) in at least one gestational-age interval (q-value &lt; 0.1).</p>
                <p><bold><xref ref-type="supplementary-material" rid="pone.0217273.s002">S2 Table</xref></bold> presents the linear fold changes of MoM values between the early preeclampsia and normal pregnancy groups as well as the nominal and FDR-adjusted p-values (q-values) for each gestational-age interval. Additionally, the heatmap presented in <bold><xref ref-type="fig" rid="pone.0217273.g007">Fig 7</xref></bold>summarizes the differential abundance patterns across all gestational-age intervals included in this study. There were 2, 37, 20, and 153 proteins associated with early preeclampsia at 8–16, 16.1–22, 22.1–28, and 28.1–32 weeks of gestation, respectively.</p>
                <fig id="pone.0217273.g007" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0217273.g007</object-id>
                  <label>Fig 7</label>
                  <caption>
                    <title>A summary of differential protein abundance between early preeclampsia and normal pregnancy throughout gestation.</title>
                    <p>The values shown using a color scheme represent the log<sub>2</sub> fold change in MoM values between the cases and controls (green = lower, red = higher mean MoM in cases versus controls). Fold changes &gt;1.5 (absolute log<sub>2</sub> fold change &gt;0.58) were reset to 1.5 to enhance visualization of the data.</p>
                  </caption>
                  <graphic xlink:href="pone.0217273.g007"/>
                </fig>
                <p>MMP-7 was elevated in three of the four gestational-age intervals. IL-1 R4 (interleukin-1 receptor-like 1), siglec-6, and activin-A were elevated while FCN2, MMP-12, VEGF121, and PlGF were lower in all three intervals from 16.1 weeks of gestation onward. Differential abundance analyses were also summarized for early preeclampsia with MVM (<bold><xref ref-type="supplementary-material" rid="pone.0217273.s003">S3 Table</xref></bold> and <bold><xref ref-type="supplementary-material" rid="pone.0217273.s006">S1 Fig</xref></bold>), as well as for severe early preeclampsia (<bold><xref ref-type="supplementary-material" rid="pone.0217273.s004">S4 Table</xref></bold> and <bold><xref ref-type="supplementary-material" rid="pone.0217273.s006">S1 Fig</xref></bold>) compared to normal pregnancy.</p>
              </sec>
              <sec id="sec024">
                <title>Biological processes and pathways perturbed in early preeclampsia during gestation</title>
                <p>Gene ontology analysis of the proteins that changed significantly between patients with a normal pregnancy and those with early preeclampsia was performed for each gestational-age interval. At 16.1–22 weeks of gestation, there were 6; at 22.1–28 weeks, there were 7; and at 28.1–32 weeks, there were 30 biological processes significantly associated with early preeclampsia (<bold><xref rid="pone.0217273.t004" ref-type="table">Table 4</xref></bold>). Biological processes associated with protein changes in at least one gestational age interval included <italic>cell adhesion</italic>, <italic>response to hypoxia</italic>, <italic>positive regulation of endothelial cell proliferation</italic>, <italic>extracellular matrix disassembly</italic>, and <italic>vascular endothelial growth factor receptor signaling pathway</italic> (all: q &lt; 0.1) (<bold><xref rid="pone.0217273.t004" ref-type="table">Table 4</xref></bold>).</p>
                <table-wrap id="pone.0217273.t004" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0217273.t004</object-id>
                  <label>Table 4</label>
                  <caption>
                    <title>Biological processes enriched in proteins with a differential abundance between early preeclampsia and normal pregnancy.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0217273.t004g" xlink:href="pone.0217273.t004"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Interval</th>
                          <th align="left" rowspan="1" colspan="1">Name</th>
                          <th align="left" rowspan="1" colspan="1">N</th>
                          <th align="left" rowspan="1" colspan="1">OR</th>
                          <th align="left" rowspan="1" colspan="1">p</th>
                          <th align="left" rowspan="1" colspan="1">q</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">xenobiotic metabolic process</td>
                          <td align="right" rowspan="1" colspan="1">3</td>
                          <td align="right" rowspan="1" colspan="1">47.1</td>
                          <td align="right" rowspan="1" colspan="1">0.000</td>
                          <td align="right" rowspan="1" colspan="1">0.008</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">negative chemotaxis</td>
                          <td align="right" rowspan="1" colspan="1">3</td>
                          <td align="right" rowspan="1" colspan="1">31.5</td>
                          <td align="right" rowspan="1" colspan="1">0.001</td>
                          <td align="right" rowspan="1" colspan="1">0.008</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>16.1–22</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">small molecule metabolic process</td>
                          <td align="right" rowspan="1" colspan="1">10</td>
                          <td align="right" rowspan="1" colspan="1">3.1</td>
                          <td align="right" rowspan="1" colspan="1">0.006</td>
                          <td align="right" rowspan="1" colspan="1">0.0485</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>weeks</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">regulation of transcription from RNA polymerase II promoter</td>
                          <td align="right" rowspan="1" colspan="1">3</td>
                          <td align="right" rowspan="1" colspan="1">9.5</td>
                          <td align="right" rowspan="1" colspan="1">0.007</td>
                          <td align="right" rowspan="1" colspan="1">0.0485</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">integrin-mediated signaling pathway</td>
                          <td align="right" rowspan="1" colspan="1">3</td>
                          <td align="right" rowspan="1" colspan="1">7.3</td>
                          <td align="right" rowspan="1" colspan="1">0.014</td>
                          <td align="right" rowspan="1" colspan="1">0.071</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">extracellular matrix disassembly</td>
                          <td align="right" rowspan="1" colspan="1">5</td>
                          <td align="right" rowspan="1" colspan="1">3.7</td>
                          <td align="right" rowspan="1" colspan="1">0.019</td>
                          <td align="right" rowspan="1" colspan="1">0.0838</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">positive regulation of endothelial cell proliferation</td>
                          <td align="right" rowspan="1" colspan="1">4</td>
                          <td align="right" rowspan="1" colspan="1">11.7</td>
                          <td align="right" rowspan="1" colspan="1">0.001</td>
                          <td align="right" rowspan="1" colspan="1">0.0128</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">cellular calcium ion homeostasis</td>
                          <td align="right" rowspan="1" colspan="1">3</td>
                          <td align="right" rowspan="1" colspan="1">7.0</td>
                          <td align="right" rowspan="1" colspan="1">0.014</td>
                          <td align="right" rowspan="1" colspan="1">0.0866</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">response to hypoxia</td>
                          <td align="right" rowspan="1" colspan="1">3</td>
                          <td align="right" rowspan="1" colspan="1">5.1</td>
                          <td align="right" rowspan="1" colspan="1">0.031</td>
                          <td align="right" rowspan="1" colspan="1">0.0866</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>22.1–28</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">cell adhesion</td>
                          <td align="right" rowspan="1" colspan="1">5</td>
                          <td align="right" rowspan="1" colspan="1">3.3</td>
                          <td align="right" rowspan="1" colspan="1">0.033</td>
                          <td align="right" rowspan="1" colspan="1">0.0866</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>weeks</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">response to drug</td>
                          <td align="right" rowspan="1" colspan="1">4</td>
                          <td align="right" rowspan="1" colspan="1">3.7</td>
                          <td align="right" rowspan="1" colspan="1">0.036</td>
                          <td align="right" rowspan="1" colspan="1">0.0866</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">positive regulation of angiogenesis</td>
                          <td align="right" rowspan="1" colspan="1">3</td>
                          <td align="right" rowspan="1" colspan="1">4.6</td>
                          <td align="right" rowspan="1" colspan="1">0.040</td>
                          <td align="right" rowspan="1" colspan="1">0.0866</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">extracellular matrix disassembly</td>
                          <td align="right" rowspan="1" colspan="1">3</td>
                          <td align="right" rowspan="1" colspan="1">4.1</td>
                          <td align="right" rowspan="1" colspan="1">0.053</td>
                          <td align="right" rowspan="1" colspan="1">0.0976</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">blood coagulation</td>
                          <td align="right" rowspan="1" colspan="1">36</td>
                          <td align="right" rowspan="1" colspan="1">2.7</td>
                          <td align="right" rowspan="1" colspan="1">0.000</td>
                          <td align="right" rowspan="1" colspan="1">0.0042</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">platelet degranulation</td>
                          <td align="right" rowspan="1" colspan="1">18</td>
                          <td align="right" rowspan="1" colspan="1">3.9</td>
                          <td align="right" rowspan="1" colspan="1">0.000</td>
                          <td align="right" rowspan="1" colspan="1">0.0045</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">blood coagulation, intrinsic pathway</td>
                          <td align="right" rowspan="1" colspan="1">8</td>
                          <td align="right" rowspan="1" colspan="1">8.9</td>
                          <td align="right" rowspan="1" colspan="1">0.000</td>
                          <td align="right" rowspan="1" colspan="1">0.0123</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">sprouting angiogenesis</td>
                          <td align="right" rowspan="1" colspan="1">6</td>
                          <td align="right" rowspan="1" colspan="1">13.1</td>
                          <td align="right" rowspan="1" colspan="1">0.000</td>
                          <td align="right" rowspan="1" colspan="1">0.0218</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">platelet activation</td>
                          <td align="right" rowspan="1" colspan="1">22</td>
                          <td align="right" rowspan="1" colspan="1">2.5</td>
                          <td align="right" rowspan="1" colspan="1">0.001</td>
                          <td align="right" rowspan="1" colspan="1">0.036</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">vascular endothelial growth factor signaling pathway</td>
                          <td align="right" rowspan="1" colspan="1">4</td>
                          <td align="right" rowspan="1" colspan="1">25.9</td>
                          <td align="right" rowspan="1" colspan="1">0.001</td>
                          <td align="right" rowspan="1" colspan="1">0.063</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">positive regulation of endothelial cell migration</td>
                          <td align="right" rowspan="1" colspan="1">7</td>
                          <td align="right" rowspan="1" colspan="1">5.8</td>
                          <td align="right" rowspan="1" colspan="1">0.002</td>
                          <td align="right" rowspan="1" colspan="1">0.0683</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">response to cold</td>
                          <td align="right" rowspan="1" colspan="1">3</td>
                          <td align="left" rowspan="1" colspan="1">Inf</td>
                          <td align="right" rowspan="1" colspan="1">0.002</td>
                          <td align="right" rowspan="1" colspan="1">0.0703</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">plasminogen activation</td>
                          <td align="right" rowspan="1" colspan="1">3</td>
                          <td align="left" rowspan="1" colspan="1">Inf</td>
                          <td align="right" rowspan="1" colspan="1">0.002</td>
                          <td align="right" rowspan="1" colspan="1">0.0703</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">nervous system development</td>
                          <td align="right" rowspan="1" colspan="1">12</td>
                          <td align="right" rowspan="1" colspan="1">3.1</td>
                          <td align="right" rowspan="1" colspan="1">0.003</td>
                          <td align="right" rowspan="1" colspan="1">0.071</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">blood circulation</td>
                          <td align="right" rowspan="1" colspan="1">5</td>
                          <td align="right" rowspan="1" colspan="1">8.1</td>
                          <td align="right" rowspan="1" colspan="1">0.003</td>
                          <td align="right" rowspan="1" colspan="1">0.071</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">negative regulation of cell-substrate adhesion</td>
                          <td align="right" rowspan="1" colspan="1">4</td>
                          <td align="right" rowspan="1" colspan="1">13.0</td>
                          <td align="right" rowspan="1" colspan="1">0.004</td>
                          <td align="right" rowspan="1" colspan="1">0.071</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">positive regulation of macrophage activation</td>
                          <td align="right" rowspan="1" colspan="1">4</td>
                          <td align="right" rowspan="1" colspan="1">13.0</td>
                          <td align="right" rowspan="1" colspan="1">0.004</td>
                          <td align="right" rowspan="1" colspan="1">0.071</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>28.1–32</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">positive regulation of synapse assembly</td>
                          <td align="right" rowspan="1" colspan="1">4</td>
                          <td align="right" rowspan="1" colspan="1">13.0</td>
                          <td align="right" rowspan="1" colspan="1">0.004</td>
                          <td align="right" rowspan="1" colspan="1">0.071</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>weeks</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">liver development</td>
                          <td align="right" rowspan="1" colspan="1">6</td>
                          <td align="right" rowspan="1" colspan="1">5.6</td>
                          <td align="right" rowspan="1" colspan="1">0.004</td>
                          <td align="right" rowspan="1" colspan="1">0.071</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">fibrinolysis</td>
                          <td align="right" rowspan="1" colspan="1">7</td>
                          <td align="right" rowspan="1" colspan="1">4.6</td>
                          <td align="right" rowspan="1" colspan="1">0.004</td>
                          <td align="right" rowspan="1" colspan="1">0.071</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">response to hypoxia</td>
                          <td align="right" rowspan="1" colspan="1">12</td>
                          <td align="right" rowspan="1" colspan="1">2.9</td>
                          <td align="right" rowspan="1" colspan="1">0.005</td>
                          <td align="right" rowspan="1" colspan="1">0.071</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">hematopoietic progenitor cell differentiation</td>
                          <td align="right" rowspan="1" colspan="1">4</td>
                          <td align="right" rowspan="1" colspan="1">8.6</td>
                          <td align="right" rowspan="1" colspan="1">0.008</td>
                          <td align="right" rowspan="1" colspan="1">0.086</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">response to vitamin D</td>
                          <td align="right" rowspan="1" colspan="1">4</td>
                          <td align="right" rowspan="1" colspan="1">8.6</td>
                          <td align="right" rowspan="1" colspan="1">0.008</td>
                          <td align="right" rowspan="1" colspan="1">0.086</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">negative regulation of fat cell differentiation</td>
                          <td align="right" rowspan="1" colspan="1">4</td>
                          <td align="right" rowspan="1" colspan="1">8.6</td>
                          <td align="right" rowspan="1" colspan="1">0.008</td>
                          <td align="right" rowspan="1" colspan="1">0.086</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">positive regulation of acute inflammatory response</td>
                          <td align="right" rowspan="1" colspan="1">3</td>
                          <td align="right" rowspan="1" colspan="1">19.3</td>
                          <td align="right" rowspan="1" colspan="1">0.009</td>
                          <td align="right" rowspan="1" colspan="1">0.086</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">cell-substrate junction assembly</td>
                          <td align="right" rowspan="1" colspan="1">3</td>
                          <td align="right" rowspan="1" colspan="1">19.3</td>
                          <td align="right" rowspan="1" colspan="1">0.009</td>
                          <td align="right" rowspan="1" colspan="1">0.086</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">negative regulation of ossification</td>
                          <td align="right" rowspan="1" colspan="1">3</td>
                          <td align="right" rowspan="1" colspan="1">19.3</td>
                          <td align="right" rowspan="1" colspan="1">0.009</td>
                          <td align="right" rowspan="1" colspan="1">0.086</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">negative regulation of B cell differentiation</td>
                          <td align="right" rowspan="1" colspan="1">3</td>
                          <td align="right" rowspan="1" colspan="1">19.3</td>
                          <td align="right" rowspan="1" colspan="1">0.009</td>
                          <td align="right" rowspan="1" colspan="1">0.086</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">cellular response to follicle-stimulating hormone stimulus</td>
                          <td align="right" rowspan="1" colspan="1">3</td>
                          <td align="right" rowspan="1" colspan="1">19.3</td>
                          <td align="right" rowspan="1" colspan="1">0.009</td>
                          <td align="right" rowspan="1" colspan="1">0.086</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">negative regulation of angiogenesis</td>
                          <td align="right" rowspan="1" colspan="1">7</td>
                          <td align="right" rowspan="1" colspan="1">3.8</td>
                          <td align="right" rowspan="1" colspan="1">0.009</td>
                          <td align="right" rowspan="1" colspan="1">0.086</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">negative regulation of cysteine-type endopeptidase activity involved in apoptotic process</td>
                          <td align="right" rowspan="1" colspan="1">7</td>
                          <td align="right" rowspan="1" colspan="1">3.8</td>
                          <td align="right" rowspan="1" colspan="1">0.009</td>
                          <td align="right" rowspan="1" colspan="1">0.086</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">positive regulation of neuron differentiation</td>
                          <td align="right" rowspan="1" colspan="1">6</td>
                          <td align="right" rowspan="1" colspan="1">4.4</td>
                          <td align="right" rowspan="1" colspan="1">0.010</td>
                          <td align="right" rowspan="1" colspan="1">0.0895</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">positive regulation of blood vessel endothelial cell migration</td>
                          <td align="right" rowspan="1" colspan="1">5</td>
                          <td align="right" rowspan="1" colspan="1">5.4</td>
                          <td align="right" rowspan="1" colspan="1">0.010</td>
                          <td align="right" rowspan="1" colspan="1">0.0895</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" rowspan="1" colspan="1">positive regulation of MAPK cascade</td>
                          <td align="right" rowspan="1" colspan="1">9</td>
                          <td align="right" rowspan="1" colspan="1">3.0</td>
                          <td align="right" rowspan="1" colspan="1">0.011</td>
                          <td align="right" rowspan="1" colspan="1">0.0953</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t004fn001">
                      <p>ID: Gene Ontology (GO) biological processes identifier; N: number of significant proteins assigned to the GO term; OR: odds ratio for enrichment; p: p-value; q: false discovery rate-adjusted p-value.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>No signaling pathways documented in the KEGG database [<xref rid="pone.0217273.ref075" ref-type="bibr">75</xref>] were found to be perturbed given the differential protein abundance observed in each interval of gestation.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec025">
              <title>Discussion</title>
              <sec id="sec026">
                <title>Principal findings of the study</title>
                <p>The principal findings of the study are as follows: 1) At 16.1–22 weeks of gestation, multi-protein models predicted early preeclampsia with a sensitivity of 71% (FPR = 10%). The most reliable predictors in this interval were an elevated MMP-7 and gpIIbIIIa complex; 2) the best predictors of the subsequent development of early preeclampsia at 22.1–28 weeks of gestation were lower PlGF and VEGF121 as well as elevated siglec-6 and activin-A (81% sensitivity, FPR = 10%); 3) at 28.1–32 weeks of gestation, the sensitivity of multi-protein models was 85% (FPR = 10%) with the most reliable predictors being ALCAM, siglec-6, and VEGF121; 4) the increase in siglec-6, activin-A, and VEGF121 at 22.1–28 weeks of gestation differentiated women who subsequently developed early preeclampsia from those who had a normal pregnancy or late preeclampsia (sensitivity 77%, FPR = 10%); 5) the sensitivity of proteomic models for early preeclampsia in women with placental lesions consistent with MVM was higher than that of the models reported for the overall early preeclampsia group from 16.1 weeks of gestation onward; and 6) the sensitivity of prediction models was higher for severe early preeclampsia than for the entire early preeclampsia group (84% versus 71% at 16.1–22 weeks).</p>
                <p>Of note, differential protein abundance results and, hence, downstream enrichment analyses are expected to vary among the different intervals of gestation due to several factors, such as: 1) differences in the sets of patients that contributed one sample in each interval, due to sample availability or to exclusion from analysis of samples at/or past the gestational age at diagnosis (see Methods); 2) differences in the magnitude of underlying disease-specific maternal plasma protein changes with preeclampsia; and 3) differences in the level of noise in the data, contributing non-biological variability.</p>
              </sec>
              <sec id="sec027">
                <title>Proteomics prediction models for the identification of patients with preeclampsia</title>
                <p>Biomarkers for the identification of patients at risk for obstetrical syndromes such as small-for-gestational-age neonates [<xref rid="pone.0217273.ref034" ref-type="bibr">34</xref>,<xref rid="pone.0217273.ref078" ref-type="bibr">78</xref>–<xref rid="pone.0217273.ref082" ref-type="bibr">82</xref>], spontaneous preterm birth [<xref rid="pone.0217273.ref083" ref-type="bibr">83</xref>–<xref rid="pone.0217273.ref094" ref-type="bibr">94</xref>], fetal death [<xref rid="pone.0217273.ref095" ref-type="bibr">95</xref>–<xref rid="pone.0217273.ref105" ref-type="bibr">105</xref>], and preeclampsia [<xref rid="pone.0217273.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0217273.ref047" ref-type="bibr">47</xref>,<xref rid="pone.0217273.ref049" ref-type="bibr">49</xref>,<xref rid="pone.0217273.ref050" ref-type="bibr">50</xref>,<xref rid="pone.0217273.ref056" ref-type="bibr">56</xref>,<xref rid="pone.0217273.ref072" ref-type="bibr">72</xref>,<xref rid="pone.0217273.ref106" ref-type="bibr">106</xref>–<xref rid="pone.0217273.ref113" ref-type="bibr">113</xref>] have been proposed. For preeclampsia, prediction models have evolved from ones that used maternal background characteristics alone (e.g., obstetrical history, chronic hypertension, familial history of preeclampsia, obesity) [<xref rid="pone.0217273.ref114" ref-type="bibr">114</xref>,<xref rid="pone.0217273.ref115" ref-type="bibr">115</xref>] to those that combine maternal demographic characteristics, obstetrical history [<xref rid="pone.0217273.ref116" ref-type="bibr">116</xref>,<xref rid="pone.0217273.ref117" ref-type="bibr">117</xref>], mean blood pressure [<xref rid="pone.0217273.ref118" ref-type="bibr">118</xref>], uterine artery Doppler studies [<xref rid="pone.0217273.ref052" ref-type="bibr">52</xref>,<xref rid="pone.0217273.ref054" ref-type="bibr">54</xref>,<xref rid="pone.0217273.ref119" ref-type="bibr">119</xref>], and molecular biomarkers [<xref rid="pone.0217273.ref056" ref-type="bibr">56</xref>,<xref rid="pone.0217273.ref120" ref-type="bibr">120</xref>–<xref rid="pone.0217273.ref122" ref-type="bibr">122</xref>] (e.g., PAPP-A [<xref rid="pone.0217273.ref088" ref-type="bibr">88</xref>,<xref rid="pone.0217273.ref123" ref-type="bibr">123</xref>–<xref rid="pone.0217273.ref125" ref-type="bibr">125</xref>] and inhibin-A [<xref rid="pone.0217273.ref124" ref-type="bibr">124</xref>,<xref rid="pone.0217273.ref126" ref-type="bibr">126</xref>–<xref rid="pone.0217273.ref128" ref-type="bibr">128</xref>]). Some of the most predictive biochemical markers include angiogenic and anti-angiogenic factors [<xref rid="pone.0217273.ref033" ref-type="bibr">33</xref>,<xref rid="pone.0217273.ref129" ref-type="bibr">129</xref>–<xref rid="pone.0217273.ref134" ref-type="bibr">134</xref>] (PlGF [<xref rid="pone.0217273.ref034" ref-type="bibr">34</xref>,<xref rid="pone.0217273.ref135" ref-type="bibr">135</xref>–<xref rid="pone.0217273.ref137" ref-type="bibr">137</xref>], sVEGFR-1[<xref rid="pone.0217273.ref138" ref-type="bibr">138</xref>–<xref rid="pone.0217273.ref142" ref-type="bibr">142</xref>], and endoglin [<xref rid="pone.0217273.ref143" ref-type="bibr">143</xref>–<xref rid="pone.0217273.ref148" ref-type="bibr">148</xref>]), or their ratios [<xref rid="pone.0217273.ref034" ref-type="bibr">34</xref>,<xref rid="pone.0217273.ref129" ref-type="bibr">129</xref>,<xref rid="pone.0217273.ref149" ref-type="bibr">149</xref>–<xref rid="pone.0217273.ref155" ref-type="bibr">155</xref>]. A limitation of current screening methods for preeclampsia is the requirement of Doppler velocimetry, which is not readily available in middle- and low-resource populations. The detection rate for early preeclampsia drops to 77% and 57% at FPRs of 10% and 5%, respectively, in the absence of Doppler information [<xref rid="pone.0217273.ref156" ref-type="bibr">156</xref>]. Therefore, there would still be a benefit in developing accurate prediction models based solely on molecular information.</p>
                <p>Discovery of molecular markers for obstetrical complications is often undertaken using “omics” technologies [<xref rid="pone.0217273.ref157" ref-type="bibr">157</xref>–<xref rid="pone.0217273.ref165" ref-type="bibr">165</xref>]: genomics [<xref rid="pone.0217273.ref166" ref-type="bibr">166</xref>,<xref rid="pone.0217273.ref167" ref-type="bibr">167</xref>], transcriptomics [<xref rid="pone.0217273.ref168" ref-type="bibr">168</xref>–<xref rid="pone.0217273.ref175" ref-type="bibr">175</xref>], proteomics [<xref rid="pone.0217273.ref072" ref-type="bibr">72</xref>,<xref rid="pone.0217273.ref165" ref-type="bibr">165</xref>,<xref rid="pone.0217273.ref176" ref-type="bibr">176</xref>–<xref rid="pone.0217273.ref187" ref-type="bibr">187</xref>], metabolomics [<xref rid="pone.0217273.ref188" ref-type="bibr">188</xref>–<xref rid="pone.0217273.ref192" ref-type="bibr">192</xref>], peptidomics [<xref rid="pone.0217273.ref193" ref-type="bibr">193</xref>–<xref rid="pone.0217273.ref198" ref-type="bibr">198</xref>], and lipidomics [<xref rid="pone.0217273.ref199" ref-type="bibr">199</xref>,<xref rid="pone.0217273.ref200" ref-type="bibr">200</xref>]. In particular, maternal proteomic profiles in preeclampsia were reported in maternal serum/plasma [<xref rid="pone.0217273.ref175" ref-type="bibr">175</xref>–<xref rid="pone.0217273.ref177" ref-type="bibr">177</xref>,<xref rid="pone.0217273.ref180" ref-type="bibr">180</xref>,<xref rid="pone.0217273.ref201" ref-type="bibr">201</xref>–<xref rid="pone.0217273.ref210" ref-type="bibr">210</xref>], urine [<xref rid="pone.0217273.ref211" ref-type="bibr">211</xref>–<xref rid="pone.0217273.ref213" ref-type="bibr">213</xref>], amniotic fluid [<xref rid="pone.0217273.ref214" ref-type="bibr">214</xref>,<xref rid="pone.0217273.ref215" ref-type="bibr">215</xref>], and the placenta [<xref rid="pone.0217273.ref179" ref-type="bibr">179</xref>,<xref rid="pone.0217273.ref182" ref-type="bibr">182</xref>,<xref rid="pone.0217273.ref216" ref-type="bibr">216</xref>–<xref rid="pone.0217273.ref228" ref-type="bibr">228</xref>]. However, most maternal plasma/serum proteomics studies to date did not involve samples collected longitudinally to determine how early molecular markers change their profiles prior to the disease onset and whether these changes are consistent throughout pregnancy, or the studies involved a small sample size.</p>
                <p>The current study is one of the largest in this field and uses a new proteomics technology based on aptamers that allows the measurement of 1,125 proteins. Using this platform (Somalogic, Inc.), we and other investigators reported the stereotypic longitudinal changes of the maternal plasma proteome in normal pregnancy [<xref rid="pone.0217273.ref229" ref-type="bibr">229</xref>,<xref rid="pone.0217273.ref230" ref-type="bibr">230</xref>] and late preeclampsia [<xref rid="pone.0217273.ref072" ref-type="bibr">72</xref>]. Our current report observing that an increased maternal plasma abundance of MMP-7 and gpIIbIIIa is predictive of early preeclampsia during the first half of pregnancy is novel.</p>
              </sec>
              <sec id="sec028">
                <title>Increased maternal plasma MMP-7 precedes diagnosis of preeclampsia</title>
                <p>A possible explanation for the increased maternal plasma MMP-7 in preeclampsia is that it is a marker of abnormal placentation. MMP-7 is expressed in the decidua and trophoblast [<xref rid="pone.0217273.ref231" ref-type="bibr">231</xref>,<xref rid="pone.0217273.ref232" ref-type="bibr">232</xref>] and has been proposed to play a role in the process of transformation of the spiral arteries [<xref rid="pone.0217273.ref233" ref-type="bibr">233</xref>,<xref rid="pone.0217273.ref234" ref-type="bibr">234</xref>]. There is also histological evidence to support the involvement of MMP-7 in the processes associated with the development of preeclampsia [<xref rid="pone.0217273.ref231" ref-type="bibr">231</xref>] and early preeclampsia [<xref rid="pone.0217273.ref233" ref-type="bibr">233</xref>]. Additionally, MMP-7 can act as a sheddase for syndecan-1 [<xref rid="pone.0217273.ref235" ref-type="bibr">235</xref>,<xref rid="pone.0217273.ref236" ref-type="bibr">236</xref>], a major transmembrane heparan sulfate proteoglycan expressed on the surface (glycocalyx) of epithelial, endothelial, and syncytiotrophoblast cells [<xref rid="pone.0217273.ref237" ref-type="bibr">237</xref>–<xref rid="pone.0217273.ref239" ref-type="bibr">239</xref>], which are implicated in the pathophysiology of preeclampsia [<xref rid="pone.0217273.ref240" ref-type="bibr">240</xref>–<xref rid="pone.0217273.ref243" ref-type="bibr">243</xref>]. MMP-7 may also be involved in processes leading to the formation of atherosclerotic plaques [<xref rid="pone.0217273.ref244" ref-type="bibr">244</xref>] that show characteristics (e.g., lipid-laden macrophages) similar to acute atherosis of the spiral arteries associated with preeclampsia [<xref rid="pone.0217273.ref245" ref-type="bibr">245</xref>,<xref rid="pone.0217273.ref246" ref-type="bibr">246</xref>]. Of note in our previous study that used the same proteomics platform, MMP-7 was found to be a sensitive biomarker during the first half of pregnancy for the detection of patients who subsequently developed late preeclampsia [<xref rid="pone.0217273.ref072" ref-type="bibr">72</xref>]; herein, we showed that is also the case for early preeclampsia.</p>
              </sec>
              <sec id="sec029">
                <title>The role of glycoprotein IIbIIIa in early preeclampsia</title>
                <p>To our knowledge, this is the first study to report that changes in the abundance of gpIIbIIIa in the maternal plasma are predictive of subsequent development of early preeclampsia. In this patient population, at 8–16 weeks of gestation, gpIIbIIIa performed better than PlGF (currently used to screen for preeclampsia) [<xref rid="pone.0217273.ref048" ref-type="bibr">48</xref>,<xref rid="pone.0217273.ref050" ref-type="bibr">50</xref>,<xref rid="pone.0217273.ref051" ref-type="bibr">51</xref>,<xref rid="pone.0217273.ref137" ref-type="bibr">137</xref>] for the detection of patients who subsequently developed early preeclampsia when profiled with the Somalogic platform (AUC = 0.60 for PlGF and 0.72 for gpIIbIIIa, see <bold><xref rid="pone.0217273.t002" ref-type="table">Table 2</xref></bold>and <bold><xref ref-type="fig" rid="pone.0217273.g002">Fig 2B</xref></bold>).</p>
                <p>Glycoprotein IIb-IIIa is a membrane glycoprotein [<xref rid="pone.0217273.ref247" ref-type="bibr">247</xref>], the most common platelet receptor [<xref rid="pone.0217273.ref247" ref-type="bibr">247</xref>,<xref rid="pone.0217273.ref248" ref-type="bibr">248</xref>]. After a conformational change occurring during platelet activation [<xref rid="pone.0217273.ref249" ref-type="bibr">249</xref>], it interacts with ligands (e.g., von Willebrand factor and fibrinogen) to play a critical role in platelet aggregation and the cross-linkage of platelets into a hemostatic plug or thrombus [<xref rid="pone.0217273.ref250" ref-type="bibr">250</xref>–<xref rid="pone.0217273.ref253" ref-type="bibr">253</xref>]. Aspirin inhibits the expression of gpIIbIIIa by platelets [<xref rid="pone.0217273.ref254" ref-type="bibr">254</xref>]. This fact is important given that aspirin is currently recommended by regulatory bodies in the United States for the prevention of preeclampsia [<xref rid="pone.0217273.ref255" ref-type="bibr">255</xref>–<xref rid="pone.0217273.ref257" ref-type="bibr">257</xref>]; moreover, this medication has recently been reported to reduce the rate of preterm preeclampsia by 62% [<xref rid="pone.0217273.ref040" ref-type="bibr">40</xref>]. Our findings suggest that gpIIbIIIa inhibitors could be further developed for the prevention of early preeclampsia.</p>
              </sec>
              <sec id="sec030">
                <title>Presence of placental lesions of maternal vascular malperfusion and disease severity increases the sensitivity of proteomic models for early preeclampsia</title>
                <p>The sensitivity of the proteomic models at each gestational-age interval from 16.1 weeks onward was higher for cases that had placental lesions consistent with MVM than for the overall group of women with early preeclampsia and even compared to those with severe early preeclampsia. Maternal vascular malperfusion is a prevalent placental histologic finding in patients with early preeclampsia [<xref rid="pone.0217273.ref028" ref-type="bibr">28</xref>], and 73% (24/33) of cases in the current study had these lesions. These results further support a previous observation that the prediction performance of angiogenic index-1 (PlGF/sVEGFR-1) for preterm delivery (&lt;34 weeks) is higher for women with these types of placental lesions [<xref rid="pone.0217273.ref063" ref-type="bibr">63</xref>].</p>
                <p>Of interest, even when only patients with lesions consistent with MVM were compared to those with a normal pregnancy, proteins of placental origin (e.g., PlGF and siglec-6) were still the most predictive of early preeclampsia, but only after 22 weeks of gestation. This finding is consistent with our earlier study in late preeclampsia [<xref rid="pone.0217273.ref072" ref-type="bibr">72</xref>] and with previous longitudinal studies of angiogenic and anti-angiogenic factors [<xref rid="pone.0217273.ref035" ref-type="bibr">35</xref>,<xref rid="pone.0217273.ref046" ref-type="bibr">46</xref>,<xref rid="pone.0217273.ref151" ref-type="bibr">151</xref>]. Moreover, the data presented herein also support our previous systems biology study in early preeclampsia showing that siglec-6 expression in the placenta increased in the second half of pregnancy due to a hypoxic-ischemic trophoblastic response to placental malperfusion [<xref rid="pone.0217273.ref258" ref-type="bibr">258</xref>].</p>
              </sec>
              <sec id="sec031">
                <title>Clinical implications</title>
                <p>The current study demonstrates the potential of maternal plasma protein changes to identify women at risk of early preeclampsia based on a single blood test. The use of disease-risk models based solely on proteomic markers would be similar to first- and second-trimester aneuploidy tests [<xref rid="pone.0217273.ref259" ref-type="bibr">259</xref>–<xref rid="pone.0217273.ref262" ref-type="bibr">262</xref>]. Such an approach can be implemented in various clinical settings, especially in low-resource areas, where Doppler velocimetry of the uterine arteries is not readily available. Moreover, the proteomics biomarkers identified in this study may assist in the introduction of novel therapeutic agents (e.g., gpIIbIIIa inhibitors) for the prevention of early preeclampsia.</p>
              </sec>
              <sec id="sec032">
                <title>Strengths and limitations of the study</title>
                <p>The major strengths of this study are its longitudinal design, the number of patients and their stratification according to placental histology, and the large number of proteins tested. In addition, best practices in terms of model development and validation were based on our award-winning classifier development pipeline [<xref rid="pone.0217273.ref067" ref-type="bibr">67</xref>–<xref rid="pone.0217273.ref069" ref-type="bibr">69</xref>]. A limitation of this study is the fact that the aptamer-based assays did not include internal standards to generate protein concentrations (as opposed to fluorescence-based abundance); hence, further studies would be needed to generate protein concentration cut-offs. Additionally, the majority of the patients included in this study were of African-American lineage, and the generalization of findings to other ethnic groups needs to be further examined. Lastly, for three of the 33 early preeclampsia cases, the information regarding 24-hour proteinuria was not available; hence, we were reliant on dipstick evaluation.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec033">
              <title>Conclusions</title>
              <p>Aptamer-based proteomic profiling of maternal plasma identified novel as well as previously known markers for early preeclampsia. At 16.1–22 weeks of gestation, more than two-thirds of patients who subsequently develop early preeclampsia can be identified by an elevated MMP-7 and gpIIbIIIa in maternal plasma (10% FPR). High abundance of siglec-6, VEGF121, and activin-A observed in the maternal circulation at 22.1–28 weeks of gestation was more specific to early rather than late preeclampsia. Proteomic markers were more sensitive for early preeclampsia cases with placental lesions consistent with MVM as well as those with a severe phenotype.</p>
            </sec>
            <sec sec-type="supplementary-material" id="sec034">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="pone.0217273.s001">
                <label>S1 Table</label>
                <caption>
                  <title>Summary of cross-validation results for prediction of early preeclampsia vs normal pregnancy.</title>
                  <p>The number in parentheses following the name of each protein (column Predictor Symbols) represents the percentage of folds in which the protein was selected in the best model. Only proteins selected in 10% or more of the 3x67 = 201 folds are listed. ACE2: angiotensin converting enzyme 2; ALCAM: activated leukocyte cell adhesion molecule; AUC: area under the receiver operating characteristic curve; GA: gestational age; gpIIbIIIa: glycoprotein IIb/IIIa; HMG-1: high-mobility group protein 1; MMP: matrix metalloproteinase; early PE: early preeclampsia; MVM: maternal vascular malperfusion; PE: preeclampsia; PlGF: placental growth factor; Siglec-6: sialic acid binding immunoglobulin-like lectin; VEGF121: vascular endothelial growth factor A, isoform 121; vWF: von Willebrand factor.</p>
                  <p>(XLSX)</p>
                </caption>
                <media xlink:href="pone.0217273.s001.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0217273.s002">
                <label>S2 Table</label>
                <caption>
                  <title>Summary of the differential abundance analysis between early preeclampsia and normal pregnancy in four intervals of gestation.</title>
                  <p>List of 175 proteins with significantly different abundance between early preeclampsia and normal pregnancy (q &lt; 0.1) in at least one interval, after adjustment for body mass index, maternal age, parity and smoking status. FC: linear fold change, with negative values denoting lower levels while positive values denote higher levels in cases than in controls.</p>
                  <p>(XLSX)</p>
                </caption>
                <media xlink:href="pone.0217273.s002.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0217273.s003">
                <label>S3 Table</label>
                <caption>
                  <title>Summary of the differential abundance analysis between early preeclampsia and normal pregnancy in four intervals of gestation.</title>
                  <p>List of 76 proteins with significantly different abundance between early preeclampsia with MVM and normal pregnancy (q &lt; 0.1) in at least one interval, after adjustment for body mass index, maternal age, parity and smoking status. FC: linear fold change, with negative values denoting lower levels while positive values denote higher levels in cases than in controls.</p>
                  <p>(XLSX)</p>
                </caption>
                <media xlink:href="pone.0217273.s003.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0217273.s004">
                <label>S4 Table</label>
                <caption>
                  <title>Summary of the differential abundance analysis between early preeclampsia and normal pregnancy in four intervals of gestation.</title>
                  <p>List of 130 proteins with significantly different abundance between severe early preeclampsia and normal pregnancy (q &lt; 0.1) in at least one interval, after adjustment for body mass index, maternal age, parity and smoking status. FC: linear fold change, with negative values denoting lower levels while positive values denote higher levels in cases than in controls.</p>
                  <p>(XLSX)</p>
                </caption>
                <media xlink:href="pone.0217273.s004.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0217273.s005">
                <label>S1 File</label>
                <caption>
                  <title>Proteomics data used in the analyses presented in this study.</title>
                  <p>Protein abundance data for each sample (rows) and each of the 1125 proteins is given in this table. Note, unlike for the early preeclampsia group, data for normal pregnancy group is the same as in in [<xref rid="pone.0217273.ref072" ref-type="bibr">72</xref>], and included in this file for convenience. ID: anonymized identifier indicator of the patient, GA: gestational age at sample, GADiagnosis: gestational age at diagnosis for cases; EarlyPE: is 1 for early preeclampsia and 0 for normal pregnancy. EarlyPE_MVM: is 1 for early preeclampsia with maternal vascular malperfusion and 0 for normal pregnancy or early preeclampsia without maternal vascular malperfusion; EarlyPE_Severe: is 1 for severe early preeclampsia cases; Protein symbol and names provided by Somalogic, Inc, are the same as S1 File in [<xref rid="pone.0217273.ref072" ref-type="bibr">72</xref>].</p>
                  <p>(CSV)</p>
                </caption>
                <media xlink:href="pone.0217273.s005.csv">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0217273.s006">
                <label>S1 Fig</label>
                <caption>
                  <title>Differential protein abundance analysis by generalized additive mixed models.</title>
                  <p>Longitudinal differences in protein abundance assessed generalized additive mixed models are shown for proteins listed in <bold><xref rid="pone.0217273.t002" ref-type="table">Table 2</xref>.</bold> For each protein, differences are shown between early preeclampsia (PE) and controls (top left) as well as between mild or severe PE and controls (top right) and between PE with or without maternal vascular malperfusion (MVM) and controls. Thick lines show averages while grey bands give the 95% confidence interval.</p>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0217273.s006.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>We thank the physicians, nurses, and research assistants from the Center for Advanced Obstetrical Care and Research, Intrapartum Unit, PRB Clinical Laboratory, and PRB Perinatal Translational Science Laboratory for their help with collecting and processing samples.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pone.0217273.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Romero</surname><given-names>R</given-names></name> (<year>1996</year>) <article-title>The child is the father of the man</article-title>. <source>Prenat Neonat Med</source>
<volume>1</volume>: <fpage>8</fpage>–<lpage>11</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Brosens</surname><given-names>I</given-names></name>, <name><surname>Pijnenborg</surname><given-names>R</given-names></name>, <name><surname>Vercruysse</surname><given-names>L</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name> (<year>2011</year>) <article-title>The "Great Obstetrical Syndromes" are associated with disorders of deep placentation</article-title>. <source>Am J Obstet Gynecol</source>
<volume>204</volume>: <fpage>193</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajog.2010.08.009</pub-id>
<?supplied-pmid 21094932?><pub-id pub-id-type="pmid">21094932</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Lockwood</surname><given-names>C</given-names></name>, <name><surname>Oyarzun</surname><given-names>E</given-names></name>, <name><surname>Hobbins</surname><given-names>JC</given-names></name> (<year>1988</year>) <article-title>Toxemia: new concepts in an old disease</article-title>. <source>Semin Perinatol</source>
<volume>12</volume>: <fpage>302</fpage>–<lpage>323</lpage>. <?supplied-pmid 3065943?><pub-id pub-id-type="pmid">3065943</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>von Dadelszen</surname><given-names>P</given-names></name>, <name><surname>Magee</surname><given-names>LA</given-names></name>, <name><surname>Roberts</surname><given-names>JM</given-names></name> (<year>2003</year>) <article-title>Subclassification of preeclampsia</article-title>. <source>Hypertens Pregnancy</source>
<volume>22</volume>: <fpage>143</fpage>–<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1081/PRG-120021060</pub-id>
<?supplied-pmid 12908998?><pub-id pub-id-type="pmid">12908998</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Vatten</surname><given-names>LJ</given-names></name>, <name><surname>Skjaerven</surname><given-names>R</given-names></name> (<year>2004</year>) <article-title>Is pre-eclampsia more than one disease?</article-title>
<source>Bjog</source>
<volume>111</volume>: <fpage>298</fpage>–<lpage>302</lpage>. <?supplied-pmid 15008762?><pub-id pub-id-type="pmid">15008762</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Valensise</surname><given-names>H</given-names></name>, <name><surname>Vasapollo</surname><given-names>B</given-names></name>, <name><surname>Gagliardi</surname><given-names>G</given-names></name>, <name><surname>Novelli</surname><given-names>GP</given-names></name> (<year>2008</year>) <article-title>Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease</article-title>. <source>Hypertension</source>
<volume>52</volume>: <fpage>873</fpage>–<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.108.117358</pub-id>
<?supplied-pmid 18824660?><pub-id pub-id-type="pmid">18824660</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Raymond</surname><given-names>D</given-names></name>, <name><surname>Peterson</surname><given-names>E</given-names></name> (<year>2011</year>) <article-title>A critical review of early-onset and late-onset preeclampsia</article-title>. <source>Obstet Gynecol Surv</source>
<volume>66</volume>: <fpage>497</fpage>–<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1097/OGX.0b013e3182331028</pub-id>
<?supplied-pmid 22018452?><pub-id pub-id-type="pmid">22018452</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Lisonkova</surname><given-names>S</given-names></name>, <name><surname>Joseph</surname><given-names>KS</given-names></name> (<year>2013</year>) <article-title>Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease</article-title>. <source>Am J Obstet Gynecol</source>
<volume>209</volume>: 544.e541-544.e512.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Tranquilli</surname><given-names>AL</given-names></name>, <name><surname>Brown</surname><given-names>MA</given-names></name>, <name><surname>Zeeman</surname><given-names>GG</given-names></name>, <name><surname>Dekker</surname><given-names>G</given-names></name>, <name><surname>Sibai</surname><given-names>BM</given-names></name> (<year>2013</year>) <article-title>The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP)</article-title>. <source>Pregnancy Hypertens</source>
<volume>3</volume>: <fpage>44</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.preghy.2012.11.001</pub-id>
<?supplied-pmid 26105740?><pub-id pub-id-type="pmid">26105740</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Verlohren</surname><given-names>S</given-names></name>, <name><surname>Melchiorre</surname><given-names>K</given-names></name>, <name><surname>Khalil</surname><given-names>A</given-names></name>, <name><surname>Thilaganathan</surname><given-names>B</given-names></name> (<year>2014</year>) <article-title>Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>44</volume>: <fpage>293</fpage>–<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1002/uog.13310</pub-id>
<?supplied-pmid 24448891?><pub-id pub-id-type="pmid">24448891</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Soto</surname><given-names>E</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Kusanovic</surname><given-names>JP</given-names></name>, <name><surname>Ogge</surname><given-names>G</given-names></name>, <name><surname>Hussein</surname><given-names>Y</given-names></name>, <name><surname>Yeo</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>25</volume>: <fpage>498</fpage>–<lpage>507</lpage>. <pub-id pub-id-type="doi">10.3109/14767058.2011.591461</pub-id>
<?supplied-pmid 21867402?><pub-id pub-id-type="pmid">21867402</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Parra-Cordero</surname><given-names>M</given-names></name>, <name><surname>Rodrigo</surname><given-names>R</given-names></name>, <name><surname>Barja</surname><given-names>P</given-names></name>, <name><surname>Bosco</surname><given-names>C</given-names></name>, <name><surname>Rencoret</surname><given-names>G</given-names></name>, <name><surname>Sepulveda-Martinez</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>41</volume>: <fpage>538</fpage>–<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1002/uog.12264</pub-id>
<?supplied-pmid 22807133?><pub-id pub-id-type="pmid">22807133</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Kucukgoz Gulec</surname><given-names>U</given-names></name>, <name><surname>Ozgunen</surname><given-names>FT</given-names></name>, <name><surname>Buyukkurt</surname><given-names>S</given-names></name>, <name><surname>Guzel</surname><given-names>AB</given-names></name>, <name><surname>Urunsak</surname><given-names>IF</given-names></name>, <name><surname>Demir</surname><given-names>SC</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Comparison of clinical and laboratory findings in early- and late-onset preeclampsia</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>26</volume>: <fpage>1228</fpage>–<lpage>1233</lpage>. <pub-id pub-id-type="doi">10.3109/14767058.2013.776533</pub-id>
<?supplied-pmid 23413799?><pub-id pub-id-type="pmid">23413799</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Lisonkova</surname><given-names>S</given-names></name>, <name><surname>Sabr</surname><given-names>Y</given-names></name>, <name><surname>Mayer</surname><given-names>C</given-names></name>, <name><surname>Young</surname><given-names>C</given-names></name>, <name><surname>Skoll</surname><given-names>A</given-names></name>, <name><surname>Joseph</surname><given-names>KS</given-names></name> (<year>2014</year>) <article-title>Maternal morbidity associated with early-onset and late-onset preeclampsia</article-title>. <source>Obstet Gynecol</source>
<volume>124</volume>: <fpage>771</fpage>–<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1097/AOG.0000000000000472</pub-id>
<?supplied-pmid 25198279?><pub-id pub-id-type="pmid">25198279</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Veerbeek</surname><given-names>JH</given-names></name>, <name><surname>Hermes</surname><given-names>W</given-names></name>, <name><surname>Breimer</surname><given-names>AY</given-names></name>, <name><surname>van Rijn</surname><given-names>BB</given-names></name>, <name><surname>Koenen</surname><given-names>SV</given-names></name>, <name><surname>Mol</surname><given-names>BW</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension</article-title>. <source>Hypertension</source>
<volume>65</volume>: <fpage>600</fpage>–<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.114.04850</pub-id>
<?supplied-pmid 25561694?><pub-id pub-id-type="pmid">25561694</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Bokslag</surname><given-names>A</given-names></name>, <name><surname>Teunissen</surname><given-names>PW</given-names></name>, <name><surname>Franssen</surname><given-names>C</given-names></name>, <name><surname>van Kesteren</surname><given-names>F</given-names></name>, <name><surname>Kamp</surname><given-names>O</given-names></name>, <name><surname>Ganzevoort</surname><given-names>W</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life</article-title>. <source>Am J Obstet Gynecol</source>
<volume>216</volume>: 523.e521-523.e527.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Christensen</surname><given-names>M</given-names></name>, <name><surname>Kronborg</surname><given-names>CS</given-names></name>, <name><surname>Carlsen</surname><given-names>RK</given-names></name>, <name><surname>Eldrup</surname><given-names>N</given-names></name>, <name><surname>Knudsen</surname><given-names>UB</given-names></name> (<year>2017</year>) <article-title>Early gestational age at preeclampsia onset is associated with subclinical atherosclerosis 12 years after delivery</article-title>. <source>Acta Obstet Gynecol Scand</source>
<volume>96</volume>: <fpage>1084</fpage>–<lpage>1092</lpage>. <pub-id pub-id-type="doi">10.1111/aogs.13173</pub-id>
<?supplied-pmid 28542803?><pub-id pub-id-type="pmid">28542803</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Jelin</surname><given-names>AC</given-names></name>, <name><surname>Cheng</surname><given-names>YW</given-names></name>, <name><surname>Shaffer</surname><given-names>BL</given-names></name>, <name><surname>Kaimal</surname><given-names>AJ</given-names></name>, <name><surname>Little</surname><given-names>SE</given-names></name>, <name><surname>Caughey</surname><given-names>AB</given-names></name> (<year>2010</year>) <article-title>Early-onset preeclampsia and neonatal outcomes</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>23</volume>: <fpage>389</fpage>–<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1080/14767050903168416</pub-id>
<?supplied-pmid 19670045?><pub-id pub-id-type="pmid">19670045</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Kovo</surname><given-names>M</given-names></name>, <name><surname>Schreiber</surname><given-names>L</given-names></name>, <name><surname>Ben-Haroush</surname><given-names>A</given-names></name>, <name><surname>Gold</surname><given-names>E</given-names></name>, <name><surname>Golan</surname><given-names>A</given-names></name>, <name><surname>Bar</surname><given-names>J</given-names></name> (<year>2012</year>) <article-title>The placental component in early-onset and late-onset preeclampsia in relation to fetal growth restriction</article-title>. <source>Prenat Diagn</source>
<volume>32</volume>: <fpage>632</fpage>–<lpage>637</lpage>. <pub-id pub-id-type="doi">10.1002/pd.3872</pub-id>
<?supplied-pmid 22565848?><pub-id pub-id-type="pmid">22565848</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Stubert</surname><given-names>J</given-names></name>, <name><surname>Ullmann</surname><given-names>S</given-names></name>, <name><surname>Dieterich</surname><given-names>M</given-names></name>, <name><surname>Diedrich</surname><given-names>D</given-names></name>, <name><surname>Reimer</surname><given-names>T</given-names></name> (<year>2014</year>) <article-title>Clinical differences between early- and late-onset severe preeclampsia and analysis of predictors for perinatal outcome</article-title>. <source>J Perinat Med</source>
<volume>42</volume>: <fpage>617</fpage>–<lpage>627</lpage>. <pub-id pub-id-type="doi">10.1515/jpm-2013-0285</pub-id>
<?supplied-pmid 24778345?><pub-id pub-id-type="pmid">24778345</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Madazli</surname><given-names>R</given-names></name>, <name><surname>Yuksel</surname><given-names>MA</given-names></name>, <name><surname>Imamoglu</surname><given-names>M</given-names></name>, <name><surname>Tuten</surname><given-names>A</given-names></name>, <name><surname>Oncul</surname><given-names>M</given-names></name>, <name><surname>Aydin</surname><given-names>B</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Comparison of clinical and perinatal outcomes in early- and late-onset preeclampsia</article-title>. <source>Arch Gynecol Obstet</source>
<volume>290</volume>: <fpage>53</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1007/s00404-014-3176-x</pub-id>
<?supplied-pmid 24549271?><pub-id pub-id-type="pmid">24549271</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Khodzhaeva</surname><given-names>ZS</given-names></name>, <name><surname>Kogan</surname><given-names>YA</given-names></name>, <name><surname>Shmakov</surname><given-names>RG</given-names></name>, <name><surname>Klimenchenko</surname><given-names>NI</given-names></name>, <name><surname>Akatyeva</surname><given-names>AS</given-names></name>, <name><surname>Vavina</surname><given-names>OV</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Clinical and pathogenetic features of early- and late-onset pre-eclampsia</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>29</volume>: <fpage>2980</fpage>–<lpage>2986</lpage>. <pub-id pub-id-type="doi">10.3109/14767058.2015.1111332</pub-id>
<?supplied-pmid 26527472?><pub-id pub-id-type="pmid">26527472</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Mor</surname><given-names>O</given-names></name>, <name><surname>Stavsky</surname><given-names>M</given-names></name>, <name><surname>Yitshak-Sade</surname><given-names>M</given-names></name>, <name><surname>Mastrolia</surname><given-names>SA</given-names></name>, <name><surname>Beer-Weisel</surname><given-names>R</given-names></name>, <name><surname>Rafaeli-Yehudai</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Early onset preeclampsia and cerebral palsy: a double hit model?</article-title>
<source>Am J Obstet Gynecol</source>
<volume>214</volume>: 105.e101-109.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Iacobelli</surname><given-names>S</given-names></name>, <name><surname>Bonsante</surname><given-names>F</given-names></name>, <name><surname>Robillard</surname><given-names>PY</given-names></name> (<year>2017</year>) <article-title>Comparison of risk factors and perinatal outcomes in early onset and late onset preeclampsia: A cohort based study in Reunion Island</article-title>. <source>J Reprod Immunol</source>
<volume>123</volume>: <fpage>12</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.jri.2017.08.005</pub-id>
<?supplied-pmid 28858635?><pub-id pub-id-type="pmid">28858635</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Moldenhauer</surname><given-names>JS</given-names></name>, <name><surname>Stanek</surname><given-names>J</given-names></name>, <name><surname>Warshak</surname><given-names>C</given-names></name>, <name><surname>Khoury</surname><given-names>J</given-names></name>, <name><surname>Sibai</surname><given-names>B</given-names></name> (<year>2003</year>) <article-title>The frequency and severity of placental findings in women with preeclampsia are gestational age dependent</article-title>. <source>Am J Obstet Gynecol</source>
<volume>189</volume>: <fpage>1173</fpage>–<lpage>1177</lpage>. <?supplied-pmid 14586374?><pub-id pub-id-type="pmid">14586374</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>van der Merwe</surname><given-names>JL</given-names></name>, <name><surname>Hall</surname><given-names>DR</given-names></name>, <name><surname>Wright</surname><given-names>C</given-names></name>, <name><surname>Schubert</surname><given-names>P</given-names></name>, <name><surname>Grove</surname><given-names>D</given-names></name> (<year>2010</year>) <article-title>Are early and late preeclampsia distinct subclasses of the disease—what does the placenta reveal?</article-title>
<source>Hypertens Pregnancy</source>
<volume>29</volume>: <fpage>457</fpage>–<lpage>467</lpage>. <pub-id pub-id-type="doi">10.3109/10641950903572282</pub-id>
<?supplied-pmid 20701467?><pub-id pub-id-type="pmid">20701467</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Sebire</surname><given-names>NJ</given-names></name>, <name><surname>Goldin</surname><given-names>RD</given-names></name>, <name><surname>Regan</surname><given-names>L</given-names></name> (<year>2005</year>) <article-title>Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity</article-title>. <source>J Obstet Gynaecol</source>
<volume>25</volume>: <fpage>117</fpage>–<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1080/014436105400041396</pub-id>
<?supplied-pmid 15814385?><pub-id pub-id-type="pmid">15814385</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Ogge</surname><given-names>G</given-names></name>, <name><surname>Chaiworapongsa</surname><given-names>T</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Hussein</surname><given-names>Y</given-names></name>, <name><surname>Kusanovic</surname><given-names>JP</given-names></name>, <name><surname>Yeo</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia</article-title>. <source>J Perinat Med</source>
<volume>39</volume>: <fpage>641</fpage>–<lpage>652</lpage>. <pub-id pub-id-type="doi">10.1515/JPM.2011.098</pub-id>
<?supplied-pmid 21848483?><pub-id pub-id-type="pmid">21848483</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Redman</surname><given-names>CW</given-names></name>, <name><surname>Sargent</surname><given-names>IL</given-names></name>, <name><surname>Staff</surname><given-names>AC</given-names></name> (<year>2014</year>) <article-title>IFPA Senior Award Lecture: making sense of pre-eclampsia—two placental causes of preeclampsia?</article-title>
<source>Placenta</source>
<volume>35</volume>
<issue>Suppl</issue>: <fpage>S20</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">24477207</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Nelson</surname><given-names>DB</given-names></name>, <name><surname>Ziadie</surname><given-names>MS</given-names></name>, <name><surname>McIntire</surname><given-names>DD</given-names></name>, <name><surname>Rogers</surname><given-names>BB</given-names></name>, <name><surname>Leveno</surname><given-names>KJ</given-names></name> (<year>2014</year>) <article-title>Placental pathology suggesting that preeclampsia is more than one disease</article-title>. <source>Am J Obstet Gynecol</source>
<volume>210</volume>: 66.e61-67.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Maynard</surname><given-names>SE</given-names></name>, <name><surname>Min</surname><given-names>JY</given-names></name>, <name><surname>Merchan</surname><given-names>J</given-names></name>, <name><surname>Lim</surname><given-names>KH</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Mondal</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia</article-title>. <source>J Clin Invest</source>
<volume>111</volume>: <fpage>649</fpage>–<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1172/JCI17189</pub-id>
<?supplied-pmid 12618519?><pub-id pub-id-type="pmid">12618519</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Lindheimer</surname><given-names>MD</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name> (<year>2007</year>) <article-title>Emerging roles of antiangiogenic and angiogenic proteins in pathogenesis and prediction of preeclampsia</article-title>. <source>Hypertension</source>
<volume>50</volume>: <fpage>35</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.107.089045</pub-id>
<?supplied-pmid 17515451?><pub-id pub-id-type="pmid">17515451</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Vatten</surname><given-names>LJ</given-names></name>, <name><surname>Eskild</surname><given-names>A</given-names></name>, <name><surname>Nilsen</surname><given-names>TI</given-names></name>, <name><surname>Jeansson</surname><given-names>S</given-names></name>, <name><surname>Jenum</surname><given-names>PA</given-names></name>, <name><surname>Staff</surname><given-names>AC</given-names></name> (<year>2007</year>) <article-title>Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia</article-title>. <source>Am J Obstet Gynecol</source>
<volume>196</volume>: 239.e231-236.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Erez</surname><given-names>O</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Espinoza</surname><given-names>J</given-names></name>, <name><surname>Fu</surname><given-names>W</given-names></name>, <name><surname>Todem</surname><given-names>D</given-names></name>, <name><surname>Kusanovic</surname><given-names>JP</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>21</volume>: <fpage>279</fpage>–<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1080/14767050802034545</pub-id>
<?supplied-pmid 18446652?><pub-id pub-id-type="pmid">18446652</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Nien</surname><given-names>JK</given-names></name>, <name><surname>Espinoza</surname><given-names>J</given-names></name>, <name><surname>Todem</surname><given-names>D</given-names></name>, <name><surname>Fu</surname><given-names>W</given-names></name>, <name><surname>Chung</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>21</volume>: <fpage>9</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1080/14767050701830480</pub-id>
<?supplied-pmid 18175241?><pub-id pub-id-type="pmid">18175241</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Gotsch</surname><given-names>F</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Kusanovic</surname><given-names>JP</given-names></name>, <name><surname>Chaiworapongsa</surname><given-names>T</given-names></name>, <name><surname>Dombrowski</surname><given-names>M</given-names></name>, <name><surname>Erez</surname><given-names>O</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>21</volume>: <fpage>389</fpage>–<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1080/14767050802046069</pub-id>
<?supplied-pmid 18570117?><pub-id pub-id-type="pmid">18570117</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Vaisbuch</surname><given-names>E</given-names></name>, <name><surname>Whitty</surname><given-names>JE</given-names></name>, <name><surname>Hassan</surname><given-names>SS</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Kusanovic</surname><given-names>JP</given-names></name>, <name><surname>Cotton</surname><given-names>DB</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Circulating angiogenic and antiangiogenic factors in women with eclampsia</article-title>. <source>Am J Obstet Gynecol</source>
<volume>204</volume>: 152.e151-159.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Bujold</surname><given-names>E</given-names></name>, <name><surname>Roberge</surname><given-names>S</given-names></name>, <name><surname>Lacasse</surname><given-names>Y</given-names></name>, <name><surname>Bureau</surname><given-names>M</given-names></name>, <name><surname>Audibert</surname><given-names>F</given-names></name>, <name><surname>Marcoux</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis</article-title>. <source>Obstet Gynecol</source>
<volume>116</volume>: <fpage>402</fpage>–<lpage>414</lpage>. <pub-id pub-id-type="doi">10.1097/AOG.0b013e3181e9322a</pub-id>
<?supplied-pmid 20664402?><pub-id pub-id-type="pmid">20664402</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Baschat</surname><given-names>AA</given-names></name> (<year>2015</year>) <article-title>First-trimester screening for pre-eclampsia: moving from personalized risk prediction to prevention</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>45</volume>: <fpage>119</fpage>–<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1002/uog.14770</pub-id>
<?supplied-pmid 25627093?><pub-id pub-id-type="pmid">25627093</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Rolnik</surname><given-names>DL</given-names></name>, <name><surname>Wright</surname><given-names>D</given-names></name>, <name><surname>Poon</surname><given-names>LC</given-names></name>, <name><surname>O'Gorman</surname><given-names>N</given-names></name>, <name><surname>Syngelaki</surname><given-names>A</given-names></name>, <name><surname>de Paco Matallana</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia</article-title>. <source>N Engl J Med</source>
<volume>377</volume>: <fpage>613</fpage>–<lpage>622</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1704559</pub-id>
<?supplied-pmid 28657417?><pub-id pub-id-type="pmid">28657417</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Groom</surname><given-names>KM</given-names></name>, <name><surname>David</surname><given-names>AL</given-names></name> (<year>2018</year>) <article-title>The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction</article-title>. <source>Am J Obstet Gynecol</source>
<volume>218</volume>: <fpage>S829</fpage>–<lpage>s840</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajog.2017.11.565</pub-id>
<?supplied-pmid 29229321?><pub-id pub-id-type="pmid">29229321</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref042">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Stampalija</surname><given-names>T</given-names></name>, <name><surname>Chaiworapongsa</surname><given-names>T</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Chaemsaithong</surname><given-names>P</given-names></name>, <name><surname>Korzeniewski</surname><given-names>SJ</given-names></name>, <name><surname>Schwartz</surname><given-names>AG</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>26</volume>: <fpage>1359</fpage>–<lpage>1370</lpage>. <pub-id pub-id-type="doi">10.3109/14767058.2013.784256</pub-id>
<?supplied-pmid 23488689?><pub-id pub-id-type="pmid">23488689</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref043">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>Baschat</surname><given-names>AA</given-names></name>, <name><surname>Magder</surname><given-names>LS</given-names></name>, <name><surname>Doyle</surname><given-names>LE</given-names></name>, <name><surname>Atlas</surname><given-names>RO</given-names></name>, <name><surname>Jenkins</surname><given-names>CB</given-names></name>, <name><surname>Blitzer</surname><given-names>MG</given-names></name> (<year>2014</year>) <article-title>Prediction of preeclampsia utilizing the first trimester screening examination</article-title>. <source>Am J Obstet Gynecol</source>
<volume>211</volume>: 514.e511-517.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref044">
                <label>44</label>
                <mixed-citation publication-type="journal"><name><surname>Gallo</surname><given-names>DM</given-names></name>, <name><surname>Wright</surname><given-names>D</given-names></name>, <name><surname>Casanova</surname><given-names>C</given-names></name>, <name><surname>Campanero</surname><given-names>M</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2016</year>) <article-title>Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19–24 weeks' gestation</article-title>. <source>Am J Obstet Gynecol</source>
<volume>214</volume>: 619 e611-619 e617.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref045">
                <label>45</label>
                <mixed-citation publication-type="journal"><name><surname>Tsiakkas</surname><given-names>A</given-names></name>, <name><surname>Saiid</surname><given-names>Y</given-names></name>, <name><surname>Wright</surname><given-names>A</given-names></name>, <name><surname>Wright</surname><given-names>D</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2016</year>) <article-title>Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30–34 weeks' gestation</article-title>. <source>Am J Obstet Gynecol</source>
<volume>215</volume>: 87 e81-87 e17.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref046">
                <label>46</label>
                <mixed-citation publication-type="journal"><name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Chaemsaithong</surname><given-names>P</given-names></name>, <name><surname>Tarca</surname><given-names>AL</given-names></name>, <name><surname>Korzeniewski</surname><given-names>SJ</given-names></name>, <name><surname>Maymon</surname><given-names>E</given-names></name>, <name><surname>Pacora</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia—a longitudinal study</article-title>. <source>J Matern Fetal Neonatal Med</source>: <fpage>1</fpage>–<lpage>15</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref047">
                <label>47</label>
                <mixed-citation publication-type="journal"><name><surname>Akolekar</surname><given-names>R</given-names></name>, <name><surname>Syngelaki</surname><given-names>A</given-names></name>, <name><surname>Poon</surname><given-names>L</given-names></name>, <name><surname>Wright</surname><given-names>D</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2013</year>) <article-title>Competing risks model in early screening for preeclampsia by biophysical and biochemical markers</article-title>. <source>Fetal Diagn Ther</source>
<volume>33</volume>: <fpage>8</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1159/000341264</pub-id>
<?supplied-pmid 22906914?><pub-id pub-id-type="pmid">22906914</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref048">
                <label>48</label>
                <mixed-citation publication-type="journal"><name><surname>Myers</surname><given-names>JE</given-names></name>, <name><surname>Kenny</surname><given-names>LC</given-names></name>, <name><surname>McCowan</surname><given-names>LM</given-names></name>, <name><surname>Chan</surname><given-names>EH</given-names></name>, <name><surname>Dekker</surname><given-names>GA</given-names></name>, <name><surname>Poston</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study</article-title>. <source>Bjog</source>
<volume>120</volume>: <fpage>1215</fpage>–<lpage>1223</lpage>. <pub-id pub-id-type="doi">10.1111/1471-0528.12195</pub-id>
<?supplied-pmid 23906160?><pub-id pub-id-type="pmid">23906160</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref049">
                <label>49</label>
                <mixed-citation publication-type="journal"><name><surname>O'Gorman</surname><given-names>N</given-names></name>, <name><surname>Wright</surname><given-names>D</given-names></name>, <name><surname>Syngelaki</surname><given-names>A</given-names></name>, <name><surname>Akolekar</surname><given-names>R</given-names></name>, <name><surname>Wright</surname><given-names>A</given-names></name>, <name><surname>Poon</surname><given-names>LC</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks gestation</article-title>. <source>Am J Obstet Gynecol</source>
<volume>214</volume>: 103.e101-103.e112.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref050">
                <label>50</label>
                <mixed-citation publication-type="journal"><name><surname>Crovetto</surname><given-names>F</given-names></name>, <name><surname>Figueras</surname><given-names>F</given-names></name>, <name><surname>Triunfo</surname><given-names>S</given-names></name>, <name><surname>Crispi</surname><given-names>F</given-names></name>, <name><surname>Rodriguez-Sureda</surname><given-names>V</given-names></name>, <name><surname>Dominguez</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors</article-title>. <source>Prenat Diagn</source>
<volume>35</volume>: <fpage>183</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1002/pd.4519</pub-id><pub-id pub-id-type="pmid">25346181</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref051">
                <label>51</label>
                <mixed-citation publication-type="journal"><name><surname>Espinoza</surname><given-names>J</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Nien</surname><given-names>JK</given-names></name>, <name><surname>Gomez</surname><given-names>R</given-names></name>, <name><surname>Kusanovic</surname><given-names>JP</given-names></name>, <name><surname>Goncalves</surname><given-names>LF</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor</article-title>. <source>Am J Obstet Gynecol</source>
<volume>196</volume>: 326.e321-313.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref052">
                <label>52</label>
                <mixed-citation publication-type="journal"><name><surname>Crispi</surname><given-names>F</given-names></name>, <name><surname>Llurba</surname><given-names>E</given-names></name>, <name><surname>Dominguez</surname><given-names>C</given-names></name>, <name><surname>Martin-Gallan</surname><given-names>P</given-names></name>, <name><surname>Cabero</surname><given-names>L</given-names></name>, <name><surname>Gratacos</surname><given-names>E</given-names></name> (<year>2008</year>) <article-title>Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>31</volume>: <fpage>303</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1002/uog.5184</pub-id>
<?supplied-pmid 18058842?><pub-id pub-id-type="pmid">18058842</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref053">
                <label>53</label>
                <mixed-citation publication-type="journal"><name><surname>Melchiorre</surname><given-names>K</given-names></name>, <name><surname>Wormald</surname><given-names>B</given-names></name>, <name><surname>Leslie</surname><given-names>K</given-names></name>, <name><surname>Bhide</surname><given-names>A</given-names></name>, <name><surname>Thilaganathan</surname><given-names>B</given-names></name> (<year>2008</year>) <article-title>First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>32</volume>: <fpage>133</fpage>–<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1002/uog.5400</pub-id>
<?supplied-pmid 18615872?><pub-id pub-id-type="pmid">18615872</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref054">
                <label>54</label>
                <mixed-citation publication-type="journal"><name><surname>Llurba</surname><given-names>E</given-names></name>, <name><surname>Carreras</surname><given-names>E</given-names></name>, <name><surname>Gratacos</surname><given-names>E</given-names></name>, <name><surname>Juan</surname><given-names>M</given-names></name>, <name><surname>Astor</surname><given-names>J</given-names></name>, <name><surname>Vives</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Maternal history and uterine artery Doppler in the assessment of risk for development of early- and late-onset preeclampsia and intrauterine growth restriction</article-title>. <source>Obstet Gynecol Int</source>
<volume>2009</volume>: <fpage>275613</fpage>
<pub-id pub-id-type="doi">10.1155/2009/275613</pub-id>
<?supplied-pmid 19936122?><pub-id pub-id-type="pmid">19936122</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref055">
                <label>55</label>
                <mixed-citation publication-type="journal"><name><surname>Poon</surname><given-names>LC</given-names></name>, <name><surname>Staboulidou</surname><given-names>I</given-names></name>, <name><surname>Maiz</surname><given-names>N</given-names></name>, <name><surname>Plasencia</surname><given-names>W</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2009</year>) <article-title>Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>34</volume>: <fpage>142</fpage>–<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1002/uog.6452</pub-id>
<?supplied-pmid 19644947?><pub-id pub-id-type="pmid">19644947</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref056">
                <label>56</label>
                <mixed-citation publication-type="journal"><name><surname>Audibert</surname><given-names>F</given-names></name>, <name><surname>Boucoiran</surname><given-names>I</given-names></name>, <name><surname>An</surname><given-names>N</given-names></name>, <name><surname>Aleksandrov</surname><given-names>N</given-names></name>, <name><surname>Delvin</surname><given-names>E</given-names></name>, <name><surname>Bujold</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women</article-title>. <source>Am J Obstet Gynecol</source>
<volume>203</volume>: 383.e381-388.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref057">
                <label>57</label>
                <mixed-citation publication-type="journal"><name><surname>Ventura</surname><given-names>W</given-names></name>, <name><surname>De Paco Matallana</surname><given-names>C</given-names></name>, <name><surname>Prieto-Sanchez</surname><given-names>MT</given-names></name>, <name><surname>Macizo</surname><given-names>MI</given-names></name>, <name><surname>Pertegal</surname><given-names>M</given-names></name>, <name><surname>Nieto</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Uterine and umbilical artery Doppler at 28 weeks for predicting adverse pregnancy outcomes in women with abnormal uterine artery Doppler findings in the early second trimester</article-title>. <source>Prenat Diagn</source>
<volume>35</volume>: <fpage>294</fpage>–<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1002/pd.4542</pub-id>
<?supplied-pmid 25483940?><pub-id pub-id-type="pmid">25483940</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref058">
                <label>58</label>
                <mixed-citation publication-type="journal">(<year>2002</year>) <article-title>ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002</article-title>. <source>Obstet Gynecol</source>
<volume>99</volume>: <fpage>159</fpage>–<lpage>167</lpage>. <?supplied-pmid 16175681?><pub-id pub-id-type="pmid">16175681</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref059">
                <label>59</label>
                <mixed-citation publication-type="journal"><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name>, <name><surname>Chaemsaithong</surname><given-names>P</given-names></name>, <name><surname>Yeo</surname><given-names>L</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name> (<year>2014</year>) <article-title>Pre-eclampsia part 1: current understanding of its pathophysiology</article-title>. <source>Nat Rev Nephrol</source>
<volume>10</volume>: <fpage>466</fpage>–<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1038/nrneph.2014.102</pub-id>
<?supplied-pmid 25003615?><pub-id pub-id-type="pmid">25003615</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref060">
                <label>60</label>
                <mixed-citation publication-type="journal"><name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Kim</surname><given-names>YM</given-names></name>, <name><surname>Pacora</surname><given-names>P</given-names></name>, <name><surname>Kim</surname><given-names>CJ</given-names></name>, <name><surname>Benshalom-Tirosh</surname><given-names>N</given-names></name>, <name><surname>Jaiman</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2018</year>) <article-title>The frequency and type of placental histologic lesions in term pregnancies with normal outcome</article-title>. <source>J Perinat Med</source>
<volume>46</volume>: <fpage>613</fpage>–<lpage>630</lpage>. <pub-id pub-id-type="doi">10.1515/jpm-2018-0055</pub-id>
<?supplied-pmid 30044764?><pub-id pub-id-type="pmid">30044764</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref061">
                <label>61</label>
                <mixed-citation publication-type="journal"><name><surname>Redline</surname><given-names>RW</given-names></name>, <name><surname>Heller</surname><given-names>D</given-names></name>, <name><surname>Keating</surname><given-names>S</given-names></name>, <name><surname>Kingdom</surname><given-names>J</given-names></name> (<year>2005</year>) <article-title>Placental diagnostic criteria and clinical correlation—a workshop report</article-title>. <source>Placenta</source>
<volume>26</volume>
<issue>Suppl A</issue>: <fpage>S114</fpage>–<lpage>117</lpage>.<pub-id pub-id-type="pmid">15837060</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref062">
                <label>62</label>
                <mixed-citation publication-type="journal"><name><surname>Khong</surname><given-names>TY</given-names></name>, <name><surname>Mooney</surname><given-names>EE</given-names></name>, <name><surname>Ariel</surname><given-names>I</given-names></name>, <name><surname>Balmus</surname><given-names>NC</given-names></name>, <name><surname>Boyd</surname><given-names>TK</given-names></name>, <name><surname>Brundler</surname><given-names>MA</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement</article-title>. <source>Arch Pathol Lab Med</source>
<volume>140</volume>: <fpage>698</fpage>–<lpage>713</lpage>. <pub-id pub-id-type="doi">10.5858/arpa.2015-0225-CC</pub-id>
<?supplied-pmid 27223167?><pub-id pub-id-type="pmid">27223167</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref063">
                <label>63</label>
                <mixed-citation publication-type="journal"><name><surname>Korzeniewski</surname><given-names>SJ</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Chaiworapongsa</surname><given-names>T</given-names></name>, <name><surname>Chaemsaithong</surname><given-names>P</given-names></name>, <name><surname>Kim</surname><given-names>CJ</given-names></name>, <name><surname>Kim</surname><given-names>YM</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study</article-title>. <source>Am J Obstet Gynecol</source>
<volume>214</volume>: 629.e621-629.e617.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref064">
                <label>64</label>
                <mixed-citation publication-type="journal"><name><surname>Gold</surname><given-names>L</given-names></name>, <name><surname>Ayers</surname><given-names>D</given-names></name>, <name><surname>Bertino</surname><given-names>J</given-names></name>, <name><surname>Bock</surname><given-names>C</given-names></name>, <name><surname>Bock</surname><given-names>A</given-names></name>, <name><surname>Brody</surname><given-names>EN</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Aptamer-based multiplexed proteomic technology for biomarker discovery</article-title>. <source>PLoS One</source>
<volume>5</volume>: <fpage>e15004</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0015004</pub-id>
<?supplied-pmid 21165148?><pub-id pub-id-type="pmid">21165148</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref065">
                <label>65</label>
                <mixed-citation publication-type="journal"><name><surname>Davies</surname><given-names>DR</given-names></name>, <name><surname>Gelinas</surname><given-names>AD</given-names></name>, <name><surname>Zhang</surname><given-names>C</given-names></name>, <name><surname>Rohloff</surname><given-names>JC</given-names></name>, <name><surname>Carter</surname><given-names>JD</given-names></name>, <name><surname>O'Connell</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>109</volume>: <fpage>19971</fpage>–<lpage>19976</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1213933109</pub-id>
<?supplied-pmid 23139410?><pub-id pub-id-type="pmid">23139410</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref066">
                <label>66</label>
                <mixed-citation publication-type="other">Bates D, Maechler M, Bolker B, Walker S (2014) lme4: Linear mixed-effects models using Eigen and S4. <ext-link ext-link-type="uri" xlink:href="http://arxivorg/abs/14065823">http://arxivorg/abs/14065823</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref067">
                <label>67</label>
                <mixed-citation publication-type="journal"><name><surname>Tarca</surname><given-names>AL</given-names></name>, <name><surname>Than</surname><given-names>N. G.</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>. (<year>2013</year>) <article-title>Methodological approach from the Best Overall Team in the sbv IMPROVER Diagnostic Signature Challenge</article-title>. <source>Systems Biomedicine</source><volume>1</volume>: <fpage>217</fpage>–<lpage>227</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref068">
                <label>68</label>
                <mixed-citation publication-type="journal"><name><surname>Tarca</surname><given-names>AL</given-names></name>, <name><surname>Lauria</surname><given-names>M</given-names></name>, <name><surname>Unger</surname><given-names>M</given-names></name>, <name><surname>Bilal</surname><given-names>E</given-names></name>, <name><surname>Boue</surname><given-names>S</given-names></name>, <name><surname>Kumar Dey</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Strengths and limitations of microarray-based phenotype prediction: lessons learned from the IMPROVER Diagnostic Signature Challenge</article-title>. <source>Bioinformatics</source>
<volume>29</volume>: <fpage>2892</fpage>–<lpage>2899</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btt492</pub-id>
<?supplied-pmid 23966112?><pub-id pub-id-type="pmid">23966112</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref069">
                <label>69</label>
                <mixed-citation publication-type="journal"><name><surname>Dayarian</surname><given-names>A</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Biehl</surname><given-names>M</given-names></name>, <name><surname>Bilal</surname><given-names>E</given-names></name>, <name><surname>Hormoz</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Predicting protein phosphorylation from gene expression: top methods from the IMPROVER Species Translation Challenge</article-title>. <source>Bioinformatics</source>: <fpage>462</fpage>–<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu490</pub-id>
<?supplied-pmid 25061067?><pub-id pub-id-type="pmid">25061067</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref070">
                <label>70</label>
                <mixed-citation publication-type="book"><name><surname>Smyth</surname><given-names>GK</given-names></name> (<year>2012</year>) <chapter-title>Limma: linear models for microarray data</chapter-title> In: <name><surname>Gentleman</surname><given-names>R</given-names></name>, <name><surname>Carey</surname><given-names>VJ</given-names></name>, <name><surname>Huber</surname><given-names>W</given-names></name>, <name><surname>Irizarry</surname><given-names>RA</given-names></name>, <name><surname>Dudoit</surname><given-names>S</given-names></name>, editors. <source>Bioinformatics and Computational Biology Solutions Using R and Bioconductor</source>: <publisher-name>Springer</publisher-name> pp. <fpage>397</fpage>–<lpage>420</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref071">
                <label>71</label>
                <mixed-citation publication-type="journal"><name><surname>Gentleman</surname><given-names>RC</given-names></name>, <name><surname>Carey</surname><given-names>VJ</given-names></name>, <name><surname>Bates</surname><given-names>DM</given-names></name>, <name><surname>Bolstad</surname><given-names>B</given-names></name>, <name><surname>Dettling</surname><given-names>M</given-names></name>, <name><surname>Dudoit</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Bioconductor: open software development for computational biology and bioinformatics</article-title>. <source>Genome Biol</source>
<volume>5</volume>: <fpage>R80</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2004-5-10-r80</pub-id>
<?supplied-pmid 15461798?><pub-id pub-id-type="pmid">15461798</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref072">
                <label>72</label>
                <mixed-citation publication-type="journal"><name><surname>Erez</surname><given-names>O</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Maymon</surname><given-names>E</given-names></name>, <name><surname>Chaemsaithong</surname><given-names>P</given-names></name>, <name><surname>Done</surname><given-names>B</given-names></name>, <name><surname>Pacora</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study</article-title>. <source>PLoS One</source>
<volume>12</volume>: <fpage>e0181468</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0181468</pub-id>
<?supplied-pmid 28738067?><pub-id pub-id-type="pmid">28738067</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref073">
                <label>73</label>
                <mixed-citation publication-type="journal"><name><surname>Maglott</surname><given-names>D</given-names></name>, <name><surname>Ostell</surname><given-names>J</given-names></name>, <name><surname>Pruitt</surname><given-names>KD</given-names></name>, <name><surname>Tatusova</surname><given-names>T</given-names></name> (<year>2005</year>) <article-title>Entrez Gene: gene-centered information at NCBI</article-title>. <source>Nucleic Acids Res</source>
<volume>33</volume>: <fpage>D54</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gki031</pub-id>
<?supplied-pmid 15608257?><pub-id pub-id-type="pmid">15608257</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref074">
                <label>74</label>
                <mixed-citation publication-type="journal"><name><surname>Ashburner</surname><given-names>M</given-names></name>, <name><surname>Ball</surname><given-names>CA</given-names></name>, <name><surname>Blake</surname><given-names>JA</given-names></name>, <name><surname>Botstein</surname><given-names>D</given-names></name>, <name><surname>Butler</surname><given-names>H</given-names></name>, <name><surname>Cherry</surname><given-names>JM</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Gene ontology: tool for the unification of biology. The Gene Ontology Consortium</article-title>. <source>Nat Genet</source>
<volume>25</volume>: <fpage>25</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1038/75556</pub-id>
<?supplied-pmid 10802651?><pub-id pub-id-type="pmid">10802651</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref075">
                <label>75</label>
                <mixed-citation publication-type="journal"><name><surname>Ogata</surname><given-names>H</given-names></name>, <name><surname>Goto</surname><given-names>S</given-names></name>, <name><surname>Sato</surname><given-names>K</given-names></name>, <name><surname>Fujibuchi</surname><given-names>W</given-names></name>, <name><surname>Bono</surname><given-names>H</given-names></name>, <name><surname>Kanehisa</surname><given-names>M</given-names></name> (<year>1999</year>) <article-title>KEGG: Kyoto Encyclopedia of Genes and Genomes</article-title>. <source>Nucleic Acids Res</source>
<volume>27</volume>: <fpage>29</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1093/nar/27.1.29</pub-id>
<?supplied-pmid 9847135?><pub-id pub-id-type="pmid">9847135</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref076">
                <label>76</label>
                <mixed-citation publication-type="journal"><name><surname>Draghici</surname><given-names>S</given-names></name>, <name><surname>Khatri</surname><given-names>P</given-names></name>, <name><surname>Tarca</surname><given-names>AL</given-names></name>, <name><surname>Amin</surname><given-names>K</given-names></name>, <name><surname>Done</surname><given-names>A</given-names></name>, <name><surname>Voichita</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>A systems biology approach for pathway level analysis</article-title>. <source>Genome Res</source>
<volume>17</volume>: <fpage>1537</fpage>–<lpage>1545</lpage>. <pub-id pub-id-type="doi">10.1101/gr.6202607</pub-id>
<?supplied-pmid 17785539?><pub-id pub-id-type="pmid">17785539</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref077">
                <label>77</label>
                <mixed-citation publication-type="journal"><name><surname>Tarca</surname><given-names>AL</given-names></name>, <name><surname>Draghici</surname><given-names>S</given-names></name>, <name><surname>Khatri</surname><given-names>P</given-names></name>, <name><surname>Hassan</surname><given-names>SS</given-names></name>, <name><surname>Mittal</surname><given-names>P</given-names></name>, <name><surname>Kim</surname><given-names>JS</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>A novel signaling pathway impact analysis</article-title>. <source>Bioinformatics</source>
<volume>25</volume>: <fpage>75</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btn577</pub-id>
<?supplied-pmid 18990722?><pub-id pub-id-type="pmid">18990722</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref078">
                <label>78</label>
                <mixed-citation publication-type="journal"><name><surname>Bobrow</surname><given-names>CS</given-names></name>, <name><surname>Holmes</surname><given-names>RP</given-names></name>, <name><surname>Muttukrishna</surname><given-names>S</given-names></name>, <name><surname>Mohan</surname><given-names>A</given-names></name>, <name><surname>Groome</surname><given-names>N</given-names></name>, <name><surname>Murphy</surname><given-names>DJ</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Maternal serum activin A, inhibin A, and follistatin in pregnancies with appropriately grown and small-for-gestational-age fetuses classified by umbilical artery Doppler ultrasound</article-title>. <source>Am J Obstet Gynecol</source>
<volume>186</volume>: <fpage>283</fpage>–<lpage>287</lpage>. <?supplied-pmid 11854651?><pub-id pub-id-type="pmid">11854651</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref079">
                <label>79</label>
                <mixed-citation publication-type="journal"><name><surname>Melchiorre</surname><given-names>K</given-names></name>, <name><surname>Leslie</surname><given-names>K</given-names></name>, <name><surname>Prefumo</surname><given-names>F</given-names></name>, <name><surname>Bhide</surname><given-names>A</given-names></name>, <name><surname>Thilaganathan</surname><given-names>B</given-names></name> (<year>2009</year>) <article-title>First-trimester uterine artery Doppler indices in the prediction of small-for-gestational age pregnancy and intrauterine growth restriction</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>33</volume>: <fpage>524</fpage>–<lpage>529</lpage>. <pub-id pub-id-type="doi">10.1002/uog.6368</pub-id>
<?supplied-pmid 19382287?><pub-id pub-id-type="pmid">19382287</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref080">
                <label>80</label>
                <mixed-citation publication-type="journal"><name><surname>Karagiannis</surname><given-names>G</given-names></name>, <name><surname>Akolekar</surname><given-names>R</given-names></name>, <name><surname>Sarquis</surname><given-names>R</given-names></name>, <name><surname>Wright</surname><given-names>D</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2011</year>) <article-title>Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11–13 weeks</article-title>. <source>Fetal Diagn Ther</source>
<volume>29</volume>: <fpage>148</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1159/000321694</pub-id>
<?supplied-pmid 21079385?><pub-id pub-id-type="pmid">21079385</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref081">
                <label>81</label>
                <mixed-citation publication-type="journal"><name><surname>Crovetto</surname><given-names>F</given-names></name>, <name><surname>Triunfo</surname><given-names>S</given-names></name>, <name><surname>Crispi</surname><given-names>F</given-names></name>, <name><surname>Rodriguez-Sureda</surname><given-names>V</given-names></name>, <name><surname>Roma</surname><given-names>E</given-names></name>, <name><surname>Dominguez</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>First-trimester screening with specific algorithms for early- and late-onset fetal growth restriction</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>48</volume>: <fpage>340</fpage>–<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1002/uog.15879</pub-id>
<?supplied-pmid 26846589?><pub-id pub-id-type="pmid">26846589</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref082">
                <label>82</label>
                <mixed-citation publication-type="journal"><name><surname>Parry</surname><given-names>S</given-names></name>, <name><surname>Sciscione</surname><given-names>A</given-names></name>, <name><surname>Haas</surname><given-names>DM</given-names></name>, <name><surname>Grobman</surname><given-names>WA</given-names></name>, <name><surname>Iams</surname><given-names>JD</given-names></name>, <name><surname>Mercer</surname><given-names>BM</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Role of early second-trimester uterine artery Doppler screening to predict small-for-gestational-age babies in nulliparous women</article-title>. <source>Am J Obstet Gynecol</source>: <fpage>30749</fpage>–<lpage>30744</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref083">
                <label>83</label>
                <mixed-citation publication-type="journal"><name><surname>Spencer</surname><given-names>K</given-names></name>, <name><surname>Cowans</surname><given-names>NJ</given-names></name>, <name><surname>Molina</surname><given-names>F</given-names></name>, <name><surname>Kagan</surname><given-names>KO</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2008</year>) <article-title>First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>31</volume>: <fpage>147</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1002/uog.5163</pub-id>
<?supplied-pmid 17992705?><pub-id pub-id-type="pmid">17992705</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref084">
                <label>84</label>
                <mixed-citation publication-type="journal"><name><surname>Antsaklis</surname><given-names>P</given-names></name>, <name><surname>Daskalakis</surname><given-names>G</given-names></name>, <name><surname>Pilalis</surname><given-names>A</given-names></name>, <name><surname>Papantoniou</surname><given-names>N</given-names></name>, <name><surname>Mesogitis</surname><given-names>S</given-names></name>, <name><surname>Antsaklis</surname><given-names>A</given-names></name> (<year>2011</year>) <article-title>The role of cervical length measurement at 11–14 weeks for the prediction of preterm delivery</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>24</volume>: <fpage>465</fpage>–<lpage>470</lpage>. <pub-id pub-id-type="doi">10.3109/14767058.2010.501124</pub-id>
<?supplied-pmid 20608797?><pub-id pub-id-type="pmid">20608797</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref085">
                <label>85</label>
                <mixed-citation publication-type="journal"><name><surname>Bakalis</surname><given-names>SP</given-names></name>, <name><surname>Poon</surname><given-names>LC</given-names></name>, <name><surname>Vayna</surname><given-names>AM</given-names></name>, <name><surname>Pafilis</surname><given-names>I</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2012</year>) <article-title>C-reactive protein at 11–13 weeks' gestation in spontaneous early preterm delivery</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>25</volume>: <fpage>2475</fpage>–<lpage>2478</lpage>. <pub-id pub-id-type="doi">10.3109/14767058.2012.717127</pub-id>
<?supplied-pmid 22900797?><pub-id pub-id-type="pmid">22900797</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref086">
                <label>86</label>
                <mixed-citation publication-type="journal"><name><surname>Gervasi</surname><given-names>MT</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Bracalente</surname><given-names>G</given-names></name>, <name><surname>Erez</surname><given-names>O</given-names></name>, <name><surname>Dong</surname><given-names>Z</given-names></name>, <name><surname>Hassan</surname><given-names>SS</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (&lt;32 weeks) and late (&gt;32 weeks) preterm delivery</article-title>. <source>J Perinat Med</source>
<volume>40</volume>: <fpage>329</fpage>–<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1515/jpm-2012-0034</pub-id>
<?supplied-pmid 22752762?><pub-id pub-id-type="pmid">22752762</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref087">
                <label>87</label>
                <mixed-citation publication-type="journal"><name><surname>Greco</surname><given-names>E</given-names></name>, <name><surname>Gupta</surname><given-names>R</given-names></name>, <name><surname>Syngelaki</surname><given-names>A</given-names></name>, <name><surname>Poon</surname><given-names>LC</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2012</year>) <article-title>First-trimester screening for spontaneous preterm delivery with maternal characteristics and cervical length</article-title>. <source>Fetal Diagn Ther</source>
<volume>31</volume>: <fpage>154</fpage>–<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1159/000335686</pub-id>
<?supplied-pmid 22399065?><pub-id pub-id-type="pmid">22399065</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref088">
                <label>88</label>
                <mixed-citation publication-type="journal"><name><surname>Goetzinger</surname><given-names>KR</given-names></name>, <name><surname>Cahill</surname><given-names>AG</given-names></name>, <name><surname>Kemna</surname><given-names>J</given-names></name>, <name><surname>Odibo</surname><given-names>L</given-names></name>, <name><surname>Macones</surname><given-names>GA</given-names></name>, <name><surname>Odibo</surname><given-names>AO</given-names></name> (<year>2012</year>) <article-title>First-trimester prediction of preterm birth using ADAM12, PAPP-A, uterine artery Doppler, and maternal characteristics</article-title>. <source>Prenat Diagn</source>
<volume>32</volume>: <fpage>1002</fpage>–<lpage>1007</lpage>. <pub-id pub-id-type="doi">10.1002/pd.3949</pub-id>
<?supplied-pmid 22847849?><pub-id pub-id-type="pmid">22847849</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref089">
                <label>89</label>
                <mixed-citation publication-type="journal"><name><surname>Stout</surname><given-names>MJ</given-names></name>, <name><surname>Goetzinger</surname><given-names>KR</given-names></name>, <name><surname>Tuuli</surname><given-names>MG</given-names></name>, <name><surname>Cahill</surname><given-names>AG</given-names></name>, <name><surname>Macones</surname><given-names>GA</given-names></name>, <name><surname>Odibo</surname><given-names>AO</given-names></name> (<year>2013</year>) <article-title>First trimester serum analytes, maternal characteristics and ultrasound markers to predict pregnancies at risk for preterm birth</article-title>. <source>Placenta</source>
<volume>34</volume>: <fpage>14</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.placenta.2012.10.013</pub-id>
<?supplied-pmid 23199792?><pub-id pub-id-type="pmid">23199792</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref090">
                <label>90</label>
                <mixed-citation publication-type="journal"><name><surname>Conde-Agudelo</surname><given-names>A</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name> (<year>2014</year>) <article-title>Prediction of preterm birth in twin gestations using biophysical and biochemical tests</article-title>. <source>Am J Obstet Gynecol</source>
<volume>211</volume>: <fpage>583</fpage>–<lpage>595</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajog.2014.07.047</pub-id>
<?supplied-pmid 25072736?><pub-id pub-id-type="pmid">25072736</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref091">
                <label>91</label>
                <mixed-citation publication-type="journal"><name><surname>Parra-Cordero</surname><given-names>M</given-names></name>, <name><surname>Sepulveda-Martinez</surname><given-names>A</given-names></name>, <name><surname>Rencoret</surname><given-names>G</given-names></name>, <name><surname>Valdes</surname><given-names>E</given-names></name>, <name><surname>Pedraza</surname><given-names>D</given-names></name>, <name><surname>Munoz</surname><given-names>H</given-names></name> (<year>2014</year>) <article-title>Is there a role for cervical assessment and uterine artery Doppler in the first trimester of pregnancy as a screening test for spontaneous preterm delivery?</article-title>
<source>Ultrasound Obstet Gynecol</source>
<volume>43</volume>: <fpage>291</fpage>–<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1002/uog.12465</pub-id>
<?supplied-pmid 23526790?><pub-id pub-id-type="pmid">23526790</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref092">
                <label>92</label>
                <mixed-citation publication-type="journal"><name><surname>Ekin</surname><given-names>A</given-names></name>, <name><surname>Gezer</surname><given-names>C</given-names></name>, <name><surname>Kulhan</surname><given-names>G</given-names></name>, <name><surname>Avci</surname><given-names>ME</given-names></name>, <name><surname>Taner</surname><given-names>CE</given-names></name> (<year>2015</year>) <article-title>Can platelet count and mean platelet volume during the first trimester of pregnancy predict preterm premature rupture of membranes</article-title>? <source>J Obstet Gynaecol Res</source>
<volume>41</volume>: <fpage>23</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1111/jog.12484</pub-id>
<?supplied-pmid 25130327?><pub-id pub-id-type="pmid">25130327</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref093">
                <label>93</label>
                <mixed-citation publication-type="journal"><name><surname>Quezada</surname><given-names>MS</given-names></name>, <name><surname>Francisco</surname><given-names>C</given-names></name>, <name><surname>Dumitrascu-Biris</surname><given-names>D</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name>, <name><surname>Poon</surname><given-names>LC</given-names></name> (<year>2015</year>) <article-title>Fetal fraction of cell-free DNA in maternal plasma in the prediction of spontaneous preterm delivery</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>45</volume>: <fpage>101</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1002/uog.14666</pub-id>
<?supplied-pmid 25251634?><pub-id pub-id-type="pmid">25251634</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref094">
                <label>94</label>
                <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>SM</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Lee</surname><given-names>J</given-names></name>, <name><surname>Chaemsaithong</surname><given-names>P</given-names></name>, <name><surname>Lee</surname><given-names>MW</given-names></name>, <name><surname>Chaiyasit</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>About one-half of early spontaneous preterm deliveries can be identified by a rapid matrix metalloproteinase-8 (MMP-8) bedside test at the time of mid-trimester genetic amniocentesis</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>29</volume>: <fpage>2414</fpage>–<lpage>2422</lpage>. <pub-id pub-id-type="doi">10.3109/14767058.2015.1094049</pub-id>
<?supplied-pmid 26643648?><pub-id pub-id-type="pmid">26643648</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref095">
                <label>95</label>
                <mixed-citation publication-type="journal"><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Korzeniewski</surname><given-names>SJ</given-names></name>, <name><surname>Kusanovic</surname><given-names>JP</given-names></name>, <name><surname>Soto</surname><given-names>E</given-names></name>, <name><surname>Lam</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia</article-title>. <source>Am J Obstet Gynecol</source>
<volume>208</volume>: 287.e281-287.e215.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref096">
                <label>96</label>
                <mixed-citation publication-type="journal"><name><surname>Conde-Agudelo</surname><given-names>A</given-names></name>, <name><surname>Bird</surname><given-names>S</given-names></name>, <name><surname>Kennedy</surname><given-names>SH</given-names></name>, <name><surname>Villar</surname><given-names>J</given-names></name>, <name><surname>Papageorghiou</surname><given-names>AT</given-names></name> (<year>2015</year>) <article-title>First- and second-trimester tests to predict stillbirth in unselected pregnant women: a systematic review and meta-analysis</article-title>. <source>Bjog</source>
<volume>122</volume>: <fpage>41</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1111/1471-0528.13096</pub-id>
<?supplied-pmid 25236870?><pub-id pub-id-type="pmid">25236870</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref097">
                <label>97</label>
                <mixed-citation publication-type="journal"><name><surname>Akolekar</surname><given-names>R</given-names></name>, <name><surname>Machuca</surname><given-names>M</given-names></name>, <name><surname>Mendes</surname><given-names>M</given-names></name>, <name><surname>Paschos</surname><given-names>V</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2016</year>) <article-title>Prediction of stillbirth from placental growth factor at 11–13 weeks</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>48</volume>: <fpage>618</fpage>–<lpage>623</lpage>. <pub-id pub-id-type="doi">10.1002/uog.17288</pub-id>
<?supplied-pmid 27854388?><pub-id pub-id-type="pmid">27854388</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref098">
                <label>98</label>
                <mixed-citation publication-type="journal"><name><surname>Aupont</surname><given-names>JE</given-names></name>, <name><surname>Akolekar</surname><given-names>R</given-names></name>, <name><surname>Illian</surname><given-names>A</given-names></name>, <name><surname>Neonakis</surname><given-names>S</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2016</year>) <article-title>Prediction of stillbirth from placental growth factor at 19–24 weeks</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>48</volume>: <fpage>631</fpage>–<lpage>635</lpage>. <pub-id pub-id-type="doi">10.1002/uog.17229</pub-id>
<?supplied-pmid 27854395?><pub-id pub-id-type="pmid">27854395</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref099">
                <label>99</label>
                <mixed-citation publication-type="journal"><name><surname>Familiari</surname><given-names>A</given-names></name>, <name><surname>Scala</surname><given-names>C</given-names></name>, <name><surname>Morlando</surname><given-names>M</given-names></name>, <name><surname>Bhide</surname><given-names>A</given-names></name>, <name><surname>Khalil</surname><given-names>A</given-names></name>, <name><surname>Thilaganathan</surname><given-names>B</given-names></name> (<year>2016</year>) <article-title>Mid-pregnancy fetal growth, uteroplacental Doppler indices and maternal demographic characteristics: role in prediction of stillbirth</article-title>. <source>Acta Obstet Gynecol Scand</source>
<volume>95</volume>: <fpage>1313</fpage>–<lpage>1318</lpage>. <pub-id pub-id-type="doi">10.1111/aogs.13012</pub-id>
<?supplied-pmid 27588413?><pub-id pub-id-type="pmid">27588413</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref100">
                <label>100</label>
                <mixed-citation publication-type="journal"><name><surname>Akolekar</surname><given-names>R</given-names></name>, <name><surname>Tokunaka</surname><given-names>M</given-names></name>, <name><surname>Ortega</surname><given-names>N</given-names></name>, <name><surname>Syngelaki</surname><given-names>A</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2016</year>) <article-title>Prediction of stillbirth from maternal factors, fetal biometry and uterine artery Doppler at 19–24 weeks</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>48</volume>: <fpage>624</fpage>–<lpage>630</lpage>. <pub-id pub-id-type="doi">10.1002/uog.17295</pub-id>
<?supplied-pmid 27854387?><pub-id pub-id-type="pmid">27854387</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref101">
                <label>101</label>
                <mixed-citation publication-type="journal"><name><surname>Kayode</surname><given-names>GA</given-names></name>, <name><surname>Grobbee</surname><given-names>DE</given-names></name>, <name><surname>Amoakoh-Coleman</surname><given-names>M</given-names></name>, <name><surname>Adeleke</surname><given-names>IT</given-names></name>, <name><surname>Ansah</surname><given-names>E</given-names></name>, <name><surname>de Groot</surname><given-names>JA</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Predicting stillbirth in a low resource setting</article-title>. <source>BMC Pregnancy Childbirth</source>
<volume>16</volume>: <fpage>274</fpage>
<pub-id pub-id-type="doi">10.1186/s12884-016-1061-2</pub-id>
<?supplied-pmid 27649795?><pub-id pub-id-type="pmid">27649795</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref102">
                <label>102</label>
                <mixed-citation publication-type="journal"><name><surname>Khalil</surname><given-names>A</given-names></name>, <name><surname>Morales-Rosello</surname><given-names>J</given-names></name>, <name><surname>Townsend</surname><given-names>R</given-names></name>, <name><surname>Morlando</surname><given-names>M</given-names></name>, <name><surname>Papageorghiou</surname><given-names>A</given-names></name>, <name><surname>Bhide</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Value of third-trimester cerebroplacental ratio and uterine artery Doppler indices as predictors of stillbirth and perinatal loss</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>47</volume>: <fpage>74</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1002/uog.15729</pub-id>
<?supplied-pmid 26327300?><pub-id pub-id-type="pmid">26327300</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref103">
                <label>103</label>
                <mixed-citation publication-type="journal"><name><surname>Mastrodima</surname><given-names>S</given-names></name>, <name><surname>Akolekar</surname><given-names>R</given-names></name>, <name><surname>Yerlikaya</surname><given-names>G</given-names></name>, <name><surname>Tzelepis</surname><given-names>T</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2016</year>) <article-title>Prediction of stillbirth from biochemical and biophysical markers at 11–13 weeks</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>48</volume>: <fpage>613</fpage>–<lpage>617</lpage>. <pub-id pub-id-type="doi">10.1002/uog.17289</pub-id>
<?supplied-pmid 27561595?><pub-id pub-id-type="pmid">27561595</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref104">
                <label>104</label>
                <mixed-citation publication-type="journal"><name><surname>Yerlikaya</surname><given-names>G</given-names></name>, <name><surname>Akolekar</surname><given-names>R</given-names></name>, <name><surname>McPherson</surname><given-names>K</given-names></name>, <name><surname>Syngelaki</surname><given-names>A</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2016</year>) <article-title>Prediction of stillbirth from maternal demographic and pregnancy characteristics</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>48</volume>: <fpage>607</fpage>–<lpage>612</lpage>. <pub-id pub-id-type="doi">10.1002/uog.17290</pub-id>
<?supplied-pmid 27561693?><pub-id pub-id-type="pmid">27561693</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref105">
                <label>105</label>
                <mixed-citation publication-type="journal"><name><surname>Trudell</surname><given-names>AS</given-names></name>, <name><surname>Tuuli</surname><given-names>MG</given-names></name>, <name><surname>Colditz</surname><given-names>GA</given-names></name>, <name><surname>Macones</surname><given-names>GA</given-names></name>, <name><surname>Odibo</surname><given-names>AO</given-names></name> (<year>2017</year>) <article-title>A stillbirth calculator: Development and internal validation of a clinical prediction model to quantify stillbirth risk</article-title>. <source>PLoS One</source>
<volume>12</volume>: <fpage>e0173461</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0173461</pub-id>
<?supplied-pmid 28267756?><pub-id pub-id-type="pmid">28267756</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref106">
                <label>106</label>
                <mixed-citation publication-type="journal"><name><surname>Madazli</surname><given-names>R</given-names></name>, <name><surname>Kuseyrioglu</surname><given-names>B</given-names></name>, <name><surname>Uzun</surname><given-names>H</given-names></name>, <name><surname>Uludag</surname><given-names>S</given-names></name>, <name><surname>Ocak</surname><given-names>V</given-names></name> (<year>2005</year>) <article-title>Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry</article-title>. <source>Int J Gynaecol Obstet</source>
<volume>89</volume>: <fpage>251</fpage>–<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijgo.2005.02.008</pub-id>
<?supplied-pmid 15919391?><pub-id pub-id-type="pmid">15919391</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref107">
                <label>107</label>
                <mixed-citation publication-type="journal"><name><surname>Poon</surname><given-names>LC</given-names></name>, <name><surname>Karagiannis</surname><given-names>G</given-names></name>, <name><surname>Leal</surname><given-names>A</given-names></name>, <name><surname>Romero</surname><given-names>XC</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2009</year>) <article-title>Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11–13 weeks</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>34</volume>: <fpage>497</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1002/uog.7439</pub-id>
<?supplied-pmid 19827052?><pub-id pub-id-type="pmid">19827052</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref108">
                <label>108</label>
                <mixed-citation publication-type="book"><name><surname>Conde-Agudelo</surname><given-names>A</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>James</surname><given-names>MR</given-names></name> (<year>2015</year>) <chapter-title>Tests to Predict Preeclampsia</chapter-title> In: <name><surname>Taylor</surname><given-names>RN</given-names></name>, <name><surname>Roberts</surname><given-names>JM</given-names></name>, <name><surname>Cunningham</surname><given-names>FG</given-names></name>, <name><surname>Lindheimer</surname><given-names>MD</given-names></name>, <name><surname>Chesley</surname><given-names>LC</given-names></name>, editors. <source>Chesley's Hypertensive disorders in pregnancy</source>. <edition>Fourth Edition</edition> ed. <publisher-loc>Amsterdam; Boston</publisher-loc>: <publisher-name>Elsevier/AP, Academic Press is an imprint of Elsevier</publisher-name>,. pp. <fpage>221</fpage>–<lpage>251</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref109">
                <label>109</label>
                <mixed-citation publication-type="journal"><name><surname>Yliniemi</surname><given-names>A</given-names></name>, <name><surname>Makikallio</surname><given-names>K</given-names></name>, <name><surname>Korpimaki</surname><given-names>T</given-names></name>, <name><surname>Kouru</surname><given-names>H</given-names></name>, <name><surname>Marttala</surname><given-names>J</given-names></name>, <name><surname>Ryynanen</surname><given-names>M</given-names></name> (<year>2015</year>) <article-title>Combination of PAPPA, fhCGbeta, AFP, PlGF, sTNFR1, and Maternal Characteristics in Prediction of Early-onset Preeclampsia</article-title>. <source>Clin Med Insights Reprod Health</source>
<volume>9</volume>: <fpage>13</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.4137/CMRH.S21865</pub-id>
<?supplied-pmid 26106266?><pub-id pub-id-type="pmid">26106266</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref110">
                <label>110</label>
                <mixed-citation publication-type="journal"><name><surname>Brunelli</surname><given-names>VB</given-names></name>, <name><surname>Prefumo</surname><given-names>F</given-names></name> (<year>2015</year>) <article-title>Quality of first trimester risk prediction models for pre-eclampsia: a systematic review</article-title>. <source>Bjog</source>
<volume>122</volume>: <fpage>904</fpage>–<lpage>914</lpage>. <pub-id pub-id-type="doi">10.1111/1471-0528.13334</pub-id>
<?supplied-pmid 25761437?><pub-id pub-id-type="pmid">25761437</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref111">
                <label>111</label>
                <mixed-citation publication-type="journal"><name><surname>Scazzocchio</surname><given-names>E</given-names></name>, <name><surname>Crovetto</surname><given-names>F</given-names></name>, <name><surname>Triunfo</surname><given-names>S</given-names></name>, <name><surname>Gratacos</surname><given-names>E</given-names></name>, <name><surname>Figueras</surname><given-names>F</given-names></name> (<year>2017</year>) <article-title>Validation of a first-trimester screening model for pre-eclampsia in an unselected population</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>49</volume>: <fpage>188</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1002/uog.15982</pub-id>
<?supplied-pmid 27257033?><pub-id pub-id-type="pmid">27257033</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref112">
                <label>112</label>
                <mixed-citation publication-type="journal"><name><surname>Guizani</surname><given-names>M</given-names></name>, <name><surname>Valsamis</surname><given-names>J</given-names></name>, <name><surname>Dutemeyer</surname><given-names>V</given-names></name>, <name><surname>Kang</surname><given-names>X</given-names></name>, <name><surname>Ceccoti</surname><given-names>V</given-names></name>, <name><surname>Khalife</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>First-Trimester Combined Multimarker Prospective Study for the Detection of Pregnancies at a High Risk of Developing Preeclampsia Using the Fetal Medicine Foundation-Algorithm</article-title>. <source>Fetal Diagn Ther</source>: <fpage>1</fpage>–<lpage>8</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref113">
                <label>113</label>
                <mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>HJ</given-names></name>, <name><surname>Kim</surname><given-names>SH</given-names></name>, <name><surname>Jung</surname><given-names>YW</given-names></name>, <name><surname>Shim</surname><given-names>SS</given-names></name>, <name><surname>Kim</surname><given-names>JY</given-names></name>, <name><surname>Cho</surname><given-names>YK</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy</article-title>. <source>BMC Pregnancy Childbirth</source>
<volume>14</volume>: <fpage>35</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2393-14-35</pub-id>
<?supplied-pmid 24444293?><pub-id pub-id-type="pmid">24444293</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref114">
                <label>114</label>
                <mixed-citation publication-type="journal"><name><surname>Sibai</surname><given-names>BM</given-names></name>, <name><surname>Gordon</surname><given-names>T</given-names></name>, <name><surname>Thom</surname><given-names>E</given-names></name>, <name><surname>Caritis</surname><given-names>SN</given-names></name>, <name><surname>Klebanoff</surname><given-names>M</given-names></name>, <name><surname>McNellis</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>1995</year>) <article-title>Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units</article-title>. <source>Am J Obstet Gynecol</source>
<volume>172</volume>: <fpage>642</fpage>–<lpage>648</lpage>. <?supplied-pmid 7856699?><pub-id pub-id-type="pmid">7856699</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref115">
                <label>115</label>
                <mixed-citation publication-type="journal"><name><surname>Sibai</surname><given-names>BM</given-names></name>, <name><surname>Ewell</surname><given-names>M</given-names></name>, <name><surname>Levine</surname><given-names>RJ</given-names></name>, <name><surname>Klebanoff</surname><given-names>MA</given-names></name>, <name><surname>Esterlitz</surname><given-names>J</given-names></name>, <name><surname>Catalano</surname><given-names>PM</given-names></name>, <etal>et al</etal> (<year>1997</year>) <article-title>Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group</article-title>. <source>Am J Obstet Gynecol</source>
<volume>177</volume>: <fpage>1003</fpage>–<lpage>1010</lpage>. <?supplied-pmid 9396883?><pub-id pub-id-type="pmid">9396883</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref116">
                <label>116</label>
                <mixed-citation publication-type="journal"><name><surname>Poon</surname><given-names>LC</given-names></name>, <name><surname>Kametas</surname><given-names>NA</given-names></name>, <name><surname>Chelemen</surname><given-names>T</given-names></name>, <name><surname>Leal</surname><given-names>A</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2010</year>) <article-title>Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach</article-title>. <source>J Hum Hypertens</source>
<volume>24</volume>: <fpage>104</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1038/jhh.2009.45</pub-id>
<?supplied-pmid 19516271?><pub-id pub-id-type="pmid">19516271</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref117">
                <label>117</label>
                <mixed-citation publication-type="journal"><name><surname>Wright</surname><given-names>D</given-names></name>, <name><surname>Syngelaki</surname><given-names>A</given-names></name>, <name><surname>Akolekar</surname><given-names>R</given-names></name>, <name><surname>Poon</surname><given-names>LC</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2015</year>) <article-title>Competing risks model in screening for preeclampsia by maternal characteristics and medical history</article-title>. <source>Am J Obstet Gynecol</source>
<volume>213</volume>: 62.e61-10.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref118">
                <label>118</label>
                <mixed-citation publication-type="journal"><name><surname>Rocha</surname><given-names>RS</given-names></name>, <name><surname>Alves</surname><given-names>JA</given-names></name>, <name><surname>Maia</surname><given-names>EHMSB</given-names></name>, <name><surname>Araujo Junior</surname><given-names>E</given-names></name>, <name><surname>Peixoto</surname><given-names>AB</given-names></name>, <name><surname>Santana</surname><given-names>EF</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Simple approach based on maternal characteristics and mean arterial pressure for the prediction of preeclampsia in the first trimester of pregnancy</article-title>. <source>J Perinat Med</source>.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref119">
                <label>119</label>
                <mixed-citation publication-type="journal"><name><surname>Crispi</surname><given-names>F</given-names></name>, <name><surname>Dominguez</surname><given-names>C</given-names></name>, <name><surname>Llurba</surname><given-names>E</given-names></name>, <name><surname>Martin-Gallan</surname><given-names>P</given-names></name>, <name><surname>Cabero</surname><given-names>L</given-names></name>, <name><surname>Gratacos</surname><given-names>E</given-names></name> (<year>2006</year>) <article-title>Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction</article-title>. <source>Am J Obstet Gynecol</source>
<volume>195</volume>: <fpage>201</fpage>–<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajog.2006.01.014</pub-id>
<?supplied-pmid 16545329?><pub-id pub-id-type="pmid">16545329</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref120">
                <label>120</label>
                <mixed-citation publication-type="journal"><name><surname>Kuc</surname><given-names>S</given-names></name>, <name><surname>Wortelboer</surname><given-names>EJ</given-names></name>, <name><surname>van Rijn</surname><given-names>BB</given-names></name>, <name><surname>Franx</surname><given-names>A</given-names></name>, <name><surname>Visser</surname><given-names>GH</given-names></name>, <name><surname>Schielen</surname><given-names>PC</given-names></name> (<year>2011</year>) <article-title>Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review</article-title>. <source>Obstet Gynecol Surv</source>
<volume>66</volume>: <fpage>225</fpage>–<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1097/OGX.0b013e3182227027</pub-id>
<?supplied-pmid 21756405?><pub-id pub-id-type="pmid">21756405</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref121">
                <label>121</label>
                <mixed-citation publication-type="journal"><name><surname>Tobinaga</surname><given-names>CM</given-names></name>, <name><surname>Torloni</surname><given-names>MR</given-names></name>, <name><surname>Gueuvoghlanian-Silva</surname><given-names>BY</given-names></name>, <name><surname>Pendeloski</surname><given-names>KP</given-names></name>, <name><surname>Akita</surname><given-names>PA</given-names></name>, <name><surname>Sass</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Angiogenic factors and uterine Doppler velocimetry in early- and late-onset preeclampsia</article-title>. <source>Acta Obstet Gynecol Scand</source>
<volume>93</volume>: <fpage>469</fpage>–<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1111/aogs.12366</pub-id>
<?supplied-pmid 24580069?><pub-id pub-id-type="pmid">24580069</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref122">
                <label>122</label>
                <mixed-citation publication-type="journal"><name><surname>Seravalli</surname><given-names>V</given-names></name>, <name><surname>Grimpel</surname><given-names>YI</given-names></name>, <name><surname>Meiri</surname><given-names>H</given-names></name>, <name><surname>Blitzer</surname><given-names>M</given-names></name>, <name><surname>Baschat</surname><given-names>AA</given-names></name> (<year>2016</year>) <article-title>Relationship between first-trimester serum placental protein-13 and maternal characteristics, placental Doppler studies and pregnancy outcome</article-title>. <source>J Perinat Med</source>
<volume>44</volume>: <fpage>543</fpage>–<lpage>549</lpage>. <pub-id pub-id-type="doi">10.1515/jpm-2015-0324</pub-id>
<?supplied-pmid 26910737?><pub-id pub-id-type="pmid">26910737</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref123">
                <label>123</label>
                <mixed-citation publication-type="journal"><name><surname>Spencer</surname><given-names>K</given-names></name>, <name><surname>Yu</surname><given-names>CK</given-names></name>, <name><surname>Cowans</surname><given-names>NJ</given-names></name>, <name><surname>Otigbah</surname><given-names>C</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2005</year>) <article-title>Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler</article-title>. <source>Prenat Diagn</source>
<volume>25</volume>: <fpage>949</fpage>–<lpage>953</lpage>. <pub-id pub-id-type="doi">10.1002/pd.1251</pub-id>
<?supplied-pmid 16086443?><pub-id pub-id-type="pmid">16086443</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref124">
                <label>124</label>
                <mixed-citation publication-type="journal"><name><surname>Spencer</surname><given-names>K</given-names></name>, <name><surname>Yu</surname><given-names>CK</given-names></name>, <name><surname>Savvidou</surname><given-names>M</given-names></name>, <name><surname>Papageorghiou</surname><given-names>AT</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2006</year>) <article-title>Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>27</volume>: <fpage>658</fpage>–<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1002/uog.2676</pub-id>
<?supplied-pmid 16493628?><pub-id pub-id-type="pmid">16493628</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref125">
                <label>125</label>
                <mixed-citation publication-type="journal"><name><surname>Poon</surname><given-names>LC</given-names></name>, <name><surname>Stratieva</surname><given-names>V</given-names></name>, <name><surname>Piras</surname><given-names>S</given-names></name>, <name><surname>Piri</surname><given-names>S</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2010</year>) <article-title>Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11–13 weeks</article-title>. <source>Prenat Diagn</source>
<volume>30</volume>: <fpage>216</fpage>–<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1002/pd.2440</pub-id>
<?supplied-pmid 20108221?><pub-id pub-id-type="pmid">20108221</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref126">
                <label>126</label>
                <mixed-citation publication-type="journal"><name><surname>Ay</surname><given-names>E</given-names></name>, <name><surname>Kavak</surname><given-names>ZN</given-names></name>, <name><surname>Elter</surname><given-names>K</given-names></name>, <name><surname>Gokaslan</surname><given-names>H</given-names></name>, <name><surname>Pekin</surname><given-names>T</given-names></name> (<year>2005</year>) <article-title>Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy</article-title>. <source>Aust N Z J Obstet Gynaecol</source>
<volume>45</volume>: <fpage>283</fpage>–<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1111/j.1479-828X.2005.00412.x</pub-id>
<?supplied-pmid 16029293?><pub-id pub-id-type="pmid">16029293</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref127">
                <label>127</label>
                <mixed-citation publication-type="journal"><name><surname>Akolekar</surname><given-names>R</given-names></name>, <name><surname>Minekawa</surname><given-names>R</given-names></name>, <name><surname>Veduta</surname><given-names>A</given-names></name>, <name><surname>Romero</surname><given-names>XC</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2009</year>) <article-title>Maternal plasma inhibin A at 11–13 weeks of gestation in hypertensive disorders of pregnancy</article-title>. <source>Prenat Diagn</source>
<volume>29</volume>: <fpage>753</fpage>–<lpage>760</lpage>. <pub-id pub-id-type="doi">10.1002/pd.2279</pub-id>
<?supplied-pmid 19412915?><pub-id pub-id-type="pmid">19412915</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref128">
                <label>128</label>
                <mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>J</given-names></name>, <name><surname>Shixia</surname><given-names>CZ</given-names></name>, <name><surname>Wu</surname><given-names>Y</given-names></name>, <name><surname>Duan</surname><given-names>T</given-names></name> (<year>2011</year>) <article-title>Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>37</volume>: <fpage>528</fpage>–<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1002/uog.8800</pub-id>
<?supplied-pmid 20737451?><pub-id pub-id-type="pmid">20737451</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref129">
                <label>129</label>
                <mixed-citation publication-type="journal"><name><surname>Levine</surname><given-names>RJ</given-names></name>, <name><surname>Maynard</surname><given-names>SE</given-names></name>, <name><surname>Qian</surname><given-names>C</given-names></name>, <name><surname>Lim</surname><given-names>KH</given-names></name>, <name><surname>England</surname><given-names>LJ</given-names></name>, <name><surname>Yu</surname><given-names>KF</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Circulating angiogenic factors and the risk of preeclampsia</article-title>. <source>N Engl J Med</source>
<volume>350</volume>: <fpage>672</fpage>–<lpage>683</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa031884</pub-id>
<?supplied-pmid 14764923?><pub-id pub-id-type="pmid">14764923</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref130">
                <label>130</label>
                <mixed-citation publication-type="journal"><name><surname>Moore</surname><given-names>AG</given-names></name>, <name><surname>Young</surname><given-names>H</given-names></name>, <name><surname>Keller</surname><given-names>JM</given-names></name>, <name><surname>Ojo</surname><given-names>LR</given-names></name>, <name><surname>Yan</surname><given-names>J</given-names></name>, <name><surname>Simas</surname><given-names>TA</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>25</volume>: <fpage>2651</fpage>–<lpage>2657</lpage>. <pub-id pub-id-type="doi">10.3109/14767058.2012.713055</pub-id>
<?supplied-pmid 22861812?><pub-id pub-id-type="pmid">22861812</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref131">
                <label>131</label>
                <mixed-citation publication-type="journal"><name><surname>Villa</surname><given-names>PM</given-names></name>, <name><surname>Hamalainen</surname><given-names>E</given-names></name>, <name><surname>Maki</surname><given-names>A</given-names></name>, <name><surname>Raikkonen</surname><given-names>K</given-names></name>, <name><surname>Pesonen</surname><given-names>AK</given-names></name>, <name><surname>Taipale</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort</article-title>. <source>BMC Pregnancy Childbirth</source>
<volume>13</volume>: <fpage>110</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2393-13-110</pub-id>
<?supplied-pmid 23663420?><pub-id pub-id-type="pmid">23663420</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref132">
                <label>132</label>
                <mixed-citation publication-type="journal"><name><surname>Allen</surname><given-names>RE</given-names></name>, <name><surname>Rogozinska</surname><given-names>E</given-names></name>, <name><surname>Cleverly</surname><given-names>K</given-names></name>, <name><surname>Aquilina</surname><given-names>J</given-names></name>, <name><surname>Thangaratinam</surname><given-names>S</given-names></name> (<year>2014</year>) <article-title>Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis</article-title>. <source>Eur J Obstet Gynecol Reprod Biol</source>
<volume>182</volume>: <fpage>194</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejogrb.2014.09.027</pub-id>
<?supplied-pmid 25305662?><pub-id pub-id-type="pmid">25305662</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref133">
                <label>133</label>
                <mixed-citation publication-type="journal"><name><surname>Wataganara</surname><given-names>T</given-names></name>, <name><surname>Pratumvinit</surname><given-names>B</given-names></name>, <name><surname>Lahfahroengron</surname><given-names>P</given-names></name>, <name><surname>Pooliam</surname><given-names>J</given-names></name>, <name><surname>Talungchit</surname><given-names>P</given-names></name>, <name><surname>Leetheeragul</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Circulating soluble fms-like tyrosine kinase-1 and placental growth factor from 10 to 40 weeks' pregnancy in normotensive women</article-title>. <source>J Perinat Med</source>
<volume>45</volume>: <fpage>895</fpage>–<lpage>901</lpage>. <pub-id pub-id-type="doi">10.1515/jpm-2017-0093</pub-id>
<?supplied-pmid 28665791?><pub-id pub-id-type="pmid">28665791</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref134">
                <label>134</label>
                <mixed-citation publication-type="journal"><name><surname>Luo</surname><given-names>Q</given-names></name>, <name><surname>Han</surname><given-names>X</given-names></name> (<year>2017</year>) <article-title>Second-trimester maternal serum markers in the prediction of preeclampsia</article-title>. <source>J Perinat Med</source>
<volume>45</volume>: <fpage>809</fpage>–<lpage>816</lpage>. <pub-id pub-id-type="doi">10.1515/jpm-2016-0249</pub-id>
<?supplied-pmid 27935854?><pub-id pub-id-type="pmid">27935854</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref135">
                <label>135</label>
                <mixed-citation publication-type="journal"><name><surname>Wikstrom</surname><given-names>AK</given-names></name>, <name><surname>Larsson</surname><given-names>A</given-names></name>, <name><surname>Eriksson</surname><given-names>UJ</given-names></name>, <name><surname>Nash</surname><given-names>P</given-names></name>, <name><surname>Norden-Lindeberg</surname><given-names>S</given-names></name>, <name><surname>Olovsson</surname><given-names>M</given-names></name> (<year>2007</year>) <article-title>Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia</article-title>. <source>Obstet Gynecol</source>
<volume>109</volume>: <fpage>1368</fpage>–<lpage>1374</lpage>. <pub-id pub-id-type="doi">10.1097/01.AOG.0000264552.85436.a1</pub-id>
<?supplied-pmid 17540809?><pub-id pub-id-type="pmid">17540809</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref136">
                <label>136</label>
                <mixed-citation publication-type="journal"><name><surname>Kurtoglu</surname><given-names>E</given-names></name>, <name><surname>Avci</surname><given-names>B</given-names></name>, <name><surname>Kokcu</surname><given-names>A</given-names></name>, <name><surname>Celik</surname><given-names>H</given-names></name>, <name><surname>Cengiz Dura</surname><given-names>M</given-names></name>, <name><surname>Malatyalioglu</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Serum VEGF and PGF may be significant markers in prediction of severity of preeclampsia</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>29</volume>: <fpage>1987</fpage>–<lpage>1992</lpage>. <pub-id pub-id-type="doi">10.3109/14767058.2015.1072157</pub-id>
<?supplied-pmid 26333278?><pub-id pub-id-type="pmid">26333278</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref137">
                <label>137</label>
                <mixed-citation publication-type="journal"><name><surname>Tsiakkas</surname><given-names>A</given-names></name>, <name><surname>Cazacu</surname><given-names>R</given-names></name>, <name><surname>Wright</surname><given-names>A</given-names></name>, <name><surname>Wright</surname><given-names>D</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2016</year>) <article-title>Maternal serum placental growth factor at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>47</volume>: <fpage>472</fpage>–<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1002/uog.15816</pub-id>
<?supplied-pmid 26582455?><pub-id pub-id-type="pmid">26582455</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref138">
                <label>138</label>
                <mixed-citation publication-type="journal"><name><surname>Tsatsaris</surname><given-names>V</given-names></name>, <name><surname>Goffin</surname><given-names>F</given-names></name>, <name><surname>Munaut</surname><given-names>C</given-names></name>, <name><surname>Brichant</surname><given-names>JF</given-names></name>, <name><surname>Pignon</surname><given-names>MR</given-names></name>, <name><surname>Noel</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences</article-title>. <source>J Clin Endocrinol Metab</source>
<volume>88</volume>: <fpage>5555</fpage>–<lpage>5563</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2003-030528</pub-id>
<?supplied-pmid 14602804?><pub-id pub-id-type="pmid">14602804</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref139">
                <label>139</label>
                <mixed-citation publication-type="journal"><name><surname>Koga</surname><given-names>K</given-names></name>, <name><surname>Osuga</surname><given-names>Y</given-names></name>, <name><surname>Yoshino</surname><given-names>O</given-names></name>, <name><surname>Hirota</surname><given-names>Y</given-names></name>, <name><surname>Ruimeng</surname><given-names>X</given-names></name>, <name><surname>Hirata</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia</article-title>. <source>J Clin Endocrinol Metab</source>
<volume>88</volume>: <fpage>2348</fpage>–<lpage>2351</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2002-021942</pub-id>
<?supplied-pmid 12727995?><pub-id pub-id-type="pmid">12727995</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref140">
                <label>140</label>
                <mixed-citation publication-type="journal"><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Espinoza</surname><given-names>J</given-names></name>, <name><surname>Bujold</surname><given-names>E</given-names></name>, <name><surname>Mee Kim</surname><given-names>Y</given-names></name>, <name><surname>Goncalves</surname><given-names>LF</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award</article-title>. <source>Am J Obstet Gynecol</source>
<volume>190</volume>: <fpage>1541</fpage>–<lpage>1547</lpage>; discussion 1547–1550. <pub-id pub-id-type="doi">10.1016/j.ajog.2004.03.043</pub-id>
<?supplied-pmid 15284729?><pub-id pub-id-type="pmid">15284729</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref141">
                <label>141</label>
                <mixed-citation publication-type="journal"><name><surname>Chung</surname><given-names>JY</given-names></name>, <name><surname>Song</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Magness</surname><given-names>RR</given-names></name>, <name><surname>Zheng</surname><given-names>J</given-names></name> (<year>2004</year>) <article-title>Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies</article-title>. <source>J Clin Endocrinol Metab</source>
<volume>89</volume>: <fpage>2484</fpage>–<lpage>2490</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2003-031580</pub-id>
<?supplied-pmid 15126581?><pub-id pub-id-type="pmid">15126581</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref142">
                <label>142</label>
                <mixed-citation publication-type="journal"><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Kim</surname><given-names>YM</given-names></name>, <name><surname>Kim</surname><given-names>GJ</given-names></name>, <name><surname>Kim</surname><given-names>MR</given-names></name>, <name><surname>Espinoza</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>17</volume>: <fpage>3</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1080/14767050400028816</pub-id>
<?supplied-pmid 15804781?><pub-id pub-id-type="pmid">15804781</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref143">
                <label>143</label>
                <mixed-citation publication-type="journal"><name><surname>Levine</surname><given-names>RJ</given-names></name>, <name><surname>Lam</surname><given-names>C</given-names></name>, <name><surname>Qian</surname><given-names>C</given-names></name>, <name><surname>Yu</surname><given-names>KF</given-names></name>, <name><surname>Maynard</surname><given-names>SE</given-names></name>, <name><surname>Sachs</surname><given-names>BP</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Soluble endoglin and other circulating antiangiogenic factors in preeclampsia</article-title>. <source>N Engl J Med</source>
<volume>355</volume>: <fpage>992</fpage>–<lpage>1005</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa055352</pub-id>
<?supplied-pmid 16957146?><pub-id pub-id-type="pmid">16957146</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref144">
                <label>144</label>
                <mixed-citation publication-type="journal"><name><surname>Stepan</surname><given-names>H</given-names></name>, <name><surname>Geipel</surname><given-names>A</given-names></name>, <name><surname>Schwarz</surname><given-names>F</given-names></name>, <name><surname>Kramer</surname><given-names>T</given-names></name>, <name><surname>Wessel</surname><given-names>N</given-names></name>, <name><surname>Faber</surname><given-names>R</given-names></name> (<year>2008</year>) <article-title>Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion</article-title>. <source>Am J Obstet Gynecol</source>
<volume>198</volume>: 175 e171-176.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref145">
                <label>145</label>
                <mixed-citation publication-type="journal"><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Kusanovic</surname><given-names>JP</given-names></name>, <name><surname>Mittal</surname><given-names>P</given-names></name>, <name><surname>Kim</surname><given-names>SK</given-names></name>, <name><surname>Gotsch</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>35</volume>: <fpage>155</fpage>–<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1002/uog.7491</pub-id>
<?supplied-pmid 20101637?><pub-id pub-id-type="pmid">20101637</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref146">
                <label>146</label>
                <mixed-citation publication-type="journal"><name><surname>Foidart</surname><given-names>JM</given-names></name>, <name><surname>Munaut</surname><given-names>C</given-names></name>, <name><surname>Chantraine</surname><given-names>F</given-names></name>, <name><surname>Akolekar</surname><given-names>R</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2010</year>) <article-title>Maternal plasma soluble endoglin at 11–13 weeks' gestation in pre-eclampsia</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>35</volume>: <fpage>680</fpage>–<lpage>687</lpage>. <pub-id pub-id-type="doi">10.1002/uog.7621</pub-id>
<?supplied-pmid 20205159?><pub-id pub-id-type="pmid">20205159</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref147">
                <label>147</label>
                <mixed-citation publication-type="journal"><name><surname>Rana</surname><given-names>S</given-names></name>, <name><surname>Cerdeira</surname><given-names>AS</given-names></name>, <name><surname>Wenger</surname><given-names>J</given-names></name>, <name><surname>Salahuddin</surname><given-names>S</given-names></name>, <name><surname>Lim</surname><given-names>KH</given-names></name>, <name><surname>Ralston</surname><given-names>SJ</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia</article-title>. <source>PLoS One</source>
<volume>7</volume>: <fpage>e48259</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0048259</pub-id>
<?supplied-pmid 23110221?><pub-id pub-id-type="pmid">23110221</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref148">
                <label>148</label>
                <mixed-citation publication-type="journal"><name><surname>Lai</surname><given-names>J</given-names></name>, <name><surname>Syngelaki</surname><given-names>A</given-names></name>, <name><surname>Poon</surname><given-names>LC</given-names></name>, <name><surname>Nucci</surname><given-names>M</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2013</year>) <article-title>Maternal serum soluble endoglin at 30–33 weeks in the prediction of preeclampsia</article-title>. <source>Fetal Diagn Ther</source>
<volume>33</volume>: <fpage>149</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1159/000343220</pub-id>
<?supplied-pmid 23154616?><pub-id pub-id-type="pmid">23154616</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref149">
                <label>149</label>
                <mixed-citation publication-type="journal"><name><surname>De Vivo</surname><given-names>A</given-names></name>, <name><surname>Baviera</surname><given-names>G</given-names></name>, <name><surname>Giordano</surname><given-names>D</given-names></name>, <name><surname>Todarello</surname><given-names>G</given-names></name>, <name><surname>Corrado</surname><given-names>F</given-names></name>, <name><surname>D'Anna</surname><given-names>R</given-names></name> (<year>2008</year>) <article-title>Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia</article-title>. <source>Acta Obstet Gynecol Scand</source>
<volume>87</volume>: <fpage>837</fpage>–<lpage>842</lpage>. <pub-id pub-id-type="doi">10.1080/00016340802253759</pub-id>
<?supplied-pmid 18607829?><pub-id pub-id-type="pmid">18607829</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref150">
                <label>150</label>
                <mixed-citation publication-type="journal"><name><surname>Baumann</surname><given-names>MU</given-names></name>, <name><surname>Bersinger</surname><given-names>NA</given-names></name>, <name><surname>Mohaupt</surname><given-names>MG</given-names></name>, <name><surname>Raio</surname><given-names>L</given-names></name>, <name><surname>Gerber</surname><given-names>S</given-names></name>, <name><surname>Surbek</surname><given-names>DV</given-names></name> (<year>2008</year>) <article-title>First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia</article-title>. <source>Am J Obstet Gynecol</source>
<volume>199</volume>: 266.e261-266.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref151">
                <label>151</label>
                <mixed-citation publication-type="journal"><name><surname>Kusanovic</surname><given-names>JP</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Chaiworapongsa</surname><given-names>T</given-names></name>, <name><surname>Erez</surname><given-names>O</given-names></name>, <name><surname>Mittal</surname><given-names>P</given-names></name>, <name><surname>Vaisbuch</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>22</volume>: <fpage>1021</fpage>–<lpage>1038</lpage>. <pub-id pub-id-type="doi">10.3109/14767050902994754</pub-id>
<?supplied-pmid 19900040?><pub-id pub-id-type="pmid">19900040</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref152">
                <label>152</label>
                <mixed-citation publication-type="journal"><name><surname>Cindrova-Davies</surname><given-names>T</given-names></name>, <name><surname>Sanders</surname><given-names>DA</given-names></name>, <name><surname>Burton</surname><given-names>GJ</given-names></name>, <name><surname>Charnock-Jones</surname><given-names>DS</given-names></name> (<year>2011</year>) <article-title>Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling</article-title>. <source>Cardiovasc Res</source>
<volume>89</volume>: <fpage>671</fpage>–<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvq346</pub-id>
<?supplied-pmid 21139021?><pub-id pub-id-type="pmid">21139021</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref153">
                <label>153</label>
                <mixed-citation publication-type="journal"><name><surname>Aggarwal</surname><given-names>PK</given-names></name>, <name><surname>Chandel</surname><given-names>N</given-names></name>, <name><surname>Jain</surname><given-names>V</given-names></name>, <name><surname>Jha</surname><given-names>V</given-names></name> (<year>2012</year>) <article-title>The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia</article-title>. <source>J Hum Hypertens</source>
<volume>26</volume>: <fpage>236</fpage>–<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1038/jhh.2011.29</pub-id>
<?supplied-pmid 21451568?><pub-id pub-id-type="pmid">21451568</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref154">
                <label>154</label>
                <mixed-citation publication-type="journal"><name><surname>Cim</surname><given-names>N</given-names></name>, <name><surname>Kurdoglu</surname><given-names>M</given-names></name>, <name><surname>Ege</surname><given-names>S</given-names></name>, <name><surname>Yoruk</surname><given-names>I</given-names></name>, <name><surname>Yaman</surname><given-names>G</given-names></name>, <name><surname>Yildizhan</surname><given-names>R</given-names></name> (<year>2016</year>) <article-title>An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia</article-title>. <source>J Matern Fetal Neonatal Med</source>: <fpage>1</fpage>–<lpage>6</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref155">
                <label>155</label>
                <mixed-citation publication-type="journal"><name><surname>Perales</surname><given-names>A</given-names></name>, <name><surname>Delgado</surname><given-names>JL</given-names></name>, <name><surname>de la Calle</surname><given-names>M</given-names></name>, <name><surname>Garcia-Hernandez</surname><given-names>JA</given-names></name>, <name><surname>Escudero</surname><given-names>AI</given-names></name>, <name><surname>Campillos</surname><given-names>JM</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain)</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>50</volume>: <fpage>373</fpage>–<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1002/uog.17373</pub-id>
<?supplied-pmid 27883242?><pub-id pub-id-type="pmid">27883242</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref156">
                <label>156</label>
                <mixed-citation publication-type="journal"><name><surname>O'Gorman</surname><given-names>N</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name>, <name><surname>Poon</surname><given-names>LC</given-names></name> (<year>2016</year>) <article-title>The use of ultrasound and other markers for early detection of preeclampsia</article-title>. <source>Womens Health (Lond)</source>
<volume>12</volume>: <fpage>199</fpage>–<lpage>207</lpage>.<pub-id pub-id-type="pmid">26900911</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref157">
                <label>157</label>
                <mixed-citation publication-type="journal"><name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Kuivaniemi</surname><given-names>H</given-names></name>, <name><surname>Tromp</surname><given-names>G</given-names></name> (<year>2002</year>) <article-title>Functional genomics and proteomics in term and preterm parturition</article-title>. <source>J Clin Endocrinol Metab</source>
<volume>87</volume>: <fpage>2431</fpage>–<lpage>2434</lpage>. <pub-id pub-id-type="doi">10.1210/jcem.87.6.8689</pub-id>
<?supplied-pmid 12050194?><pub-id pub-id-type="pmid">12050194</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref158">
                <label>158</label>
                <mixed-citation publication-type="journal"><name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Espinoza</surname><given-names>J</given-names></name>, <name><surname>Gotsch</surname><given-names>F</given-names></name>, <name><surname>Kusanovic</surname><given-names>JP</given-names></name>, <name><surname>Friel</surname><given-names>LA</given-names></name>, <name><surname>Erez</surname><given-names>O</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome</article-title>. <source>Bjog</source>
<volume>113</volume>
<issue>Suppl 3</issue>: <fpage>118</fpage>–<lpage>135</lpage>.<pub-id pub-id-type="pmid">17206980</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref159">
                <label>159</label>
                <mixed-citation publication-type="journal"><name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Tromp</surname><given-names>G</given-names></name> (<year>2006</year>) <article-title>High-dimensional biology in obstetrics and gynecology: functional genomics in microarray studies</article-title>. <source>Am J Obstet Gynecol</source>
<volume>195</volume>: <fpage>360</fpage>–<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajog.2006.06.077</pub-id>
<?supplied-pmid 16890547?><pub-id pub-id-type="pmid">16890547</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref160">
                <label>160</label>
                <mixed-citation publication-type="journal"><name><surname>Blankley</surname><given-names>RT</given-names></name>, <name><surname>Robinson</surname><given-names>NJ</given-names></name>, <name><surname>Aplin</surname><given-names>JD</given-names></name>, <name><surname>Crocker</surname><given-names>IP</given-names></name>, <name><surname>Gaskell</surname><given-names>SJ</given-names></name>, <name><surname>Whetton</surname><given-names>AD</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>A gel-free quantitative proteomics analysis of factors released from hypoxic-conditioned placentae</article-title>. <source>Reprod Sci</source>
<volume>17</volume>: <fpage>247</fpage>–<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1177/1933719109351320</pub-id>
<?supplied-pmid 19907055?><pub-id pub-id-type="pmid">19907055</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref161">
                <label>161</label>
                <mixed-citation publication-type="journal"><name><surname>Cox</surname><given-names>J</given-names></name>, <name><surname>Mann</surname><given-names>M</given-names></name> (<year>2011</year>) <article-title>Quantitative, high-resolution proteomics for data-driven systems biology</article-title>. <source>Annu Rev Biochem</source>
<volume>80</volume>: <fpage>273</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biochem-061308-093216</pub-id>
<?supplied-pmid 21548781?><pub-id pub-id-type="pmid">21548781</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref162">
                <label>162</label>
                <mixed-citation publication-type="journal"><name><surname>Klein</surname><given-names>J</given-names></name>, <name><surname>Buffin-Meyer</surname><given-names>B</given-names></name>, <name><surname>Mullen</surname><given-names>W</given-names></name>, <name><surname>Carty</surname><given-names>DM</given-names></name>, <name><surname>Delles</surname><given-names>C</given-names></name>, <name><surname>Vlahou</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Clinical proteomics in obstetrics and neonatology</article-title>. <source>Expert Rev Proteomics</source>
<volume>11</volume>: <fpage>75</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1586/14789450.2014.872564</pub-id>
<?supplied-pmid 24404900?><pub-id pub-id-type="pmid">24404900</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref163">
                <label>163</label>
                <mixed-citation publication-type="journal"><name><surname>Hernandez-Nunez</surname><given-names>J</given-names></name>, <name><surname>Valdes-Yong</surname><given-names>M</given-names></name> (<year>2015</year>) <article-title>Utility of proteomics in obstetric disorders: a review</article-title>. <source>Int J Womens Health</source>
<volume>7</volume>: <fpage>385</fpage>–<lpage>391</lpage>. <pub-id pub-id-type="doi">10.2147/IJWH.S79577</pub-id>
<?supplied-pmid 25926758?><pub-id pub-id-type="pmid">25926758</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref164">
                <label>164</label>
                <mixed-citation publication-type="journal"><name><surname>Edlow</surname><given-names>AG</given-names></name>, <name><surname>Slonim</surname><given-names>DK</given-names></name>, <name><surname>Wick</surname><given-names>HC</given-names></name>, <name><surname>Hui</surname><given-names>L</given-names></name>, <name><surname>Bianchi</surname><given-names>DW</given-names></name> (<year>2015</year>) <article-title>The pathway not taken: understanding 'omics data in the perinatal context</article-title>. <source>Am J Obstet Gynecol</source>
<volume>213</volume>: 59.e51-172.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref165">
                <label>165</label>
                <mixed-citation publication-type="journal"><name><surname>Kolialexi</surname><given-names>A</given-names></name>, <name><surname>Mavreli</surname><given-names>D</given-names></name>, <name><surname>Papantoniou</surname><given-names>N</given-names></name> (<year>2017</year>) <article-title>Proteomics for early prenatal screening of pregnancy complications: a 2017 perspective</article-title>. <source>Expert Rev Proteomics</source>
<volume>14</volume>: <fpage>113</fpage>–<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1080/14789450.2017.1275574</pub-id>
<?supplied-pmid 28002974?><pub-id pub-id-type="pmid">28002974</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref166">
                <label>166</label>
                <mixed-citation publication-type="journal"><name><surname>Nejatizadeh</surname><given-names>A</given-names></name>, <name><surname>Stobdan</surname><given-names>T</given-names></name>, <name><surname>Malhotra</surname><given-names>N</given-names></name>, <name><surname>Pasha</surname><given-names>MA</given-names></name> (<year>2008</year>) <article-title>The genetic aspects of pre-eclampsia: achievements and limitations</article-title>. <source>Biochem Genet</source>
<volume>46</volume>: <fpage>451</fpage>–<lpage>479</lpage>. <pub-id pub-id-type="doi">10.1007/s10528-008-9163-9</pub-id>
<?supplied-pmid 18437552?><pub-id pub-id-type="pmid">18437552</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref167">
                <label>167</label>
                <mixed-citation publication-type="journal"><name><surname>Johnson</surname><given-names>M</given-names></name>, <name><surname>Brennecke</surname><given-names>S</given-names></name>, <name><surname>Iversen</surname><given-names>AC</given-names></name>, <name><surname>East</surname><given-names>C</given-names></name>, <name><surname>Olsen</surname><given-names>G</given-names></name>, <name><surname>Kent</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>OS046. Genome-wide association scans identify novel maternalsusceptibility loci for preeclampsia</article-title>. <source>Pregnancy Hypertens</source>
<volume>2</volume>: <fpage>202</fpage>.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref168">
                <label>168</label>
                <mixed-citation publication-type="journal"><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Whitten</surname><given-names>A</given-names></name>, <name><surname>Tarca</surname><given-names>AL</given-names></name>, <name><surname>Bhatti</surname><given-names>G</given-names></name>, <name><surname>Draghici</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa</article-title>. <source>J Perinat Med</source>
<volume>41</volume>: <fpage>485</fpage>–<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1515/jpm-2013-0082</pub-id>
<?supplied-pmid 23793063?><pub-id pub-id-type="pmid">23793063</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref169">
                <label>169</label>
                <mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>P</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>M</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>H</given-names></name>, <name><surname>Li</surname><given-names>YX</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Variations of microRNAs in human placentas and plasma from preeclamptic pregnancy</article-title>. <source>Hypertension</source>
<volume>63</volume>: <fpage>1276</fpage>–<lpage>1284</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.113.02647</pub-id>
<?supplied-pmid 24664294?><pub-id pub-id-type="pmid">24664294</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref170">
                <label>170</label>
                <mixed-citation publication-type="journal"><name><surname>Yong</surname><given-names>HE</given-names></name>, <name><surname>Melton</surname><given-names>PE</given-names></name>, <name><surname>Johnson</surname><given-names>MP</given-names></name>, <name><surname>Freed</surname><given-names>KA</given-names></name>, <name><surname>Kalionis</surname><given-names>B</given-names></name>, <name><surname>Murthi</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Genome-wide transcriptome directed pathway analysis of maternal pre-eclampsia susceptibility genes</article-title>. <source>PLoS One</source>
<volume>10</volume>: <fpage>e0128230</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0128230</pub-id>
<?supplied-pmid 26010865?><pub-id pub-id-type="pmid">26010865</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref171">
                <label>171</label>
                <mixed-citation publication-type="journal"><name><surname>Sober</surname><given-names>S</given-names></name>, <name><surname>Reiman</surname><given-names>M</given-names></name>, <name><surname>Kikas</surname><given-names>T</given-names></name>, <name><surname>Rull</surname><given-names>K</given-names></name>, <name><surname>Inno</surname><given-names>R</given-names></name>, <name><surname>Vaas</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Extensive shift in placental transcriptome profile in preeclampsia and placental origin of adverse pregnancy outcomes</article-title>. <source>Sci Rep</source>
<volume>5</volume>: <fpage>13336</fpage>
<pub-id pub-id-type="doi">10.1038/srep13336</pub-id>
<?supplied-pmid 26268791?><pub-id pub-id-type="pmid">26268791</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref172">
                <label>172</label>
                <mixed-citation publication-type="journal"><name><surname>Whitehead</surname><given-names>CL</given-names></name>, <name><surname>Walker</surname><given-names>SP</given-names></name>, <name><surname>Tong</surname><given-names>S</given-names></name> (<year>2016</year>) <article-title>Measuring circulating placental RNAs to non-invasively assess the placental transcriptome and to predict pregnancy complications</article-title>. <source>Prenat Diagn</source>
<volume>36</volume>: <fpage>997</fpage>–<lpage>1008</lpage>. <pub-id pub-id-type="doi">10.1002/pd.4934</pub-id>
<?supplied-pmid 27711965?><pub-id pub-id-type="pmid">27711965</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref173">
                <label>173</label>
                <mixed-citation publication-type="journal"><name><surname>Luo</surname><given-names>S</given-names></name>, <name><surname>Cao</surname><given-names>N</given-names></name>, <name><surname>Tang</surname><given-names>Y</given-names></name>, <name><surname>Gu</surname><given-names>W</given-names></name> (<year>2017</year>) <article-title>Identification of key microRNAs and genes in preeclampsia by bioinformatics analysis</article-title>. <source>PLoS One</source>
<volume>12</volume>: <fpage>e0178549</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0178549</pub-id>
<?supplied-pmid 28594854?><pub-id pub-id-type="pmid">28594854</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref174">
                <label>174</label>
                <mixed-citation publication-type="journal"><name><surname>Ashar-Patel</surname><given-names>A</given-names></name>, <name><surname>Kaymaz</surname><given-names>Y</given-names></name>, <name><surname>Rajakumar</surname><given-names>A</given-names></name>, <name><surname>Bailey</surname><given-names>JA</given-names></name>, <name><surname>Karumanchi</surname><given-names>SA</given-names></name>, <name><surname>Moore</surname><given-names>MJ</given-names></name> (<year>2017</year>) <article-title>FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsia</article-title>. <source>Sci Rep</source>
<volume>7</volume>: <fpage>12139</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-11639-6</pub-id>
<?supplied-pmid 28939845?><pub-id pub-id-type="pmid">28939845</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref175">
                <label>175</label>
                <mixed-citation publication-type="journal"><name><surname>Than</surname><given-names>NG</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Tarca</surname><given-names>AL</given-names></name>, <name><surname>Kekesi</surname><given-names>KA</given-names></name>, <name><surname>Xu</surname><given-names>Y</given-names></name>, <name><surname>Xu</surname><given-names>Z</given-names></name>, <etal>et al</etal> (<year>2018</year>) <article-title>Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia</article-title>. <source>Front Immunol</source>
<volume>9</volume>: <fpage>1661</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2018.01661</pub-id>
<?supplied-pmid 30135684?><pub-id pub-id-type="pmid">30135684</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref176">
                <label>176</label>
                <mixed-citation publication-type="journal"><name><surname>Kolla</surname><given-names>V</given-names></name>, <name><surname>Jeno</surname><given-names>P</given-names></name>, <name><surname>Moes</surname><given-names>S</given-names></name>, <name><surname>Lapaire</surname><given-names>O</given-names></name>, <name><surname>Hoesli</surname><given-names>I</given-names></name>, <name><surname>Hahn</surname><given-names>S</given-names></name> (<year>2012</year>) <article-title>Quantitative proteomic (iTRAQ) analysis of 1st trimester maternal plasma samples in pregnancies at risk for preeclampsia</article-title>. <source>J Biomed Biotechnol</source>
<volume>2012</volume>: <fpage>305964</fpage>
<pub-id pub-id-type="doi">10.1155/2012/305964</pub-id>
<?supplied-pmid 22570525?><pub-id pub-id-type="pmid">22570525</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref177">
                <label>177</label>
                <mixed-citation publication-type="journal"><name><surname>Myers</surname><given-names>JE</given-names></name>, <name><surname>Tuytten</surname><given-names>R</given-names></name>, <name><surname>Thomas</surname><given-names>G</given-names></name>, <name><surname>Laroy</surname><given-names>W</given-names></name>, <name><surname>Kas</surname><given-names>K</given-names></name>, <name><surname>Vanpoucke</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Integrated proteomics pipeline yields novel biomarkers for predicting preeclampsia</article-title>. <source>Hypertension</source>
<volume>61</volume>: <fpage>1281</fpage>–<lpage>1288</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.113.01168</pub-id>
<?supplied-pmid 23547239?><pub-id pub-id-type="pmid">23547239</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref178">
                <label>178</label>
                <mixed-citation publication-type="journal"><name><surname>Law</surname><given-names>KP</given-names></name>, <name><surname>Han</surname><given-names>TL</given-names></name>, <name><surname>Tong</surname><given-names>C</given-names></name>, <name><surname>Baker</surname><given-names>PN</given-names></name> (<year>2015</year>) <article-title>Mass spectrometry-based proteomics for pre-eclampsia and preterm birth</article-title>. <source>Int J Mol Sci</source>
<volume>16</volume>: <fpage>10952</fpage>–<lpage>10985</lpage>. <pub-id pub-id-type="doi">10.3390/ijms160510952</pub-id>
<?supplied-pmid 26006232?><pub-id pub-id-type="pmid">26006232</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref179">
                <label>179</label>
                <mixed-citation publication-type="journal"><name><surname>Founds</surname><given-names>S</given-names></name>, <name><surname>Zeng</surname><given-names>X</given-names></name>, <name><surname>Lykins</surname><given-names>D</given-names></name>, <name><surname>Roberts</surname><given-names>JM</given-names></name> (<year>2015</year>) <article-title>Developing Potential Candidates of Preclinical Preeclampsia</article-title>. <source>Int J Mol Sci</source>
<volume>16</volume>: <fpage>27208</fpage>–<lpage>27227</lpage>. <pub-id pub-id-type="doi">10.3390/ijms161126023</pub-id>
<?supplied-pmid 26580600?><pub-id pub-id-type="pmid">26580600</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref180">
                <label>180</label>
                <mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>Q</given-names></name>, <name><surname>Liu</surname><given-names>C</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>N</given-names></name>, <name><surname>Deng</surname><given-names>H</given-names></name>, <name><surname>Zhang</surname><given-names>Z</given-names></name> (<year>2016</year>) <article-title>Serum markers of pre-eclampsia identified on proteomics</article-title>. <source>J Obstet Gynaecol Res</source>
<volume>42</volume>: <fpage>1111</fpage>–<lpage>1118</lpage>. <pub-id pub-id-type="doi">10.1111/jog.13037</pub-id>
<?supplied-pmid 27279411?><pub-id pub-id-type="pmid">27279411</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref181">
                <label>181</label>
                <mixed-citation publication-type="journal"><name><surname>Jin</surname><given-names>X</given-names></name>, <name><surname>Xu</surname><given-names>Z</given-names></name>, <name><surname>Cao</surname><given-names>J</given-names></name>, <name><surname>Shao</surname><given-names>P</given-names></name>, <name><surname>Zhou</surname><given-names>M</given-names></name>, <name><surname>Qin</surname><given-names>Z</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Proteomics analysis of human placenta reveals glutathione metabolism dysfunction as the underlying pathogenesis for preeclampsia</article-title>. <source>Biochim Biophys Acta</source>
<volume>1865</volume>: <fpage>1207</fpage>–<lpage>1214</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref182">
                <label>182</label>
                <mixed-citation publication-type="journal"><name><surname>Qi</surname><given-names>WH</given-names></name>, <name><surname>Zheng</surname><given-names>MY</given-names></name>, <name><surname>Li</surname><given-names>C</given-names></name>, <name><surname>Xu</surname><given-names>L</given-names></name>, <name><surname>Xu</surname><given-names>JE</given-names></name> (<year>2017</year>) <article-title>Screening of differential proteins of placenta tissues in patients with pre-eclampsia by iTRAQ proteomics techniques</article-title>. <source>Minerva Med</source>
<volume>108</volume>: <fpage>389</fpage>–<lpage>395</lpage>. <pub-id pub-id-type="doi">10.23736/S0026-4806.17.05080-7</pub-id>
<?supplied-pmid 28728340?><pub-id pub-id-type="pmid">28728340</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref183">
                <label>183</label>
                <mixed-citation publication-type="journal"><name><surname>Lynch</surname><given-names>AM</given-names></name>, <name><surname>Wagner</surname><given-names>BD</given-names></name>, <name><surname>Deterding</surname><given-names>RR</given-names></name>, <name><surname>Giclas</surname><given-names>PC</given-names></name>, <name><surname>Gibbs</surname><given-names>RS</given-names></name>, <name><surname>Janoff</surname><given-names>EN</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>The relationship of circulating proteins in early pregnancy with preterm birth</article-title>. <source>Am J Obstet Gynecol</source>
<volume>214</volume>: 517.e511-518.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref184">
                <label>184</label>
                <mixed-citation publication-type="journal"><name><surname>Myers</surname><given-names>J</given-names></name>, <name><surname>Macleod</surname><given-names>M</given-names></name>, <name><surname>Reed</surname><given-names>B</given-names></name>, <name><surname>Harris</surname><given-names>N</given-names></name>, <name><surname>Mires</surname><given-names>G</given-names></name>, <name><surname>Baker</surname><given-names>P</given-names></name> (<year>2004</year>) <article-title>Use of proteomic patterns as a novel screening tool in pre-eclampsia</article-title>. <source>J Obstet Gynaecol</source>
<volume>24</volume>: <fpage>873</fpage>–<lpage>874</lpage>. <pub-id pub-id-type="doi">10.1080/01443610400018791</pub-id>
<?supplied-pmid 16147639?><pub-id pub-id-type="pmid">16147639</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref185">
                <label>185</label>
                <mixed-citation publication-type="journal"><name><surname>Webster</surname><given-names>RP</given-names></name>, <name><surname>Myatt</surname><given-names>L</given-names></name> (<year>2007</year>) <article-title>Elucidation of the molecular mechanisms of preeclampsia using proteomic technologies</article-title>. <source>Proteomics Clin Appl</source>
<volume>1</volume>: <fpage>1147</fpage>–<lpage>1155</lpage>. <pub-id pub-id-type="doi">10.1002/prca.200700128</pub-id>
<?supplied-pmid 21136764?><pub-id pub-id-type="pmid">21136764</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref186">
                <label>186</label>
                <mixed-citation publication-type="journal"><name><surname>Baker</surname><given-names>PN</given-names></name>, <name><surname>Myers</surname><given-names>JE</given-names></name> (<year>2009</year>) <article-title>Preeclamptic toxemia: a disease ripe for proteomic discovery</article-title>. <source>Expert Rev Proteomics</source>
<volume>6</volume>: <fpage>107</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1586/epr.09.5</pub-id>
<?supplied-pmid 19385936?><pub-id pub-id-type="pmid">19385936</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref187">
                <label>187</label>
                <mixed-citation publication-type="journal"><name><surname>Carty</surname><given-names>DM</given-names></name>, <name><surname>Schiffer</surname><given-names>E</given-names></name>, <name><surname>Delles</surname><given-names>C</given-names></name> (<year>2013</year>) <article-title>Proteomics in hypertension</article-title>. <source>J Hum Hypertens</source>
<volume>27</volume>: <fpage>211</fpage>–<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1038/jhh.2012.30</pub-id>
<?supplied-pmid 22874797?><pub-id pub-id-type="pmid">22874797</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref188">
                <label>188</label>
                <mixed-citation publication-type="journal"><name><surname>Bahado-Singh</surname><given-names>RO</given-names></name>, <name><surname>Akolekar</surname><given-names>R</given-names></name>, <name><surname>Mandal</surname><given-names>R</given-names></name>, <name><surname>Dong</surname><given-names>E</given-names></name>, <name><surname>Xia</surname><given-names>J</given-names></name>, <name><surname>Kruger</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Metabolomics and first-trimester prediction of early-onset preeclampsia</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>25</volume>: <fpage>1840</fpage>–<lpage>1847</lpage>. <pub-id pub-id-type="doi">10.3109/14767058.2012.680254</pub-id>
<?supplied-pmid 22494326?><pub-id pub-id-type="pmid">22494326</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref189">
                <label>189</label>
                <mixed-citation publication-type="journal"><name><surname>Kuc</surname><given-names>S</given-names></name>, <name><surname>Koster</surname><given-names>MP</given-names></name>, <name><surname>Pennings</surname><given-names>JL</given-names></name>, <name><surname>Hankemeier</surname><given-names>T</given-names></name>, <name><surname>Berger</surname><given-names>R</given-names></name>, <name><surname>Harms</surname><given-names>AC</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Metabolomics profiling for identification of novel potential markers in early prediction of preeclampsia</article-title>. <source>PLoS One</source>
<volume>9</volume>: <fpage>e98540</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0098540</pub-id>
<?supplied-pmid 24873829?><pub-id pub-id-type="pmid">24873829</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref190">
                <label>190</label>
                <mixed-citation publication-type="journal"><name><surname>Austdal</surname><given-names>M</given-names></name>, <name><surname>Tangeras</surname><given-names>LH</given-names></name>, <name><surname>Skrastad</surname><given-names>RB</given-names></name>, <name><surname>Salvesen</surname><given-names>K</given-names></name>, <name><surname>Austgulen</surname><given-names>R</given-names></name>, <name><surname>Iversen</surname><given-names>AC</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study</article-title>. <source>Int J Mol Sci</source>
<volume>16</volume>: <fpage>21520</fpage>–<lpage>21538</lpage>. <pub-id pub-id-type="doi">10.3390/ijms160921520</pub-id>
<?supplied-pmid 26370975?><pub-id pub-id-type="pmid">26370975</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref191">
                <label>191</label>
                <mixed-citation publication-type="journal"><name><surname>Koster</surname><given-names>MP</given-names></name>, <name><surname>Vreeken</surname><given-names>RJ</given-names></name>, <name><surname>Harms</surname><given-names>AC</given-names></name>, <name><surname>Dane</surname><given-names>AD</given-names></name>, <name><surname>Kuc</surname><given-names>S</given-names></name>, <name><surname>Schielen</surname><given-names>PC</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>First-Trimester Serum Acylcarnitine Levels to Predict Preeclampsia: A Metabolomics Approach</article-title>. <source>Dis Markers</source>
<volume>2015</volume>: <fpage>857108</fpage>
<pub-id pub-id-type="doi">10.1155/2015/857108</pub-id>
<?supplied-pmid 26146448?><pub-id pub-id-type="pmid">26146448</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref192">
                <label>192</label>
                <mixed-citation publication-type="journal"><name><surname>Benton</surname><given-names>SJ</given-names></name>, <name><surname>Ly</surname><given-names>C</given-names></name>, <name><surname>Vukovic</surname><given-names>S</given-names></name>, <name><surname>Bainbridge</surname><given-names>SA</given-names></name> (<year>2016</year>) <article-title>Andree Gruslin award lecture: Metabolomics as an important modality to better understand preeclampsia</article-title>. <source>Placenta</source>: <fpage>1</fpage>–<lpage>9</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref193">
                <label>193</label>
                <mixed-citation publication-type="journal"><name><surname>de Groot</surname><given-names>CJ</given-names></name>, <name><surname>Guzel</surname><given-names>C</given-names></name>, <name><surname>Steegers-Theunissen</surname><given-names>RP</given-names></name>, <name><surname>de Maat</surname><given-names>M</given-names></name>, <name><surname>Derkx</surname><given-names>P</given-names></name>, <name><surname>Roes</surname><given-names>EM</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Specific peptides identified by mass spectrometry in placental tissue from pregnancies complicated by early onset preeclampsia attained by laser capture dissection</article-title>. <source>Proteomics Clin Appl</source>
<volume>1</volume>: <fpage>325</fpage>–<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1002/prca.200600911</pub-id>
<?supplied-pmid 21136682?><pub-id pub-id-type="pmid">21136682</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref194">
                <label>194</label>
                <mixed-citation publication-type="journal"><name><surname>Hamamura</surname><given-names>K</given-names></name>, <name><surname>Nonaka</surname><given-names>D</given-names></name>, <name><surname>Ishikawa</surname><given-names>H</given-names></name>, <name><surname>Banzai</surname><given-names>M</given-names></name>, <name><surname>Yanagida</surname><given-names>M</given-names></name>, <name><surname>Nojima</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Simple quantitation for potential serum disease biomarker peptides, primarily identified by a peptidomics approach in the serum with hypertensive disorders of pregnancy</article-title>. <source>Ann Clin Biochem</source>
<volume>53</volume>: <fpage>85</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1177/0004563215583697</pub-id>
<?supplied-pmid 25838414?><pub-id pub-id-type="pmid">25838414</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref195">
                <label>195</label>
                <mixed-citation publication-type="journal"><name><surname>Kononikhin</surname><given-names>AS</given-names></name>, <name><surname>Starodubtseva</surname><given-names>NL</given-names></name>, <name><surname>Bugrova</surname><given-names>AE</given-names></name>, <name><surname>Shirokova</surname><given-names>VA</given-names></name>, <name><surname>Chagovets</surname><given-names>VV</given-names></name>, <name><surname>Indeykina</surname><given-names>MI</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>An untargeted approach for the analysis of the urine peptidome of women with preeclampsia</article-title>. <source>J Proteomics</source>
<volume>149</volume>: <fpage>38</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.jprot.2016.04.024</pub-id>
<?supplied-pmid 27109351?><pub-id pub-id-type="pmid">27109351</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref196">
                <label>196</label>
                <mixed-citation publication-type="journal"><name><surname>Kedia</surname><given-names>K</given-names></name>, <name><surname>Smith</surname><given-names>SF</given-names></name>, <name><surname>Wright</surname><given-names>AH</given-names></name>, <name><surname>Barnes</surname><given-names>JM</given-names></name>, <name><surname>Tolley</surname><given-names>HD</given-names></name>, <name><surname>Esplin</surname><given-names>MS</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Global "omics" evaluation of human placental responses to preeclamptic conditions</article-title>. <source>Am J Obstet Gynecol</source>
<volume>215</volume>: 238.e231-238.e220.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref197">
                <label>197</label>
                <mixed-citation publication-type="journal"><name><surname>Dai</surname><given-names>X</given-names></name>, <name><surname>Song</surname><given-names>X</given-names></name>, <name><surname>Rui</surname><given-names>C</given-names></name>, <name><surname>Meng</surname><given-names>L</given-names></name>, <name><surname>Xue</surname><given-names>X</given-names></name>, <name><surname>Ding</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Peptidome Analysis of Human Serum From Normal and Preeclamptic Pregnancies</article-title>. <source>J Cell Biochem</source>: <fpage>1</fpage>–<lpage>8</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref198">
                <label>198</label>
                <mixed-citation publication-type="journal"><name><surname>Qian</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Rui</surname><given-names>C</given-names></name>, <name><surname>Ding</surname><given-names>H</given-names></name>, <name><surname>Mao</surname><given-names>P</given-names></name>, <name><surname>Ruan</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Peptidome analysis of amniotic fluid from pregnancies with preeclampsia</article-title>. <source>Mol Med Rep</source>: <fpage>7337</fpage>–<lpage>7344</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2017.7582</pub-id>
<?supplied-pmid 28944906?><pub-id pub-id-type="pmid">28944906</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref199">
                <label>199</label>
                <mixed-citation publication-type="journal"><name><surname>Anand</surname><given-names>S</given-names></name>, <name><surname>Young</surname><given-names>S</given-names></name>, <name><surname>Esplin</surname><given-names>MS</given-names></name>, <name><surname>Peaden</surname><given-names>B</given-names></name>, <name><surname>Tolley</surname><given-names>HD</given-names></name>, <name><surname>Porter</surname><given-names>TF</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Detection and confirmation of serum lipid biomarkers for preeclampsia using direct infusion mass spectrometry</article-title>. <source>J Lipid Res</source>
<volume>57</volume>: <fpage>687</fpage>–<lpage>696</lpage>. <pub-id pub-id-type="doi">10.1194/jlr.P064451</pub-id>
<?supplied-pmid 26891737?><pub-id pub-id-type="pmid">26891737</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref200">
                <label>200</label>
                <mixed-citation publication-type="journal"><name><surname>Brown</surname><given-names>SH</given-names></name>, <name><surname>Eather</surname><given-names>SR</given-names></name>, <name><surname>Freeman</surname><given-names>DJ</given-names></name>, <name><surname>Meyer</surname><given-names>BJ</given-names></name>, <name><surname>Mitchell</surname><given-names>TW</given-names></name> (<year>2016</year>) <article-title>A Lipidomic Analysis of Placenta in Preeclampsia: Evidence for Lipid Storage</article-title>. <source>PLoS One</source>
<volume>11</volume>: <fpage>e0163972</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0163972</pub-id>
<?supplied-pmid 27685997?><pub-id pub-id-type="pmid">27685997</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref201">
                <label>201</label>
                <mixed-citation publication-type="journal"><name><surname>Watanabe</surname><given-names>H</given-names></name>, <name><surname>Hamada</surname><given-names>H</given-names></name>, <name><surname>Yamada</surname><given-names>N</given-names></name>, <name><surname>Sohda</surname><given-names>S</given-names></name>, <name><surname>Yamakawa-Kobayashi</surname><given-names>K</given-names></name>, <name><surname>Yoshikawa</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia</article-title>. <source>Proteomics</source>
<volume>4</volume>: <fpage>537</fpage>–<lpage>543</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.200300565</pub-id>
<?supplied-pmid 14760726?><pub-id pub-id-type="pmid">14760726</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref202">
                <label>202</label>
                <mixed-citation publication-type="journal"><name><surname>Blankley</surname><given-names>RT</given-names></name>, <name><surname>Gaskell</surname><given-names>SJ</given-names></name>, <name><surname>Whetton</surname><given-names>AD</given-names></name>, <name><surname>Dive</surname><given-names>C</given-names></name>, <name><surname>Baker</surname><given-names>PN</given-names></name>, <name><surname>Myers</surname><given-names>JE</given-names></name> (<year>2009</year>) <article-title>A proof-of-principle gel-free proteomics strategy for the identification of predictive biomarkers for the onset of pre-eclampsia</article-title>. <source>Bjog</source>
<volume>116</volume>: <fpage>1473</fpage>–<lpage>1480</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-0528.2009.02283.x</pub-id>
<?supplied-pmid 19663911?><pub-id pub-id-type="pmid">19663911</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref203">
                <label>203</label>
                <mixed-citation publication-type="journal"><name><surname>Auer</surname><given-names>J</given-names></name>, <name><surname>Camoin</surname><given-names>L</given-names></name>, <name><surname>Guillonneau</surname><given-names>F</given-names></name>, <name><surname>Rigourd</surname><given-names>V</given-names></name>, <name><surname>Chelbi</surname><given-names>ST</given-names></name>, <name><surname>Leduc</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology</article-title>. <source>J Proteomics</source>
<volume>73</volume>: <fpage>1004</fpage>–<lpage>1017</lpage>. <pub-id pub-id-type="doi">10.1016/j.jprot.2009.12.014</pub-id>
<?supplied-pmid 20079470?><pub-id pub-id-type="pmid">20079470</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref204">
                <label>204</label>
                <mixed-citation publication-type="journal"><name><surname>Rasanen</surname><given-names>J</given-names></name>, <name><surname>Girsen</surname><given-names>A</given-names></name>, <name><surname>Lu</surname><given-names>X</given-names></name>, <name><surname>Lapidus</surname><given-names>JA</given-names></name>, <name><surname>Standley</surname><given-names>M</given-names></name>, <name><surname>Reddy</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia</article-title>. <source>J Proteome Res</source>
<volume>9</volume>: <fpage>4274</fpage>–<lpage>4281</lpage>. <pub-id pub-id-type="doi">10.1021/pr100198m</pub-id>
<?supplied-pmid 20568817?><pub-id pub-id-type="pmid">20568817</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref205">
                <label>205</label>
                <mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>C</given-names></name>, <name><surname>Zhang</surname><given-names>N</given-names></name>, <name><surname>Yu</surname><given-names>H</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Liang</surname><given-names>Y</given-names></name>, <name><surname>Deng</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Proteomic analysis of human serum for finding pathogenic factors and potential biomarkers in preeclampsia</article-title>. <source>Placenta</source>
<volume>32</volume>: <fpage>168</fpage>–<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1016/j.placenta.2010.11.007</pub-id>
<?supplied-pmid 21145106?><pub-id pub-id-type="pmid">21145106</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref206">
                <label>206</label>
                <mixed-citation publication-type="journal"><name><surname>Hsu</surname><given-names>TY</given-names></name>, <name><surname>Hsieh</surname><given-names>TT</given-names></name>, <name><surname>Yang</surname><given-names>KD</given-names></name>, <name><surname>Tsai</surname><given-names>CC</given-names></name>, <name><surname>Ou</surname><given-names>CY</given-names></name>, <name><surname>Cheng</surname><given-names>BH</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Proteomic profiling reveals alpha1-antitrypsin, alpha1-microglobulin, and clusterin as preeclampsia-related serum proteins in pregnant women</article-title>. <source>Taiwan J Obstet Gynecol</source>
<volume>54</volume>: <fpage>499</fpage>–<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1016/j.tjog.2014.01.007</pub-id>
<?supplied-pmid 26522099?><pub-id pub-id-type="pmid">26522099</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref207">
                <label>207</label>
                <mixed-citation publication-type="journal"><name><surname>Kolialexi</surname><given-names>A</given-names></name>, <name><surname>Gourgiotis</surname><given-names>D</given-names></name>, <name><surname>Daskalakis</surname><given-names>G</given-names></name>, <name><surname>Marmarinos</surname><given-names>A</given-names></name>, <name><surname>Lykoudi</surname><given-names>A</given-names></name>, <name><surname>Mavreli</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Validation of serum biomarkers derived from proteomic analysis for the early screening of preeclampsia</article-title>. <source>Dis Markers</source>
<volume>2015</volume>: <fpage>121848</fpage>
<pub-id pub-id-type="doi">10.1155/2015/121848</pub-id>
<?supplied-pmid 25628472?><pub-id pub-id-type="pmid">25628472</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref208">
                <label>208</label>
                <mixed-citation publication-type="journal"><name><surname>Anand</surname><given-names>S</given-names></name>, <name><surname>Bench Alvarez</surname><given-names>TM</given-names></name>, <name><surname>Johnson</surname><given-names>WE</given-names></name>, <name><surname>Esplin</surname><given-names>MS</given-names></name>, <name><surname>Merrell</surname><given-names>K</given-names></name>, <name><surname>Porter</surname><given-names>TF</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Serum biomarkers predictive of pre-eclampsia</article-title>. <source>Biomark Med</source>
<volume>9</volume>: <fpage>563</fpage>–<lpage>575</lpage>. <pub-id pub-id-type="doi">10.2217/bmm.15.21</pub-id>
<?supplied-pmid 26079961?><pub-id pub-id-type="pmid">26079961</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref209">
                <label>209</label>
                <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>SM</given-names></name>, <name><surname>Cho</surname><given-names>BK</given-names></name>, <name><surname>Kang</surname><given-names>MJ</given-names></name>, <name><surname>Norwitz</surname><given-names>ER</given-names></name>, <name><surname>Lee</surname><given-names>SM</given-names></name>, <name><surname>Lee</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Expression changes of proteins associated with the development of preeclampsia in maternal plasma: A case-control study</article-title>. <source>Proteomics</source>
<volume>16</volume>: <fpage>1581</fpage>–<lpage>1589</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.201500381</pub-id>
<?supplied-pmid 27001287?><pub-id pub-id-type="pmid">27001287</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref210">
                <label>210</label>
                <mixed-citation publication-type="journal"><name><surname>Kolialexi</surname><given-names>A</given-names></name>, <name><surname>Tsangaris</surname><given-names>GT</given-names></name>, <name><surname>Sifakis</surname><given-names>S</given-names></name>, <name><surname>Gourgiotis</surname><given-names>D</given-names></name>, <name><surname>Katsafadou</surname><given-names>A</given-names></name>, <name><surname>Lykoudi</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Plasma biomarkers for the identification of women at risk for early-onset preeclampsia</article-title>. <source>Expert Rev Proteomics</source>
<volume>14</volume>: <fpage>269</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1080/14789450.2017.1291345</pub-id>
<?supplied-pmid 28222616?><pub-id pub-id-type="pmid">28222616</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref211">
                <label>211</label>
                <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>G</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Jin</surname><given-names>X</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Zhou</surname><given-names>Y</given-names></name>, <name><surname>Niu</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS/MS</article-title>. <source>Proteomics Clin Appl</source>
<volume>5</volume>: <fpage>300</fpage>–<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1002/prca.201000100</pub-id>
<?supplied-pmid 21538910?><pub-id pub-id-type="pmid">21538910</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref212">
                <label>212</label>
                <mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>SM</given-names></name>, <name><surname>Park</surname><given-names>JS</given-names></name>, <name><surname>Norwitz</surname><given-names>ER</given-names></name>, <name><surname>Kim</surname><given-names>SM</given-names></name>, <name><surname>Kim</surname><given-names>BJ</given-names></name>, <name><surname>Park</surname><given-names>CW</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Characterization of discriminatory urinary proteomic biomarkers for severe preeclampsia using SELDI-TOF mass spectrometry</article-title>. <source>J Perinat Med</source>
<volume>39</volume>: <fpage>391</fpage>–<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1515/JPM.2011.028</pub-id>
<?supplied-pmid 21557676?><pub-id pub-id-type="pmid">21557676</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref213">
                <label>213</label>
                <mixed-citation publication-type="journal"><name><surname>Kolialexi</surname><given-names>A</given-names></name>, <name><surname>Mavreli</surname><given-names>D</given-names></name>, <name><surname>Tounta</surname><given-names>G</given-names></name>, <name><surname>Mavrou</surname><given-names>A</given-names></name>, <name><surname>Papantoniou</surname><given-names>N</given-names></name> (<year>2015</year>) <article-title>Urine proteomic studies in preeclampsia</article-title>. <source>Proteomics Clin Appl</source>
<volume>9</volume>: <fpage>501</fpage>–<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1002/prca.201400092</pub-id>
<?supplied-pmid 25644222?><pub-id pub-id-type="pmid">25644222</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref214">
                <label>214</label>
                <mixed-citation publication-type="journal"><name><surname>Vascotto</surname><given-names>C</given-names></name>, <name><surname>Salzano</surname><given-names>AM</given-names></name>, <name><surname>D'Ambrosio</surname><given-names>C</given-names></name>, <name><surname>Fruscalzo</surname><given-names>A</given-names></name>, <name><surname>Marchesoni</surname><given-names>D</given-names></name>, <name><surname>di Loreto</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia</article-title>. <source>J Proteome Res</source>
<volume>6</volume>: <fpage>160</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1021/pr060315z</pub-id>
<?supplied-pmid 17203960?><pub-id pub-id-type="pmid">17203960</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref215">
                <label>215</label>
                <mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>JS</given-names></name>, <name><surname>Oh</surname><given-names>KJ</given-names></name>, <name><surname>Norwitz</surname><given-names>ER</given-names></name>, <name><surname>Han</surname><given-names>JS</given-names></name>, <name><surname>Choi</surname><given-names>HJ</given-names></name>, <name><surname>Seong</surname><given-names>HS</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Identification of proteomic biomarkers of preeclampsia in amniotic fluid using SELDI-TOF mass spectrometry</article-title>. <source>Reprod Sci</source>
<volume>15</volume>: <fpage>457</fpage>–<lpage>468</lpage>. <pub-id pub-id-type="doi">10.1177/1933719108316909</pub-id>
<?supplied-pmid 18579854?><pub-id pub-id-type="pmid">18579854</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref216">
                <label>216</label>
                <mixed-citation publication-type="journal"><name><surname>Webster</surname><given-names>RP</given-names></name>, <name><surname>Pitzer</surname><given-names>BA</given-names></name>, <name><surname>Roberts</surname><given-names>VH</given-names></name>, <name><surname>Brockman</surname><given-names>D</given-names></name>, <name><surname>Myatt</surname><given-names>L</given-names></name> (<year>2007</year>) <article-title>Differences in the proteome profile in placenta from normal term and preeclamptic preterm pregnancies</article-title>. <source>Proteomics Clin Appl</source>
<volume>1</volume>: <fpage>446</fpage>–<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1002/prca.200600745</pub-id>
<?supplied-pmid 21136696?><pub-id pub-id-type="pmid">21136696</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref217">
                <label>217</label>
                <mixed-citation publication-type="journal"><name><surname>Sun</surname><given-names>LZ</given-names></name>, <name><surname>Yang</surname><given-names>NN</given-names></name>, <name><surname>De</surname><given-names>W</given-names></name>, <name><surname>Xiao</surname><given-names>YS</given-names></name> (<year>2007</year>) <article-title>Proteomic analysis of proteins differentially expressed in preeclamptic trophoblasts</article-title>. <source>Gynecol Obstet Invest</source>
<volume>64</volume>: <fpage>17</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1159/000098399</pub-id>
<?supplied-pmid 17199091?><pub-id pub-id-type="pmid">17199091</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref218">
                <label>218</label>
                <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>YN</given-names></name>, <name><surname>Kim</surname><given-names>HK</given-names></name>, <name><surname>Warda</surname><given-names>M</given-names></name>, <name><surname>Kim</surname><given-names>N</given-names></name>, <name><surname>Park</surname><given-names>WS</given-names></name>, <name><surname>Prince Adel</surname><given-names>B</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Toward a better understanding of preeclampsia: Comparative proteomic analysis of preeclamptic placentas</article-title>. <source>Proteomics Clin Appl</source>
<volume>1</volume>: <fpage>1625</fpage>–<lpage>1636</lpage>. <pub-id pub-id-type="doi">10.1002/prca.200700034</pub-id>
<?supplied-pmid 21136660?><pub-id pub-id-type="pmid">21136660</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref219">
                <label>219</label>
                <mixed-citation publication-type="journal"><name><surname>Jin</surname><given-names>H</given-names></name>, <name><surname>Ma</surname><given-names>KD</given-names></name>, <name><surname>Hu</surname><given-names>R</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Yang</surname><given-names>F</given-names></name>, <name><surname>Yao</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Analysis of expression and comparative profile of normal placental tissue proteins and those in preeclampsia patients using proteomic approaches</article-title>. <source>Anal Chim Acta</source>
<volume>629</volume>: <fpage>158</fpage>–<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/j.aca.2008.09.015</pub-id>
<?supplied-pmid 18940332?><pub-id pub-id-type="pmid">18940332</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref220">
                <label>220</label>
                <mixed-citation publication-type="journal"><name><surname>Gharesi-Fard</surname><given-names>B</given-names></name>, <name><surname>Zolghadri</surname><given-names>J</given-names></name>, <name><surname>Kamali-Sarvestani</surname><given-names>E</given-names></name> (<year>2010</year>) <article-title>Proteome differences of placenta between pre-eclampsia and normal pregnancy</article-title>. <source>Placenta</source>
<volume>31</volume>: <fpage>121</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.placenta.2009.11.004</pub-id>
<?supplied-pmid 19954843?><pub-id pub-id-type="pmid">19954843</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref221">
                <label>221</label>
                <mixed-citation publication-type="journal"><name><surname>Centlow</surname><given-names>M</given-names></name>, <name><surname>Hansson</surname><given-names>SR</given-names></name>, <name><surname>Welinder</surname><given-names>C</given-names></name> (<year>2010</year>) <article-title>Differential proteome analysis of the preeclamptic placenta using optimized protein extraction</article-title>. <source>J Biomed Biotechnol</source>
<volume>2010</volume>: <fpage>458748</fpage>
<pub-id pub-id-type="doi">10.1155/2010/458748</pub-id>
<?supplied-pmid 19756160?><pub-id pub-id-type="pmid">19756160</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref222">
                <label>222</label>
                <mixed-citation publication-type="journal"><name><surname>Shin</surname><given-names>JK</given-names></name>, <name><surname>Baek</surname><given-names>JC</given-names></name>, <name><surname>Kang</surname><given-names>MY</given-names></name>, <name><surname>Park</surname><given-names>JK</given-names></name>, <name><surname>Lee</surname><given-names>SA</given-names></name>, <name><surname>Lee</surname><given-names>JH</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Proteomic analysis reveals an elevated expression of heat shock protein 27 in preeclamptic placentas</article-title>. <source>Gynecol Obstet Invest</source>
<volume>71</volume>: <fpage>151</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1159/000315162</pub-id>
<?supplied-pmid 21335933?><pub-id pub-id-type="pmid">21335933</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref223">
                <label>223</label>
                <mixed-citation publication-type="journal"><name><surname>Feng</surname><given-names>YL</given-names></name>, <name><surname>Zhou</surname><given-names>CJ</given-names></name>, <name><surname>Li</surname><given-names>XM</given-names></name>, <name><surname>Liang</surname><given-names>XQ</given-names></name> (<year>2012</year>) <article-title>Alpha-1-antitrypsin acts as a preeclampsia-related protein: a proteomic study</article-title>. <source>Gynecol Obstet Invest</source>
<volume>73</volume>: <fpage>252</fpage>–<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1159/000334820</pub-id>
<?supplied-pmid 22414876?><pub-id pub-id-type="pmid">22414876</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref224">
                <label>224</label>
                <mixed-citation publication-type="journal"><name><surname>Epiney</surname><given-names>M</given-names></name>, <name><surname>Ribaux</surname><given-names>P</given-names></name>, <name><surname>Arboit</surname><given-names>P</given-names></name>, <name><surname>Irion</surname><given-names>O</given-names></name>, <name><surname>Cohen</surname><given-names>M</given-names></name> (<year>2012</year>) <article-title>Comparative analysis of secreted proteins from normal and preeclamptic trophoblastic cells using proteomic approaches</article-title>. <source>J Proteomics</source>
<volume>75</volume>: <fpage>1771</fpage>–<lpage>1777</lpage>. <pub-id pub-id-type="doi">10.1016/j.jprot.2011.12.021</pub-id>
<?supplied-pmid 22234358?><pub-id pub-id-type="pmid">22234358</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref225">
                <label>225</label>
                <mixed-citation publication-type="journal"><name><surname>Baig</surname><given-names>S</given-names></name>, <name><surname>Kothandaraman</surname><given-names>N</given-names></name>, <name><surname>Manikandan</surname><given-names>J</given-names></name>, <name><surname>Rong</surname><given-names>L</given-names></name>, <name><surname>Ee</surname><given-names>KH</given-names></name>, <name><surname>Hill</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Proteomic analysis of human placental syncytiotrophoblast microvesicles in preeclampsia</article-title>. <source>Clin Proteomics</source>
<volume>11</volume>: <fpage>40</fpage>
<pub-id pub-id-type="doi">10.1186/1559-0275-11-40</pub-id>
<?supplied-pmid 25469110?><pub-id pub-id-type="pmid">25469110</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref226">
                <label>226</label>
                <mixed-citation publication-type="journal"><name><surname>Ma</surname><given-names>K</given-names></name>, <name><surname>Jin</surname><given-names>H</given-names></name>, <name><surname>Hu</surname><given-names>R</given-names></name>, <name><surname>Xiong</surname><given-names>Y</given-names></name>, <name><surname>Zhou</surname><given-names>S</given-names></name>, <name><surname>Ting</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>A proteomic analysis of placental trophoblastic cells in preeclampsia-eclampsia</article-title>. <source>Cell Biochem Biophys</source>
<volume>69</volume>: <fpage>247</fpage>–<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1007/s12013-013-9792-4</pub-id>
<?supplied-pmid 24343450?><pub-id pub-id-type="pmid">24343450</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref227">
                <label>227</label>
                <mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>JI</given-names></name>, <name><surname>Kong</surname><given-names>TW</given-names></name>, <name><surname>Kim</surname><given-names>HS</given-names></name>, <name><surname>Kim</surname><given-names>HY</given-names></name> (<year>2015</year>) <article-title>The Proteomic Analysis of Human Placenta with Pre-eclampsia and Normal Pregnancy</article-title>. <source>J Korean Med Sci</source>
<volume>30</volume>: <fpage>770</fpage>–<lpage>778</lpage>. <pub-id pub-id-type="doi">10.3346/jkms.2015.30.6.770</pub-id>
<?supplied-pmid 26028931?><pub-id pub-id-type="pmid">26028931</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref228">
                <label>228</label>
                <mixed-citation publication-type="journal"><name><surname>Mary</surname><given-names>S</given-names></name>, <name><surname>Kulkarni</surname><given-names>MJ</given-names></name>, <name><surname>Malakar</surname><given-names>D</given-names></name>, <name><surname>Joshi</surname><given-names>SR</given-names></name>, <name><surname>Mehendale</surname><given-names>SS</given-names></name>, <name><surname>Giri</surname><given-names>AP</given-names></name> (<year>2017</year>) <article-title>Placental Proteomics Provides Insights into Pathophysiology of Pre-Eclampsia and Predicts Possible Markers in Plasma</article-title>. <source>J Proteome Res</source>
<volume>16</volume>: <fpage>1050</fpage>–<lpage>1060</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.6b00955</pub-id>
<?supplied-pmid 28030762?><pub-id pub-id-type="pmid">28030762</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref229">
                <label>229</label>
                <mixed-citation publication-type="journal"><name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Erez</surname><given-names>O</given-names></name>, <name><surname>Maymon</surname><given-names>E</given-names></name>, <name><surname>Chaemsaithong</surname><given-names>P</given-names></name>, <name><surname>Xu</surname><given-names>Z</given-names></name>, <name><surname>Pacora</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study</article-title>. <source>Am J Obstet Gynecol</source>
<volume>217</volume>: 67.e61-67.e21.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref230">
                <label>230</label>
                <mixed-citation publication-type="journal"><name><surname>Aghaeepour</surname><given-names>N</given-names></name>, <name><surname>Lehallier</surname><given-names>B</given-names></name>, <name><surname>Baca</surname><given-names>Q</given-names></name>, <name><surname>Ganio</surname><given-names>EA</given-names></name>, <name><surname>Wong</surname><given-names>RJ</given-names></name>, <name><surname>Ghaemi</surname><given-names>MS</given-names></name>, <etal>et al</etal> (<year>2018</year>) <article-title>A proteomic clock of human pregnancy</article-title>. <source>Am J Obstet Gynecol</source>
<volume>218</volume>: 347.e341-347.e314.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref231">
                <label>231</label>
                <mixed-citation publication-type="journal"><name><surname>Vettraino</surname><given-names>IM</given-names></name>, <name><surname>Roby</surname><given-names>J</given-names></name>, <name><surname>Tolley</surname><given-names>T</given-names></name>, <name><surname>Parks</surname><given-names>WC</given-names></name> (<year>1996</year>) <article-title>Collagenase-I, stromelysin-I, and matrilysin are expressed within the placenta during multiple stages of human pregnancy</article-title>. <source>Placenta</source>
<volume>17</volume>: <fpage>557</fpage>–<lpage>563</lpage>. <?supplied-pmid 8916203?><pub-id pub-id-type="pmid">8916203</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref232">
                <label>232</label>
                <mixed-citation publication-type="journal"><name><surname>Weiss</surname><given-names>A</given-names></name>, <name><surname>Goldman</surname><given-names>S</given-names></name>, <name><surname>Shalev</surname><given-names>E</given-names></name> (<year>2007</year>) <article-title>The matrix metalloproteinases (MMPS) in the decidua and fetal membranes</article-title>. <source>Front Biosci</source>
<volume>12</volume>: <fpage>649</fpage>–<lpage>659</lpage>. <?supplied-pmid 17127325?><pub-id pub-id-type="pmid">17127325</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref233">
                <label>233</label>
                <mixed-citation publication-type="journal"><name><surname>Reister</surname><given-names>F</given-names></name>, <name><surname>Kingdom</surname><given-names>JC</given-names></name>, <name><surname>Ruck</surname><given-names>P</given-names></name>, <name><surname>Marzusch</surname><given-names>K</given-names></name>, <name><surname>Heyl</surname><given-names>W</given-names></name>, <name><surname>Pauer</surname><given-names>U</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Altered protease expression by periarterial trophoblast cells in severe early-onset preeclampsia with IUGR</article-title>. <source>J Perinat Med</source>
<volume>34</volume>: <fpage>272</fpage>–<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1515/JPM.2006.052</pub-id>
<?supplied-pmid 16856814?><pub-id pub-id-type="pmid">16856814</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref234">
                <label>234</label>
                <mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>SD</given-names></name>, <name><surname>Dunk</surname><given-names>CE</given-names></name>, <name><surname>Aplin</surname><given-names>JD</given-names></name>, <name><surname>Harris</surname><given-names>LK</given-names></name>, <name><surname>Jones</surname><given-names>RL</given-names></name> (<year>2009</year>) <article-title>Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy</article-title>. <source>Am J Pathol</source>
<volume>174</volume>: <fpage>1959</fpage>–<lpage>1971</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2009.080995</pub-id>
<?supplied-pmid 19349361?><pub-id pub-id-type="pmid">19349361</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref235">
                <label>235</label>
                <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Park</surname><given-names>PW</given-names></name>, <name><surname>Wilson</surname><given-names>CL</given-names></name>, <name><surname>Parks</surname><given-names>WC</given-names></name> (<year>2002</year>) <article-title>Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury</article-title>. <source>Cell</source>
<volume>111</volume>: <fpage>635</fpage>–<lpage>646</lpage>. <?supplied-pmid 12464176?><pub-id pub-id-type="pmid">12464176</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref236">
                <label>236</label>
                <mixed-citation publication-type="journal"><name><surname>Manon-Jensen</surname><given-names>T</given-names></name>, <name><surname>Multhaupt</surname><given-names>HA</given-names></name>, <name><surname>Couchman</surname><given-names>JR</given-names></name> (<year>2013</year>) <article-title>Mapping of matrix metalloproteinase cleavage sites on syndecan-1 and syndecan-4 ectodomains</article-title>. <source>FEBS J</source>
<volume>280</volume>: <fpage>2320</fpage>–<lpage>2331</lpage>. <pub-id pub-id-type="doi">10.1111/febs.12174</pub-id>
<?supplied-pmid 23384311?><pub-id pub-id-type="pmid">23384311</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref237">
                <label>237</label>
                <mixed-citation publication-type="journal"><name><surname>Jokimaa</surname><given-names>V</given-names></name>, <name><surname>Inki</surname><given-names>P</given-names></name>, <name><surname>Kujari</surname><given-names>H</given-names></name>, <name><surname>Hirvonen</surname><given-names>O</given-names></name>, <name><surname>Ekholm</surname><given-names>E</given-names></name>, <name><surname>Anttila</surname><given-names>L</given-names></name> (<year>1998</year>) <article-title>Expression of syndecan-1 in human placenta and decidua</article-title>. <source>Placenta</source>
<volume>19</volume>: <fpage>157</fpage>–<lpage>163</lpage>. <?supplied-pmid 9548182?><pub-id pub-id-type="pmid">9548182</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref238">
                <label>238</label>
                <mixed-citation publication-type="journal"><name><surname>Stepp</surname><given-names>MA</given-names></name>, <name><surname>Pal-Ghosh</surname><given-names>S</given-names></name>, <name><surname>Tadvalkar</surname><given-names>G</given-names></name>, <name><surname>Pajoohesh-Ganji</surname><given-names>A</given-names></name> (<year>2015</year>) <article-title>Syndecan-1 and Its Expanding List of Contacts</article-title>. <source>Adv Wound Care (New Rochelle)</source>
<volume>4</volume>: <fpage>235</fpage>–<lpage>249</lpage>.<pub-id pub-id-type="pmid">25945286</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref239">
                <label>239</label>
                <mixed-citation publication-type="journal"><name><surname>Teng</surname><given-names>YH</given-names></name>, <name><surname>Aquino</surname><given-names>RS</given-names></name>, <name><surname>Park</surname><given-names>PW</given-names></name> (<year>2012</year>) <article-title>Molecular functions of syndecan-1 in disease</article-title>. <source>Matrix Biol</source>
<volume>31</volume>: <fpage>3</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2011.10.001</pub-id>
<?supplied-pmid 22033227?><pub-id pub-id-type="pmid">22033227</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref240">
                <label>240</label>
                <mixed-citation publication-type="journal"><name><surname>Gandley</surname><given-names>RE</given-names></name>, <name><surname>Althouse</surname><given-names>A</given-names></name>, <name><surname>Jeyabalan</surname><given-names>A</given-names></name>, <name><surname>Bregand-White</surname><given-names>JM</given-names></name>, <name><surname>McGonigal</surname><given-names>S</given-names></name>, <name><surname>Myerski</surname><given-names>AC</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Low Soluble Syndecan-1 Precedes Preeclampsia</article-title>. <source>PLoS One</source>
<volume>11</volume>: <fpage>e0157608</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0157608</pub-id>
<?supplied-pmid 27299886?><pub-id pub-id-type="pmid">27299886</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref241">
                <label>241</label>
                <mixed-citation publication-type="journal"><name><surname>Alici Davutoglu</surname><given-names>E</given-names></name>, <name><surname>Akkaya Firat</surname><given-names>A</given-names></name>, <name><surname>Ozel</surname><given-names>A</given-names></name>, <name><surname>Yilmaz</surname><given-names>N</given-names></name>, <name><surname>Uzun</surname><given-names>I</given-names></name>, <name><surname>Temel Yuksel</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2018</year>) <article-title>Evaluation of maternal serum hypoxia inducible factor-1alpha, progranulin and syndecan-1 levels in pregnancies with early- and late-onset preeclampsia</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>31</volume>: <fpage>1976</fpage>–<lpage>1982</lpage>. <pub-id pub-id-type="doi">10.1080/14767058.2017.1333098</pub-id>
<?supplied-pmid 28574293?><pub-id pub-id-type="pmid">28574293</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref242">
                <label>242</label>
                <mixed-citation publication-type="journal"><name><surname>Jokimaa</surname><given-names>VI</given-names></name>, <name><surname>Kujari</surname><given-names>HP</given-names></name>, <name><surname>Ekholm</surname><given-names>EM</given-names></name>, <name><surname>Inki</surname><given-names>PL</given-names></name>, <name><surname>Anttila</surname><given-names>L</given-names></name> (<year>2000</year>) <article-title>Placental expression of syndecan 1 is diminished in preeclampsia</article-title>. <source>Am J Obstet Gynecol</source>
<volume>183</volume>: <fpage>1495</fpage>–<lpage>1498</lpage>. <pub-id pub-id-type="doi">10.1067/mob.2000.107320</pub-id>
<?supplied-pmid 11120517?><pub-id pub-id-type="pmid">11120517</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref243">
                <label>243</label>
                <mixed-citation publication-type="journal"><name><surname>Szabo</surname><given-names>S</given-names></name>, <name><surname>Xu</surname><given-names>Y</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Fule</surname><given-names>T</given-names></name>, <name><surname>Karaszi</surname><given-names>K</given-names></name>, <name><surname>Bhatti</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome</article-title>. <source>Virchows Arch</source>
<volume>463</volume>: <fpage>445</fpage>–<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1007/s00428-013-1426-0</pub-id>
<?supplied-pmid 23807541?><pub-id pub-id-type="pmid">23807541</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref244">
                <label>244</label>
                <mixed-citation publication-type="journal"><name><surname>Halpert</surname><given-names>I</given-names></name>, <name><surname>Sires</surname><given-names>UI</given-names></name>, <name><surname>Roby</surname><given-names>JD</given-names></name>, <name><surname>Potter-Perigo</surname><given-names>S</given-names></name>, <name><surname>Wight</surname><given-names>TN</given-names></name>, <name><surname>Shapiro</surname><given-names>SD</given-names></name>, <etal>et al</etal> (<year>1996</year>) <article-title>Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>93</volume>: <fpage>9748</fpage>–<lpage>9753</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.93.18.9748</pub-id>
<?supplied-pmid 8790402?><pub-id pub-id-type="pmid">8790402</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref245">
                <label>245</label>
                <mixed-citation publication-type="journal"><name><surname>Katabuchi</surname><given-names>H</given-names></name>, <name><surname>Yih</surname><given-names>S</given-names></name>, <name><surname>Ohba</surname><given-names>T</given-names></name>, <name><surname>Matsui</surname><given-names>K</given-names></name>, <name><surname>Takahashi</surname><given-names>K</given-names></name>, <name><surname>Takeya</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Characterization of macrophages in the decidual atherotic spiral artery with special reference to the cytology of foam cells</article-title>. <source>Med Electron Microsc</source>
<volume>36</volume>: <fpage>253</fpage>–<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1007/s00795-003-0223-2</pub-id>
<?supplied-pmid 16228658?><pub-id pub-id-type="pmid">16228658</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref246">
                <label>246</label>
                <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>YM</given-names></name>, <name><surname>Chaemsaithong</surname><given-names>P</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Shaman</surname><given-names>M</given-names></name>, <name><surname>Kim</surname><given-names>CJ</given-names></name>, <name><surname>Kim</surname><given-names>JS</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small-for-gestational age, fetal death and midtrimester spontaneous abortion</article-title>. <source>J Matern Fetal Neonatal Med</source>
<volume>28</volume>: <fpage>2001</fpage>–<lpage>2009</lpage>. <pub-id pub-id-type="doi">10.3109/14767058.2014.976198</pub-id>
<?supplied-pmid 25308204?><pub-id pub-id-type="pmid">25308204</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref247">
                <label>247</label>
                <mixed-citation publication-type="journal"><name><surname>Elangbam</surname><given-names>CS</given-names></name>, <name><surname>Qualls</surname><given-names>CW</given-names><suffix>Jr.</suffix></name>, <name><surname>Dahlgren</surname><given-names>RR</given-names></name> (<year>1997</year>) <article-title>Cell adhesion molecules—update</article-title>. <source>Vet Pathol</source>
<volume>34</volume>: <fpage>61</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1177/030098589703400113</pub-id>
<?supplied-pmid 9150551?><pub-id pub-id-type="pmid">9150551</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref248">
                <label>248</label>
                <mixed-citation publication-type="journal"><name><surname>Tomer</surname><given-names>A</given-names></name> (<year>2004</year>) <article-title>Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry</article-title>. <source>J Biol Regul Homeost Agents</source>
<volume>18</volume>: <fpage>172</fpage>–<lpage>177</lpage>. <?supplied-pmid 15471223?><pub-id pub-id-type="pmid">15471223</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref249">
                <label>249</label>
                <mixed-citation publication-type="journal"><name><surname>Takagi</surname><given-names>J</given-names></name>, <name><surname>Petre</surname><given-names>BM</given-names></name>, <name><surname>Walz</surname><given-names>T</given-names></name>, <name><surname>Springer</surname><given-names>TA</given-names></name> (<year>2002</year>) <article-title>Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling</article-title>. <source>Cell</source>
<volume>110</volume>: <fpage>599</fpage>–<lpage>511</lpage>. <?supplied-pmid 12230977?><pub-id pub-id-type="pmid">12230977</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref250">
                <label>250</label>
                <mixed-citation publication-type="journal"><name><surname>Pytela</surname><given-names>R</given-names></name>, <name><surname>Pierschbacher</surname><given-names>MD</given-names></name>, <name><surname>Ginsberg</surname><given-names>MH</given-names></name>, <name><surname>Plow</surname><given-names>EF</given-names></name>, <name><surname>Ruoslahti</surname><given-names>E</given-names></name> (<year>1986</year>) <article-title>Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp—specific adhesion receptors</article-title>. <source>Science</source>
<volume>231</volume>: <fpage>1559</fpage>–<lpage>1562</lpage>. <?supplied-pmid 2420006?><pub-id pub-id-type="pmid">2420006</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref251">
                <label>251</label>
                <mixed-citation publication-type="journal"><name><surname>Janes</surname><given-names>SL</given-names></name>, <name><surname>Goodall</surname><given-names>AH</given-names></name> (<year>1994</year>) <article-title>Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy</article-title>. <source>Clin Sci (Lond)</source>
<volume>86</volume>: <fpage>731</fpage>–<lpage>739</lpage>.<pub-id pub-id-type="pmid">8062509</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref252">
                <label>252</label>
                <mixed-citation publication-type="journal"><name><surname>Hodivala-Dilke</surname><given-names>KM</given-names></name>, <name><surname>McHugh</surname><given-names>KP</given-names></name>, <name><surname>Tsakiris</surname><given-names>DA</given-names></name>, <name><surname>Rayburn</surname><given-names>H</given-names></name>, <name><surname>Crowley</surname><given-names>D</given-names></name>, <name><surname>Ullman-Cullere</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival</article-title>. <source>J Clin Invest</source>
<volume>103</volume>: <fpage>229</fpage>–<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1172/JCI5487</pub-id>
<?supplied-pmid 9916135?><pub-id pub-id-type="pmid">9916135</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref253">
                <label>253</label>
                <mixed-citation publication-type="journal"><name><surname>Tronik-Le Roux</surname><given-names>D</given-names></name>, <name><surname>Roullot</surname><given-names>V</given-names></name>, <name><surname>Poujol</surname><given-names>C</given-names></name>, <name><surname>Kortulewski</surname><given-names>T</given-names></name>, <name><surname>Nurden</surname><given-names>P</given-names></name>, <name><surname>Marguerie</surname><given-names>G</given-names></name> (<year>2000</year>) <article-title>Thrombasthenic mice generated by replacement of the integrin alpha(IIb) gene: demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitment</article-title>. <source>Blood</source>
<volume>96</volume>: <fpage>1399</fpage>–<lpage>1408</lpage>. <?supplied-pmid 10942384?><pub-id pub-id-type="pmid">10942384</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref254">
                <label>254</label>
                <mixed-citation publication-type="journal"><name><surname>McKenzie</surname><given-names>ME</given-names></name>, <name><surname>Malinin</surname><given-names>AI</given-names></name>, <name><surname>Bell</surname><given-names>CR</given-names></name>, <name><surname>Dzhanashvili</surname><given-names>A</given-names></name>, <name><surname>Horowitz</surname><given-names>ED</given-names></name>, <name><surname>Oshrine</surname><given-names>BR</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets</article-title>. <source>Blood Coagul Fibrinolysis</source>
<volume>14</volume>: <fpage>249</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1097/01.mbc.0000046182.72384.ab</pub-id>
<?supplied-pmid 12695747?><pub-id pub-id-type="pmid">12695747</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref255">
                <label>255</label>
                <mixed-citation publication-type="journal"><name><surname>LeFevre</surname><given-names>ML</given-names></name> (<year>2014</year>) <article-title>Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement</article-title>. <source>Ann Intern Med</source>
<volume>161</volume>: <fpage>819</fpage>–<lpage>826</lpage>. <pub-id pub-id-type="doi">10.7326/M14-1884</pub-id>
<?supplied-pmid 25200125?><pub-id pub-id-type="pmid">25200125</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref256">
                <label>256</label>
                <mixed-citation publication-type="other">ACOG American College of Obstetricians and Gynecologists: Practice advisory on low-dose aspirin and prevention of preeclampsia: updated recommendations. Washington, DC: 2016. <ext-link ext-link-type="uri" xlink:href="https://www.acog.org/About-ACOG/News-Room/Practice-Advisories/Practice-Advisory-Low-Dose-Aspirin-and-Prevention-of-Preeclampsia-Updated-Recommendations">https://www.acog.org/About-ACOG/News-Room/Practice-Advisories/Practice-Advisory-Low-Dose-Aspirin-and-Prevention-of-Preeclampsia-Updated-Recommendations</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref257">
                <label>257</label>
                <mixed-citation publication-type="journal"><name><surname>Seidler</surname><given-names>AL</given-names></name>, <name><surname>Askie</surname><given-names>L</given-names></name>, <name><surname>Ray</surname><given-names>JG</given-names></name> (<year>2018</year>) <article-title>Optimal aspirin dosing for preeclampsia prevention</article-title>. <source>Am J Obstet Gynecol</source>
<volume>219</volume>: <fpage>117</fpage>–<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajog.2018.03.018</pub-id>
<?supplied-pmid 29588190?><pub-id pub-id-type="pmid">29588190</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref258">
                <label>258</label>
                <mixed-citation publication-type="journal"><name><surname>Than</surname><given-names>N</given-names></name>, <name><surname>Romero</surname><given-names>R</given-names></name>, <name><surname>Tarca</surname><given-names>A</given-names></name>, <name><surname>Kekesi</surname><given-names>K</given-names></name>, <name><surname>Xu</surname><given-names>Y</given-names></name>, <name><surname>Juhasz</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Systems biology identifies key molecular networks and hub factors in placental pathways of preeclampsia</article-title>. <source>Reproductive Sciences</source>, <volume>24</volume>(<issue>1 Suppl</issue>), <fpage>278A</fpage>.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref259">
                <label>259</label>
                <mixed-citation publication-type="journal"><name><surname>Spencer</surname><given-names>K</given-names></name>, <name><surname>Macri</surname><given-names>JN</given-names></name>, <name><surname>Aitken</surname><given-names>DA</given-names></name>, <name><surname>Connor</surname><given-names>JM</given-names></name> (<year>1992</year>) <article-title>Free beta-hCG as first-trimester marker for fetal trisomy</article-title>. <source>Lancet</source>
<volume>339</volume>: <fpage>1480</fpage>.</mixed-citation>
              </ref>
              <ref id="pone.0217273.ref260">
                <label>260</label>
                <mixed-citation publication-type="journal"><name><surname>Spencer</surname><given-names>K</given-names></name> (<year>2000</year>) <article-title>Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome</article-title>. <source>Prenat Diagn</source>
<volume>20</volume>: <fpage>652</fpage>–<lpage>656</lpage>. <?supplied-pmid 10951476?><pub-id pub-id-type="pmid">10951476</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref261">
                <label>261</label>
                <mixed-citation publication-type="journal"><name><surname>Kagan</surname><given-names>KO</given-names></name>, <name><surname>Wright</surname><given-names>D</given-names></name>, <name><surname>Spencer</surname><given-names>K</given-names></name>, <name><surname>Molina</surname><given-names>FS</given-names></name>, <name><surname>Nicolaides</surname><given-names>KH</given-names></name> (<year>2008</year>) <article-title>First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics</article-title>. <source>Ultrasound Obstet Gynecol</source>
<volume>31</volume>: <fpage>493</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1002/uog.5332</pub-id>
<?supplied-pmid 18432600?><pub-id pub-id-type="pmid">18432600</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0217273.ref262">
                <label>262</label>
                <mixed-citation publication-type="journal"><name><surname>Colosi</surname><given-names>E</given-names></name>, <name><surname>D'Ambrosio</surname><given-names>V</given-names></name>, <name><surname>Periti</surname><given-names>E</given-names></name> (<year>2016</year>) <article-title>First trimester contingent screening for trisomies 21,18,13: is this model cost efficient and feasible in public health system?</article-title>
<source>J Matern Fetal Neonatal Med</source>: <fpage>1</fpage>–<lpage>13</lpage>.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
